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General introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part of this chapter is based on: “Alzheimer’s Disease: Patophysiology 
and Applications of Magnetic Nanoparticles as MRI Theranostic Agents”. 
Amiri H, Saeidi K, Borhani P, Manafirad A, Ghavami M, Zerbi V.  
ACS Chemical Neuroscience, 2013 Sep 11. 
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General introduction 
Alzheimer’s disease (AD) is named after the German psychiatrist and 
neuropathologist Alois Alzheimer, who described his first case, a 55 years old 
female patient (i.e. Auguste Deter), in 1906. The pathology of Auguste was 
characterized by deteriorated memory, speaking, physical, and social abilities. 
After her decease, the autopsy revealed brain atrophy, atherosclerosis in larger 
cerebral vessels, neuronal loss and numerous small foci distributed over the 
entire cortex, which were perceivable even without staining. It took over 70 
years to reveal that those foci consist of aggregates of extracellular loads of small 
peptides called amyloid-β (Aβ), that are considered today one of the hallmarks of 
the disease (figure 1) (Masters, et al., 1985).  
Over more than a century, AD transformed from what was thought to be a rare, 
sporadic, and non-inherited disease into one of the major socioeconomic 
problems of our time, and the most common form of dementia in elderly (Wimo, 
et al., 2006). According to the World Alzheimer Report, in 2010 approximately 
35.6 million people worldwide suffered from AD. Mainly due to the increased 
aging of the population, this number is expected to increase to over 100 million 
people by 2050, corresponding to 1 in 85 persons (Clegg, et al., 2001,Zheng and 
Koo, 2006). To date, no treatments are available to prevent the progression of 
AD. Several different pharmacological agents only ameliorate or provide 
temporary alleviation of the symptoms (Selkoe and Schenk, 2003). 
 
Clinical aspects and etiology of the Alzheimer’s disease 
AD affects a person’s ability to carry out daily activities and is characterized by 
gradual memory loss, anomia (i.e. difficulties with word finding), apraxia (i.e. 
difficulties with complex movements), confusion, and general withdrawal. As the 
disease progresses, severe cognitive impairment, impaired executive functions 
and personality changes worsen the lifestyle condition. Patients in more 
advanced stages become very susceptible to infections, pneumonia, and 
decubitus ulcers. Life expectancy after a diagnosis of AD is usually between 7 and 
10 years (Helzner, et al., 2008,Xie, et al., 2008). AD can be divided into two major 
forms termed early onset or presenile AD, and late onset or sporadic AD. Patients 
are classified as early onset AD when the first symptoms of AD occur at an age 
earlier than 65 (see: http://www.alz.org/downloads/facts_figures_2012.pdf). 
Early onset AD accounts for 5% of all AD cases worldwide and is caused by 
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Figure 1. The Aβ is generated by sequential cleavage of the transmembrane amyloid 
precursor protein (APP), via groups of enzymes named α-, β- and γ-secretases (Allinson, et 
al., 2003,Van Dam and De Deyn, 2006). When the APP protein is cleaved by the α-
secretase, a soluble amino (N)-terminal ectodomain (sAPPα) and a C-terminal fragment 
(CTF) are released. Thereby the formation of Aβ is prohibited, because the cleaving occurs 
inside the Aβ region (Wisniewski T, 2010). This is known as the “non-amyloidogenic” 
pathway. The “amyloidogenic” pathway generates Aβ when the precursor protein is 
cleaved by a β-secretase (BACE: β-site APP cleaving enzyme) at the N-terminal domain, 
releasing a soluble N-terminal fragment (sAPPb) and the remaining C-terminal part (b-
CTF). The CTF and b-CTF are then cleaved in the transmembrane domain by the γ-
secretase to release either extracellular p2 or Aβ respectively. Cleavage by γ-secretase 
takes place at position 40 or 42 of the protein, which generates amyloid-β 40 (Aβ40) or 
amyloid-β 42 (Aβ42), respectively. Approximately 90% of the residues consist of Aβ40. 
However, the Aβ42 aggregates more readily. For this reason, Aβ42 is the most abundant 
isoform in amyloid plaques. 
 
 
genetic mutations, as the persons affected generally have a positive family 
history (Selkoe and Schenk, 2003). Several mutations in the transmembrane 
amyloid precursor protein (APP) on chromosome 21, in presenilin 1 (PS1) on 
chromosome 12 and presenilin 2 (PS2) on chromosome 1 have shown to be 
autosomal-dominant inheritable (Rademakers, et al., 2003). Mutations in PS1 
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and PS2 lead to an increased production of the strong self-aggregating Aβ42 
peptide by elevating the γ-secretase activity. This causes the most aggressive 
form of AD with an early onset that can occur even earlier than age of 40. 
However, mutations in APP, PS1 and PS2 have been found to cause less than 30% 
of the early onset AD. So far little is known about the other genetic disorders that 
may be responsible for the remaining cases of early onset (Tanzi and Bertram, 
2001).  
Patients with late onset AD account for the remaining 95% of AD cases. The exact 
causes of late onset AD are still elusive. Despite that aging is known as the most 
important risk factor for AD (Mayeux, 2003), a large number of risk factors for 
the development of AD has been identified; these include smoking, dietary fat 
intake, stroke, hypertension, heart disease, hypercholesterolemia, and diabetes 
mellitus (table 1) (Kivipelto, et al., 2001,Van Duijn, et al., 1994). Interestingly, 
most of these factors are linked to pathologies of the vascular system. The only 
gene that has currently been identified as a risk factor for the late onset AD is the 
ε4 allele of the cholesterol transport protein, apolipoprotein E (apoE) (Corder, et 
al., 1993,Strittmatter, et al., 1993). ApoE is a 34-kDa cholesterol transport 
glycoprotein that exists in three isoforms: apoE -ε2, -ε3 and -ε4, which differ 
between each other by one or two amino acid residues 112 and 158 (Zannis, et 
al., 1982). This difference strongly affects the conformation and the structure of 
apoE and influences its ability to bind lipids, receptors and amyloid-β (Aβ) 
(Frieden and Garai, 2012). 
 
Alzheimer’s disease risk factors  
Ageing 
APOE ε4 genotype 
Hypertension 
Congestive heart failure 
Atrial fibrillation 
Hyperhomocysteinemia 
Atherosclerosis 
Smoking 
Alcoholism 
High intake of saturated fat 
Diabetes mellitus 
Stroke 
Head injury 
Menopause 
Lower education 
Depression 
Sedentary lifestyle 
Overweight 
White matter lesions 
Table 1. Risk factors for Alzheimer’s disease 
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The highest expression of apoE is found in the liver, followed by the brain where 
it is mainly expressed by astrocytes and to a certain extent by microglia (Grehan, 
et al., 2001,Pitas RE, 1987). Neurons are also capable of producing apoE under 
certain conditions, but much less than astrocytes (Xu, et al., 1999,Xu, et al., 
2006). Extensive epidemiological studies demonstrated that the inheritance of 
one apoE-ε4 allele is associated with an increased risk of developing AD by 2-5 
fold and the inheritance of both ε4 alleles elevates this risk by 4-10 fold 
compared to expression of the most common isoform ε3 (Mahley and Rall, 
2000). The ε4 allele is also associated with earlier onset and with an increased 
conversion from mild cognitive impairment (MCI) to AD (Blacker, et al., 
1997,Tierney, et al., 1996). The inheritance of the ε2 allele, on the contrary, 
appears to protect against AD pathogenesis (Corder, et al., 1994).  Furthermore, 
apoE- ε4 carriers show significantly higher levels of Aβ, even in the absence of 
neurological symptoms. The apoE-ε4 isoform is also strongly associated with the 
presence of Aβ in the vascular walls and the occurrence of cerebral amyloid 
angiopathy (CAA) (Kinnecom, et al., 2007). The mechanisms by which the apoE-
ε4 promotes the disease have been recently reviewed and classified as both gain 
of toxic functions and loss of neuronal protection (Liu, et al., 2013). 
 
Amyloid cascade hypothesis 
To date, many theories about the causes of AD have been postulated; among 
them, the “amyloid cascade hypothesis” and the “vascular hypothesis” are the 
most widely accepted. As described above, genetic risk factors for AD include 
mutations in genes expressing APP, PS1, PS2, and ApoE4. Most of these 
mutations result in an elevated Aβ peptide production or failure of Aβ clearance 
mechanisms, leading to an abnormal accumulation of Aβ in the brain. 
Furthermore, patients with Down syndrome develop AD early in life and show 
overproduction of Aβ and plaque deposition in the brain before other AD lesions 
(Lemere, et al., 1996). Based on these observations, the accumulation of Aβ in 
the brain was more than 20 years ago described by John Hardy and David Allsop 
as the key event in the pathogenesis of AD (Hardy and Allsop, 1991). The so 
called “amyloid cascade hypothesis” suggested that the accumulation and 
aggregation of Aβ, specifically Aβ42, would trigger further pathological events that 
causes AD. However, later studies revealed that the amount of fibrillar Aβ 
deposits in AD brain poorly correlated with the severity of cognitive impairment 
(Dickson, et al., 1995,Terry, et al., 1991).  
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Figure 2. Revision of the amyloid hypothesis. Amyloid-β (Aβ) monomers are formed by β- 
and γ-secretase cleavage of the amyloid precursor protein (APP). These monomers 
accumulate in the extracellular space and trigger several processes associated with AD 
pathophysiology. Aβ monomers can initiate the formation of fibrillar Aβ aggregates, 
possibly by an initial aggregation in the form of Aβ dimers, or non-fibrillar Aβ aggregates, 
by an initial aggregation in the form of Aβ trimers. Accumulation of Aβ also results in an 
activation of microglial cell, which increase the production of cytokines that can damage 
neuronal health when expressed in high concentrations. Furthermore, Aβ can aggregate 
in the cerebral blood vessels causing cerebral amyloid angiopathy (CAA), impairing 
neurovascular function and decreasing oxygen and nutrients supply to brain cells. 
 
 
Instead, non-fibrillar oligomeric Aβ species were found to be highly neurotoxic 
and their levels much better correlated with severity of disease and synaptic loss 
(Lue, et al., 1999,McLean, et al., 1999). These findings formed the basis for a 
revision of the amyloid hypothesis by Hardly and Selkoe, pointing towards the 
oligomeric Aβ species as the initiator culprits of AD rather than Aβ plaques 
(Hardy and Selkoe, 2002) (see figure 2). Reports confirmed that soluble Aβ 
oligomers inhibit neuronal function (Walsh and Selkoe, 2007), induce dendritic 
spine loss (tShankar, et al., 2007), and alter neuronal plasticity (Li, et al., 2009). A 
recent study from Selkoe and colleagues reported that Aβ dimers could trigger 
tau hyperphosphorylation and tau-dependent cytoskeletal microtubule 
abnormalities in primary neurons (Jin, et al., 2011). To date, the revisited amyloid 
cascade hypothesis is still holding up fairly well. Upcoming methodologies for the 
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isolation and identification of proprieties for specific Aβ oligomers (dimers, 
trimers and high-molecular weight oligomers) will possibly bring the amyloid 
cascade hypothesis at another level of complexity in the near future (Larson and 
Lesne, 2012).  
 
Vascular hypothesis  
Although the amyloid hypothesis provides a good explanation of how and why 
amyloid species are formed in the brain, several flaws remain to explain the 
development of AD. Most importantly, there is still no solid prove supporting the 
neurotoxic properties of insoluble Aβ in vivo. Secondly, there is not a general 
agreement that Aβ plaques are the cause of neural impairment, rather than the 
result of sick neurons (de la Torre, 2004). In addition, amyloid deposition does 
not correlate well with neuron loss (Schmitz, et al., 2004) and presence of Aβ 
plaques is also seen in non-demented subjects (Arriagada, et al., 1992,Davis, et 
al., 1999). Finally, different treatment approaches that target amyloid clearance 
or plaque formation have not yet provided any significant therapeutic 
improvement (Kurz and Perneczky, 2011). 
 The first description of a possible vascular, instead of an amyloid cause of AD, 
was reported in 1993 (de la Torre and Mussivand, 1993). Since then, increasing 
evidence from epidemiological, pharmacological and neuroimaging studies, has 
suggested that vascular disorders with chronic cerebral hypoperfusion might 
trigger the cascade of AD-related metabolic, anatomical and cognitive 
impairments (de la Torre, 2002,de la Torre, 2004,Grammas, 2000,Iadecola, 
2004,Kalaria, 2002). In 2000, de la Torre hypothesized that aging in combination 
with decreased cerebral perfusion could lead to oxidative stress and decreased 
energy metabolism, followed by increased glutamate production (de la Torre, 
2000b). These events may directly contribute to progressive synaptic loss, 
increased Aβ and NFTs production, increased brain inflammation, brain tissue 
atrophy, neurodegeneration and cognitive decline (de la Torre, 2000a,de la 
Torre, 2000c,de la Torre and Stefano, 2000). Recent studies further suggest that 
impaired brain vasculature plays a causative role in AD pathology progression 
(Altman and Rutledge, 2010,Zlokovic, 2011). 
 
Diagnosis of AD: the use of biomarkers 
In 2011, the National Institute on Aging (NIA) and the Alzheimer’s Association 
recommended new diagnostic criteria and guidelines for AD (Jack, et al., 2011). 
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According to these criteria and guidelines, three stages of the disease are 
identified: preclinical AD, MCI due to AD and dementia due to AD. Importantly, it 
is proposed that new technologies have the potential to identify brain changes 
related to Alzheimer that occur before clinical symptoms are evident.  
To establish a diagnosis of dementia, a physician must determine the cause of 
the dementia-like symptoms, based on the criteria given in the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (Cooper, 1995). 
The diagnosis of AD is often associated with a low score in cognitive and memory 
tests, such as the mini-mental state examination (Folstein, et al., 1975), the 
clock-drawing test (Berger, et al., 2008), and other sensory-related tests (e.g. the 
odor identification test (Wilson, et al., 2006)). Once the cognitive deficits have 
been objectively demonstrated, biomarker evaluation that accurately indicates 
the presence or absence of disease, or the risk of later developing a disease is 
demanded. The new criteria and guidelines identify two biomarker categories: (1) 
biomarkers showing the level of beta-amyloid accumulation in the brain and (2) 
biomarkers showing that brain is injured or actually degenerating. Routinely, 
these AD biomarkers are identified based on magnetic resonance imaging (MRI) 
and positron emission tomography (PET).  
The presence of Aβ plaques in the brain can be readily revealed in-vivo with the 
use of a PET-imaging agent that binds amyloidosis deposits, known as Pittsburgh 
Compound-B (PiB) (Klunk, et al., 2004). PiB has been used to follow the evolution 
of amyloidosis during the progression of the disease, and to study its relationship 
with cognitive decline and possible treatments (Pike, et al., 2007,Rinne, et al., 
2010). Other emerging imaging techniques, like MR T2
* susceptibility changes, 
showed good co-localization with Aβ plaques in-vivo, yet improvements in 
shortening the acquisition time are required (Baltes, et al., 2011). Despite the 
advantages of direct plaque imaging, these methods present several limitations; 
for example, they may display Aβ also in the brain of non-demented subjects 
(Mintun, et al., 2006) and they don’t readily detect soluble oligomeric forms of 
Aβ, which are considered highly pathogenic (Selkoe, 2008). For those reasons, 
complementary methods for the detection of other biomarkers, which better 
describes structural and functional changes related to AD, are often required by 
physicians.  
Compared to other methodologies, MRI is very versatile and offers several tools 
to detect AD biomarkers, with the advantages of being non-invasive, highly 
informative on the disease status and easily accessible by most of the patients. In 
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MRI, protons in water, which are abundantly present in the body, generate a 
signal in the presence of a magnetic field. This signal is used to reconstruct 
images. Because it is sensitive to various local magnetic and other conditions, a 
large range of different anatomical and functional contrasts can be recorded for 
these images. The details of MRI have been described in several handbooks 
[Bernstein, et al., 2004,Haacke, et al., 1999). The most promising MR imaging 
tools and their applications in the field of AD research and clinical routine are 
discussed more in detail in the next section. 
 
MR biomarkers for detection of AD progression 
A recent study from the US Alzheimer’s Association predicted that by delaying 
the onset of AD by just 5 years, it would bring a reduction of the related costs for 
the society of approximately 50% 
(http://www.alz.org/documents_custom/trajectory.pdf). Such an ambitious plan 
requires further research to assess novel therapeutic strategies combined with 
an early diagnosis of the disease. As previously mentioned, MRI offers a range of 
advanced neuroimaging tools that might not only improve diagnostic accuracy 
but also accelerate treatment discovery. These novel neuroimaging techniques 
and scanning methods could eventually be used to detect neurodegeneration 
before clinical symptoms are obvious, so that physicians can identify treatment 
candidates for future preventive therapies. Traditionally, MR neuroimaging 
techniques have been categorised as either structural or functional, according to 
the primary information they provide. 
 
Brain atrophy 
The most obvious age-related bran change is atrophy, which occurs during 
normal aging, but can drastically accelerate in specific areas in case of dementia, 
including AD, mainly due to synaptic and neuronal loss (Josephs, et al., 2008). In 
patients with AD, atrophy is particularly evident in the medial temporal area, 
including the hippocampus and the entorhinal cortex, together with an 
enlargement of the ventricles (Neary, et al., 2005). Standard structural MRI 
approaches, commonly by recording high-resolution T1-weighted or T2-weighted 
images, can reveal these changes by comparing brain scans taken over the years 
from the same patient. Several studies reported a high correlation between rate 
of atrophy in the entorhinal cortex and hippocampus and an increased risk of 
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developing AD (Apostolova, et al., 2006,Stoub, et al., 2005). However, these 
changes might not be specific to AD and occur also in other dementia disorders.  
 
Water diffusion imaging 
A more advanced imaging approach to identify microstructural differences 
between normal subjects and AD patients relies on the measure of directionality 
(and anisotropy) of water diffusion. Diffusion tensor MR imaging (DT-MRI) 
models the degree of water diffusion measured in multiple orientations into a 
diffusion ellipsoid. Because in the brain water diffusion is restricted by cell 
membranes, axonal bundles and other organelles, the size and the shape of the 
diffusion ellipsoid reflect local fibre orientation, neuronal organization and tissue 
architecture integrity. When the ellipsoid is reconstructed in every voxel of 
interest, DT-MRI provides unique information of neuronal connectivity and 
microstructural integrity in white matter (WM) and, in some extent, also in grey 
matter (GM) (Basser, et al., 1994). 
With advances in acquisition and analysis methods, DT-MRI is gaining acceptance 
as preferred technique for assessing structural integrity in aging and dementia. In 
AD patients, changes in DT-MRI parameters are particularly consistent, showing 
reduced degree of diffusion anisotropy (or fractional anisotropy, FA) in white 
matter tracts and increased mean diffusivity (MD) in grey matter areas, 
specifically in the hippocampus (Clerx, et al., 2012). Most of these studies 
suggested that such differences in AD brains reflect myelin degradation and 
axonal degeneration in WM, and neuronal loss in GM. Interestingly, increased 
MD in GM predicted the conversion from MCI to AD better than hippocampal 
volumetric changes in two independent studies (Fellgiebel, et al., 2006). DT-MRI 
has also been reported to differentiate between AD patients from MCI patients 
(Zhang, et al., 2007) and from those with dementia with Lewis bodies (Firbank, et 
al., 2007). Finally, diffusion-related changes were also shown in pre-symptomatic 
carriers of AD mutation (Ringman, et al., 2007). Taken together, these findings 
point out the advantage of DT-MRI in providing complementary information to 
the macrostructural changes by conventional MRI, for early diagnosis and disease 
characterization. However, more studies are needed to specify the biological 
underpinnings of diffusion changes, in relationship with the development of 
pathology in AD brains.  
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Perfusion imaging 
As explained by the “vascular hypothesis”, the presence of cerebrovascular 
pathologies, such as brain hypoperfusion, might contribute to the initial 
expression of AD (Altman and Rutledge, 2010,Zlokovic, 2011). The early 
detection of cerebrovascular pathology in patients with suspected AD is 
therefore of primary importance for the initiation of preventive strategies. 
Deficits in the cerebrovascular system can be readily assessed in vivo with MRI. 
Two important parameters measurable with MRI are cerebral blood volume 
(CBV), which describes the cerebrovascular integrity and blood reserves, and 
cerebral blood flow (CBF), to measure brain perfusion; both these parameters 
are correlated with neural tissue health and function. In most of the cases, CBV 
and CBF are measured either with dynamic susceptibility contrast perfusion MRI 
(DSC-MRI), which require the intravenous injection of a contrast agent (eg. 
gadolinium compounds), or by using arterial spin labeling (ASL) techniques, 
whereby arterial blood is magnetically tagged before it enters the tissue of 
interest (Calamante, et al., 1999). These techniques have been widely used to 
study hemodynamic alterations and cerebral hypoperfusion in AD patients 
(Alsop, et al., 2000,Johnson, et al., 2005,Ruitenberg, et al., 2005,Schreiber, et al., 
2005) and have served as diagnostic tool to distinguish AD from other forms of 
dementia (Du, et al., 2006). Improving the knowledge and characterizing the 
vascular changes in relation with other AD biomarkers is an essential challenge 
for future research to clarify the role of vascular impairments in the development 
of the disease. 
 
Functional MRI 
Neural activity is associated with a local transient increase in blood flow (Roy and 
Sherrington, 1890). The resulting changes in deoxyhemoglobin-hemoglobin ratio 
modulate the magnetic proprieties of the blood, which can be detected with 
spin-echo or gradient-echo MRI sequences. By measuring the fluctuations in 
blood oxygen content (often called the blood oxygenation level dependent, or 
BOLD signal), either during a specific designed task that the patient needs to 
perform in the MR scanner, or at rest, maps of neural activity can be assessed 
(Kwong, et al., 1992,Ogawa, et al., 1992). The temporal correlation of the BOLD 
fluctuations between different brain regions is often defined as functional 
connectivity. 
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The applications of functional MRI (fMRI) are enormous, from basic research on 
the functions of the human brain, to clinical assessment of brain and behaviour 
pathologies (Minati, et al., 2007). In particular, the examination of functional 
connectivity has generated a big deal of interest among neuroscientists, as it 
provides new insights into the reorganization of neural processes during aging 
and diseases (Damoiseaux, et al., 2008,van den Heuvel, et al., 2009). A large 
number of fMRI studies have revealed that the patterns of activation or 
deactivation are changed in AD patients during the performance of tasks 
(Buckner, et al., 2000,Gould, et al., 2005). Interestingly, many deactivated brain 
regions appear to be largely task independent (Raichle and Mintun, 2006). 
Consequently, resting-state fMRI, in which no stimulation and responses are 
required, has attracted considerable attention of researchers in recent years. 
With this method, the spontaneous neuronal activity and resting functional 
connectivity can be measured (Fox and Raichle, 2007). Resting-state fMRI studies 
in AD patients have revealed a decreased activity in the posterior cingulate 
cortex and hippocampus, suggesting a disrupted connectivity between these two 
regions (Greicius, et al., 2004). Similar evidence of disrupted functional 
connectivity between hippocampus and several other regions, such as the medial 
prefrontal cortex and the ventral anterior cingulate cortex, were also shown in 
AD patients (Allen, et al., 2007). Furthermore, significant differences in resting 
brain activity have been reported comparing cognitively normal carriers of the 
APOE-ε4 and APOE-ε3 alleles (Bookheimer, et al., 2000)-104]. Despite the 
numerous and consisting evidence that relate AD (or AD risk factors) to region-
specific decreased neural activity and impaired functions, the exact meaning of 
resting-state fMRI changes is still a point of discussion. An issue needing further 
exploration is the degree to which hemodynamic response alter fMRI 
fluctuations, in particular when pathologies that affect the neurovascular 
coupling are examined (Buckner, et al., 2000). 
 
Magnetic resonance spectroscopy (MRS) 
MR spectroscopy (MRS) is another technique that has become well established 
as a tool to study biological systems in vivo and in vitro. The physical basis of MRS 
is the chemical shift effect, which arises because nuclei located in different 
molecular environments (e.g. different molecules or different locations within a 
molecule) sense slightly different magnetic fields, causing them to precess at 
different rates. In vivo MRS provides plots (or spectra) of signal intensity, which is 
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proportional to concentration, versus precession rate shift with respect to a 
reference, expressed in parts per million (ppm). Molecular groups generate 
specific resonance patterns in the spectra, either as single peaks, doublets or 
more complex shapes. A given molecule therefore may have multiple 
corresponding peaks, only some of which may be observable. Even though any 
nucleus with nonzero spin could in principle be studied, clinical MRS is most 
commonly using the hydrogen nucleus (Govindaraju, et al., 2000)(de Graaf, 
2013). The set of molecules visible by neuro-MRS in vivo is limited to 15 - 20 and 
usually comprises creatine, choline, N-acetyl-aspartate (NAA), myoinositol, 
glutamate/glutamine and lipids. Quantitation of these NMR-observable 
metabolites can provide considerable biochemical information, and can help 
clinical investigators in understanding the role of metabolites in normal and 
pathological conditions. In patients with AD and MCI, the central spectroscopy 
findings are an age-related reduction in the concentration of NAA, indicating 
reduced neural volume and/or viability, accompanied by a significant increase in 
the level of myoinositol, likely caused by gliosis and metabolic dysfunction 
(Catani, et al., 2001,Chantal, et al., 2004,Chantal, et al., 2002). These findings 
motivate further studies, aimed at evaluating the potential role of MRS as a 
diagnostic tool to detect the neurometabolic correlates of decline in cognitive 
function. 
 
In conclusion, we foresee that advanced MR neuroimaging methods will be 
increasingly used as a tool to explore the structural and functional abnormalities 
of AD patients, due to the relatively easy applicability and the unique information 
provided. It is now believed that future treatments to slow or stop the 
progression of AD will be most effective when administered during the preclinical 
and MCI stages of the disease. In this scenario, biomarker tests will be essential 
to identify which individuals are in these early stages and should receive disease-
modifying treatment when it becomes available. They also will be critical for 
monitoring the effects of such treatments. 
 
Dietary intervention as a strategy to treat AD 
An extensive search to find a treatment for AD has been pursued for several 
decades. However, no treatment is yet available nor seems near. Preventive 
approaches have therefore consistently emerged as key policy priorities in 
recently formulated national dementia strategies. These approaches include 
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modifying health-compromising behaviours that can lead to AD, such as lifestyle 
and dietary intake. For example, high consumption of fruit, vegetables and 
legumes, moderate consumption of fish and the use of olive oil as the main 
source of fats, collectively known as the Mediterranean diet, have been 
associated with a reduced risk for AD (Scarmeas, et al., 2006,Sofi, et al., 2008) 
and with a lower mortality in AD (Scarmeas, et al., 2007). The mechanisms by 
which dietary intake influence the pathology onset and progression are still a 
matter of investigation. One possible explanation is given by the beneficial effect 
that some nutrients, such as omega 3 (n3) long-chain polyunsaturated fatty acids 
(LCPUFA), express on the vascular system (Lee, et al., 2008). The AD prevalence 
would then decrease by reducing the exposure to AD vascular risk factor, like 
atherosclerosis (Thies, et al., 2003), high blood pressure (Geleijnse, et al., 2002) 
and cardiovascular diseases (Daviglus, et al., 1997,Hu, et al., 2002,Thies, et al., 
2003,von Schacky and Harris, 2007). Other nutrients may instead directly act in 
restoring or reducing synaptic loss; for instance, the formation of 
phosphatidylcholine, the most common phosphatide in the brain and a major 
component of the synaptic membrane, is enhanced when its precursors are 
supplemented in the diet (Weiss and Kennedy, 1956,Wurtman, et al., 2010) 
(figure 3). Several preclinical studies confirmed these findings, showing that 
animals supplemented with all these membrane precursors had increased levels 
of brain phospholipids, dendritic spines and neurite outgrowth, with beneficial 
effects on cognition (Cansev and Wurtman, 2007,Sakamoto, et al., 
2007,Wurtman, et al., 2006). Based on these evidences, a novel combination diet 
that also includes other precursors and cofactors in membrane synthesis (such as 
phosphatidylcholine, B-vitamins and antioxidants) has been proposed for the 
dietary management of AD (Kamphuis and Scheltens, 2010). To date, two 
randomized controlled clinical trials have shown improvements in the delayed 
verbal recall task and better cognitive performance in mild AD patients 
supplemented with this multi-nutrient component diet (Cummings, 
2012,Scheltens, et al., 2010,Scheltens, et al., 2012). The processes by which 
these dietary nutrients influence the pathophysiology of AD yet need to be 
elucidated, and there is the need for more studies to confirm their efficacy. 
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Figure 3. The Kennedy cycle. Essential precursors for phosphatidylcholine (PC) formation 
are uridine (mostly as uridine monophosphate  (UMP)), choline, docosahexaenoic acid 
(DHA) and other omega-3-fatty acids (e.g. eicosapentaenoic acid (EPA)). The formation of 
PC consists of 3 sequential enzymatic reactions. In short, ATP and choline are utilized to 
form phosphocholine, followed by combination of cytidine triphosphate (CTP; mostly 
derived from uridine (Wurtman, et al., 2000)) and the newly formed phosphocholine to 
form a CDP-choline. Lastly CDP-choline is bound to diacylglycerol (DAG; which is formed 
from DHA and indirectly from other omega-3-fatty acids) which will yield a PC (Weiss and 
Kennedy, 1956,Wurtman, et al., 2010). 
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Thesis overview 
The two main aims of this thesis are to describe work done: 
 
 to provide the tools to study brain structure and function with magnetic 
resonance imaging in mouse models for AD and vascular risk factors  
 to investigate the mechanism by which specific multi-nutrient diets can 
avert AD pathology onset and progression  
 
To this end, the work presented in this thesis is divided in two parts. The first 
part, which includes chapter 2, chapter 3 and chapter 4, is dedicated to the 
development of novel MR methods to assess AD biomarkers for preclinical 
studies. In the second part, covered by chapter 5 and chapter 6, we studied the 
effect of specific nutritional treatment approaches in mouse models for genetic 
AD and for vascular risk factors.  
 
One of the main open questions in AD research is how deficits in brain 
vasculature affect the development of the disease. In particular, it is still not clear 
in which way the different forms of amyloid beta - aggregates and oligomers - 
can trigger micro and macrovasculature defects. In order to address this 
question, in chapter 2 we developed an MR imaging method to follow 
longitudinally the progression of cerebral blood volume (CBV) in a mouse model 
of AD. The CBV results were compared in the same study with the amount of 
capillaries measured with immunohistochemistry, with the amount of Aβ 
deposition in parenchyma and in blood vessel walls and with Aβ oligomers.  
 
In chapter 3 we aimed to assess brain diffusion changes in an AD mouse model, 
and to specify the biological underpinning of such changes. The differences in 
diffusion-related parameters found in white matter tracts well-matched previous 
findings of axonal disconnection and myelin degradation in AD patients. 
Furthermore, we noted an increased mean diffusivity in the granulate molecular 
layer of the dentate gyrus, which we relate to neuronal loss as visualized with 
immunohistochemical staining for neurons and myelin.  
 
The study presented in chapter 4 is directed to explore the functional 
connectivity (FC) changes measured with resting-state fMRI in aging apoE-ε4 and 
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apoE-ko mouse models. In the same animals, cerebral blood flow (CBF), DT-MRI 
and post-synaptic density were also measured, with the scope of understanding 
their possible role in FC signal changes.  
 
The application of these methods to study the efficacy of specific multi-nutrient 
diets against AD progression is presented in chapter 5 and chapter 6.  
 
In chapter 5 we combined CBV and MR spectroscopy measures with behavioural 
tests and neuropathology to evaluate the effect of long-term intake of a multi-
component diet in apoE-ε4 and apoE-ko mice. This diet is found to increase CBV, 
to reduce anxiety and to reduce the blood cholesterol levels in these mice. 
 
In chapter 6, two specific multinutrient diets have been supplied in AD transgenic 
mice. CBF and DT-MRI analyses revealed a possible beneficial effect of the diets 
by improving contemporarily brain perfusion and protecting against 
neurodegeneration. 
 
Chapter 7 and 8 are dedicated to a summary and a general discussion of these 
findings and suggestions for future studies.  
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Abstract 
Vascular disorders can either be cause or consequence in the pathophysiology of 
Alzheimer’s disease (AD). To comprehensively characterize the occurrence of 
vascular impairment in a double transgenic mouse model for AD (APPswe/PS1dE9) 
during aging, we developed a new method to obtain microvascular relative 
cerebral blood volume (rCBVmicro) maps from gradient echo MR imaging by 
histogram evaluation and we applied a voxel-wise approach to detect rCBVmicro 
changes. With this methodology the development of cerebral microvascular 
impairments can be described in vivo with 0.16 millimeter isotropic resolution for 
the whole mouse brain. At 8 months of age, impaired rCBVmicro appeared in some 
cortical regions and in the thalamus, which spreads over several sub-cortical 
areas and the hippocampus at 13 months of age. With a ROI-based approach, we 
further showed that hippocampal rCBVmicro in 13-month-old wild type and 
APPswe/PS1dE9 mice correlates well with capillary density measured with 
immunohistochemical staining. However, no differences in capillary density were 
detected between genotypes. The rCBVmicro values showed no significant 
correlation with amyloid-β (Aβ) plaque deposition, Aβ at bloodvessel walls and 
biochemically measured levels of Aβ1-40, Aβ1-42 oligomers and fibrillar forms. These 
results suggest that rCBVmicro reduction is caused by an impaired vasoactivity of 
capillaries and arterioles, which is not directly correlated with the amount of Aβ 
deposition in parenchyma nor bloodvessel walls.   
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Introduction 
Well-known neuropathological hallmarks of Alzheimer’s disease (AD) are the 
presence of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) in cerebral 
tissue and a massive loss of neuronal cells and of the white matter. Besides many 
reports on the causative role for Aβ in AD (Walsh and Selkoe, 2007), large 
epidemiological studies demonstrated that vascular disorders are important risk 
factors, with chronic brain hypoperfusion and cerebrovascular pathology among 
the earliest markers of AD (Breteler, 2000,de la Torre, 2002,de la Torre, 
2004,Grammas, 2000,Iadecola, 2004,Kalaria, 2002,Meyer, et al., 2000,Skoog and 
Gustafson, 2002). In 2000, de la Torre hypothesized that aging in combination 
with decreased cerebral perfusion could lead to oxidative stress and decreased 
energy metabolism, followed by increased glutamate production (de la Torre, 
2000b). These events contribute to progressive synaptic loss, increased Aβ and 
NFTs production, increased brain inflammation, brain tissue atrophy, 
neurodegeneration and cognitive decline (de la Torre, 2000a,de la Torre, 
2000c,de la Torre and Stefano, 2000). Recent studies further showed evidence 
for impaired vasculature being also a causative factor in AD pathology 
progression (Altman and Rutledge, 2010,Zlokovic, 2011).  
Transgenic mouse models with targeted expression of mutant amyloid precursor 
protein (APP) reflect many of the behavioral and neuropathological traits of AD. 
Besides the parenchymal Aβ accumulation, these mice also manifest early 
impairment in cerebrovascular autoregulation and cerebral blood flow and 
abnormalities in the cortical microvasculature similar to AD brains (El Tayara Nel, 
et al., 2010,Meyer, et al., 2008,Niwa, et al., 2002a,Niwa, et al., 2002b). These 
deficits in the cerebrovascular system can be readily assessed in vivo with 
magnetic resonance imaging (MRI). An important parameter measurable with 
MRI is cerebral blood volume (CBV), which describes the cerebrovascular 
integrity and, indirectly, the neural tissue physiological status and function. A 
reduction of relative CBV (rCBV) in a 4 months old transgenic APP mouse model 
(V717F, K670N/M671L) was first described by Wu and colleagues with 
intravascular superparamagnetic susceptibility contrast enhanced (CE) MRI (Wu, 
et al., 2004). Other studies in different mice strains showed similar findings 
(Weidensteiner, et al., 2009). In these studies the methodology applied for the 
analysis of vascular defects used a region of interest (ROI) based approach with 
no further spatial characterization. Thus, a ROI approach generally doesn’t 
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consider the whole brain area and may not reveal subtle or local CBV variation 
that occurs in a fraction of the selected regions.  
 In this paper, we aimed for a more comprehensive and spatially determined 
analysis of the rCBV changes occurring during ageing in the double transgenic AD 
mice (APPswe/PS1dE9) (Jankowsky, et al., 2004,Jankowsky, et al., 2001). These mice 
exhibit progressive parenchymal and vascular Aβ accumulation, leading to 
cerebral amyloid angiopathy (CAA) (Garcia-Alloza, et al., 2006). In our previous 
experiments we found a decreased rCBV in the hippocampus and in cortical 
regions at 15 months of age (Hooijmans, et al., 2009). 
For this study we employed APPswe/PS1dE9 mice of the same breeding at 8 and 13 
months of age and we spatially localize vascular changes with an explorative 
whole-brain voxel-wise approach. As second aim, we wanted to investigate the 
advantages of a vascular compartment separation for the analysis of rCBV 
changes. For this purpose, we developed a post-processing method based on 
histogram analysis of high-resolution rCBV maps in order to distinguish between 
blood volume changes of large cerebral vessels and capillaries. We validated this 
approach with an immunohistochemical staining for capillaries in order to 
determine capillary density. This non-invasive methodology allows to monitor 
local cerebrovascular changes over time which can be used in translational 
research on AD treatment in the earlier stages of the disease with vascular 
impairment. 
 
 
Materials and methods 
 
Animals 
For this study, we used the APPswe mice, line 85, which expresses a Mo/Hu 
APPswe construct in conjunction with the exon-9-deleted variant of human 
presenilin 1 (PS1-dE9) (Jankowsky, et al., 2004,Jankowsky, et al., 2001) 
(Jankowsky, et al., 2004,Jankowsky, et al., 2001) (Jankowsky, et al., 
2004,Jankowsky, et al., 2001). This line was originally maintained in a hybrid 
background by backcrossing to C3HeJ  C57BL6/J F1 mice for 9 generations. The 
APPswe/PS1dE9 founders were obtained from Johns Hopkins University, Baltimore, 
MD, USA (D. Borchelt and J. Jankowsky, Dept. of Pathology) and a colony was 
established at the Central Animal Facility (CDL) of the Radboud University 
Nijmegen Medical Centre, the Netherlands. Throughout the experiment the 
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animals were housed in groups of 2-3 mice per cage in a controlled environment 
with room temperature at 21°, an artificial 12:12h light:dark cycle and they were 
fed ad libitum. The experiment was performed according to the Dutch federal 
regulations for animal protection and was approved by the Veterinary Authority 
of the Radboud University Nijmegen Medical Centre, the Netherlands. 
 
MR imaging 
7 APPswe/PS1dE9 and 9 non-transgenic littermates mice underwent rCBV 
measurements at 8 and 13 months of age. The MRI measurements were 
performed on a shielded 7T/300mm horizontal-bore MR magnet interfaced to a 
clinical console (ClinScan, Bruker BioSpin, Ettlingen, Germany). A circular 
polarized 1H transmit volume coil (200mm/154mm outer/inner diameter) was 
used for excitation and was combined with a circular polarized 1H receive surface 
coil with a shape adapted to the mouse head for signal reception. Before the MR 
measurements, all mice were weighed and received an intravenous (i.v.) tail vein 
catheter. During the experiment mice were anesthetised using 2% isoflurane 
(Abott, Cham, Switzerland) in a 2:1 oxygen and N2O mixture. Isoflurane was 
chosen as it induces low cerebral hemodynamic changes (Hansen, et al., 1989). 
Mice were placed in a stereotactic holder to prevent unwanted movement 
during the scanning. Body temperature was maintained at physiological 
temperature with heated airflow and monitored with a rectal optical 
temperature probe. Respiration of the animal was monitored using a pneumatic 
cushion respiratory monitoring system (Small Animal Instruments Inc, NY, USA). 
Initially, multislice Turbo Spin Echo images in the coronal, transversal and 
longitudinal orientation were acquired to visualize the anatomy and the 
morphology of the mouse brain structures. Imaging parameters were FOV = 
2525 mm, matrix size = 256256, slice thickness = 0.5 mm, TE = 46 ms, TR = 
3500 ms. 
rCBV measurement 
To assess changes in rCBV, we used a susceptibility contrast enhanced MRI 
technique using ultra small particles of iron oxide (USPIO – AMI-277, Sinerem®, 
Guerbet Laboratories, France) as previously described (Dennie, et al., 1998,Le 
Duc, et al., 1999). By allowing the contrast agent (CA) to distribute in the 
vasculature after intravenous injection, the rCBV can be estimated as the 
transverse relaxation rate increase, which can be calculated from T2
 or T2
* images 
acquired before and after the CA injection. Both empirical data (Belliveau, et al., 
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1990) and Monte Carlo modeling (Boxerman, et al., 1995) indicate an 
approximately linear relationship between the increase of relaxation rate 
calculated with spin echo (SE) and gradient echo (GE) sequences (ΔR2 and ΔR2
* 
respectively) and rCBV fraction over the physiologically relevant range. In this 
work, a 3D multi echo GE FLASH sequence was performed prior to and 1 min 
after administration of an i.v. injection with USPIO at the dose of 140μg 
Fe/mouse. Imaging parameters were: FOV = 303014 mm, matrix size = 
19219288, total resolution = 0.16×0.16×0.16 mm, TEs = 5.13 – 7.28 – 9.40 ms, 
TR = 50 ms, resulting in a total scan time of 35 min per mouse.  
 
Data pre-processing and cerebral blood volume calculation 
For the 8- and 13-months-old mice groups, individual image sets were spatially 
normalized into a standardised coordinate space defined by a study-specific 
template of the mouse brain. The creation of the template was performed using 
Advanced Normalization Tools (ANTs. V1.9, http://picsl.upenn.edu/ANTS/). GE 
datasets from wild type and transgenic animals were co-registered to this 
template. Briefly, spatial normalization was achieved by applying a 12-parameter 
affine transformation and then followed by non-linear deformations using a 
diffeomorphic model (Avants, et al., 2008). A mask that included the entire brain 
was manually defined in the normalized coordinate space and applied to all the 
images. Spatially normalized and masked datasets were then imported in MatLab 
and, for each mouse, a pixel-by-pixel delta relaxation rate ΔR2
* map was obtained 
using the formula: 
 
Δ  
  
 
  
     
    
    
  
 
where S is the signal amplitude before-CA (Sbef ) and after-CA (Saft). Image sets 
from the three TEs were used for the calculation of three ΔR2
* values and 
thereafter these values were averaged for ∆R2
* maps. The TE values were chosen 
as a compromise between signal-to-noise ratio and the T1–weighting of CA 
effects that occurs at short TR (Tropres, et al., 2001).  
 
Analysis of the histogram 
While the ∆R2, measured with spin echo sequences, has an intrinsic higher 
sensitivity for small caliber vessels, the ∆R2
*, obtained with GE-based sequences, 
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is equally sensitive to all vessel radii for a sufficient dose of contrast agent 
(Boxerman, et al., 1995,Dennie, et al., 1998,Tropres, et al., 2001). Nevertheless, 
the measurement of blood volume in fast-flowing arteries and veins acquired 
with GE sequences is more susceptible to noise and quantification errors, and 
this may result in inaccurate values. To circumvent these problems and to focus 
on the microvascular compartment (eg. capillaries, arterioles and venules with 
diameters ranging approximately from 3 to 20 μm), we developed an histogram 
analysis technique on the ∆R2
* to mask pial and other large perforating arteries 
and veins. First, an averaged ΔR2
* map was defined in the normalized space and 
for each slice the corresponding histograms were computed with number of bins 
equal to the maximum ΔR2
* intensity value (MV). The histograms were then fitted 
with a polynomial function. Subsequently, peak height position (PHP) and the Full 
Width Half Maximum (FWHM) of the curve were calculated; these values were 
used as thresholds to create masks of rCBV in the microvascular (rCBVmicro) and 
macrovascular (rCBVMacro) compartment with the following criteria:  
 
1)      
    
 
                  
    
 
   
 
 2)                        
  
These thresholds were then applied to each individual spatially normalized ΔR2
* 
maps. Only the voxels included in the rCBVmicro mask, which were non-zeros in all 
mice, were kept for further calculations. To validate this approach, we correlated 
the individual non-normalized rCBVmicro data with the capillary density measured 
with Glucose transporter-1 staining determined by immunohistochemistry in the 
hippocampus region. Then, to ensure that all large blood vessels were excluded, 
visual identification of the rCBVMacro maps was performed with Image J (3D 
volume viewer tool, ver. 1.41, National Institute of Health, USA) and compared 
with the vasculature from an anatomical atlas (Dorr, et al., 2007). Because rCBV 
was mapped as ∆R2
*, several experimental variation such as USPIO dosage and 
mouse body weight composition could influence its values. To avoid these 
problems, normalization to the individual averaged rCBVmicro of the entire brain 
was performed. 
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Voxel-wise group comparison 
Regional differences in spatially normalized rCBVmicro maps between APPswe/PS1dE9 
mice and wild type littermates were assessed voxel-wise using MATLAB R2008a 
(Mathworks, Natick, MA, USA) and statistical parametric mapping 5 (SPM5, 
Wellcome Department of Clinical Neurology, London) with SPMMouse toolbox 
(Sawiak, et al., 2009). Spatially normalized rCBVmicro datasets were first smoothed 
with a 500μm isotropic Gaussian kernel to correct for imperfect registration and 
subsequently a two-group t test was performed to identify genotype-wise 
changes in the framework of the general linear model (GLM). Statistical 
significance for an individual voxel was established at p<0.01, uncorrected for 
multiple comparisons (Ashburner and Friston, 2000). The locations of significant 
voxels were compared to the anatomical atlas of (Franklin K, 1997,Franklin and 
Paxinos, 1997). 
 
ROIs based approach 
Normalized ∆R2
* maps and rCBVmicro maps were additionally measured for each 
animals in their original coordinate system with a region of interests (ROIs) group 
comparison. For the ROI-based approach, we evaluated significant effects of 
genotype and aging. ROIs that included hippocampus, cerebral cortex (all cortical 
areas above the corpus callosum), and thalamus were drawn based on the atlas 
of (Franklin K, 1997,Franklin and Paxinos, 1997).  
 
Immunohistochemistry 
For immunohistochemical staining we used a separate group from the same 
breeding of 8-month-old mice (7 APPswe/PS1dE9 and 7 wild type littermates) and 
the 13-month-old mice (7 APPswe/PS1dE9 and 9 wild type littermates), which were 
sacrificed directly after MR measurements. The 8 months old mice were 
transcardially perfused starting with 0.1M phosphate buffered saline (PBS) 
followed by Somogyi’s fixative (4% paraformaldehyde, 0.05% gluteraldehyde and 
0.2% picric acid in 0.1M phosphate buffer, pH 7.2). The group of 13 months old 
mice was sacrificed after the MR experiment by cervical dislocation and the 
brains cut mid sagittally for immunohistochemistry (immersion fixation of left 
hemisphere) and biochemistry. Six series of 40μm thick coronal sections were cut 
using a sliding microtome (Microm HM 440, Walldorf, Germany).  
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Amyloid-β load 
Amyloid-β deposits were visualized using WO-2 antibody (mouse anti-human 
Aβ4–10 from K. Beyreuther, Centre for Molecular Biology, University of Heidelberg, 
Germany). In brief, sections were pretreated with sodium citrate solution 0.05M 
at 85 °C for 30 min and incubated for 18h at room temperature with primary 
antibody mouse anti-human Aβ4–10 (1:20.000 in TBS-T). The next day sections 
were rinsed in TBS-T and incubated for 90 min with the secondary antibody 
donkey-anti mouse biotin (1:1500, Jackson ImmunoResearch). Thereafter, 
sections were transferred to a solution containing Vector ABC-Elite 1:800 (Vector 
laboratories, Burlingame, CA, USA). The sections were incubated in DAB-Ni 
solution with perhydrol for 10 min and mounted on gelatin-coated slides. After 
dehydration in alcohol series, slices were cleared with xylol and mounted in 
Entellan. 
 
GLUT-1 
The glucose transporter type 1 (GLUT-1) is a membrane protein responsible for 
the active glucose transport across the blood brain barrier and is primarily 
localized in vascular endothelial cells (Choeiri, et al., 2002); In this study, GLUT-1 
staining was performed to quantify capillary bloodvessels density as previously 
described (Hooijmans, et al., 2007b). The amount of GLUT-1 was visualized using 
rabbit anti GLUT-1 transporter antibody (AB 1340, Chemicon International, Inc., 
Temecula, CA, USA). Briefly, the sections were pre-treated against endogenous 
peroxidase for 30 min with 0.3% H2O2 in 0.1 M PBS. After sequentially rinsing in 
PBS and pre-incubation in 0.1 M PBS containing 1% bovine serum albumin (BSA) 
and 0.3% Triton X-100 (PBS–BT) the section were incubated for 18h with anti-
GLUT-1 (1:10.000 in 0,1M PBS-BT). Following incubation, the sections were 
rinsed thoroughly with PBS and transferred to donkey-anti-rabbit biotin 1:1500 
(Jackson ImmunoResearch) for 90 min. The sections were rinsed three times and 
transferred to a solution containing Vector ABC-elite 1:800 (Vector laboratories) 
for another 90 min. Visualization of the GLUT-1 amount was achieved by 
incubation with DAB–Ni solution. All stained sections were mounted on gelatin-
coated slides and dehydrated in alcohol series, cleared with xylol and mounted in 
Entellan.  
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Quantification 
The amount of β-amyloid and GLUT-1 was determined in appropriate sections 
digitized using a Carl Zeiss Axioskop microscope, equipped with hardware and 
software of Microbrightfield (Williston, USA).  Serial images with 20× and 40× 
magnifications were used for the quantification by two double blind 
investigators.  
Extracellular Aβ plaque load was quantified with a computer-assisted analysis 
system (Stereo Investigator, Microbrightfield, Williston, USA) using Cavalieri’s 
probe. Contours along the hippocampal regions (cornu Ammonis area 1 and 3 
(CA1, CA3) and dentate gyrus (DG)) and in the frontal prelimbic area (PLA) and 
anterior cingulate gyrus (ACg) were drawn on the selected slices. Measurement 
of Aβ load was defined as the percentage of area covered by Aβ plaques. In 
addition, we determined the amount of Aβ in and around the vascular walls in 
the entire hippocampus in 13 months old APPswe/PS1dE9 mice. Measurements 
were defined as the percentage of area covered by Aβ in the bloodvessels, 
including the vessels in the hippocampal fissure. 
 
GLUT-1 density was quantified with a computer-assisted analysis system (Stereo 
Investigator) using Cavalieri’s probe. Contours were drawn along the CA1, CA3 
and DG on the selected slices. Measurement of GLUT-1 density was defined as 
the percentage of the area covered by GLUT-1 immunoreactivity compared to 
the total area of the region measured.  
 
Soluble Amyloid-β oligomers biochemical analysis 
For biochemical analysis we used half brain of 13-month-old mice (7 
APPswe/PS1dE9 and 8 wild type). The brains were homogenized as previously 
described (Maier, et al., 2008). Briefly, frozen hemispheres were homogenized in 
a carbonate buffer (CB: 100mM Na2CO3, 50mM NaCl, pH 11.5) containing 
protease inhibitor cocktail (Roche Applied Science, Mannheim, Germany) and 
centrifuged at 16.000g for 30min at 4°C. Then, the pellet was resuspended in 
guanidine choloride buffer and extracted for 4 hours. 
We separated the brain homogenates into three different fractions: the TBS-
fraction contains more soluble monomeric Aβ, the TBS-T (TBS plus 1% Triton) is 
related to membrane-associated Aβ and enriched with oligomeric Aβ and the 
guanidine-HCL fraction, which contains mainly highly aggregated Aβ. Since we 
were mainly interested in Aβ oligomers and aggregated forms, presence of Aβ40 
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and Aβ42 were measured in the TBS-T and guanidine-HCL fractions using the Aβ 
kits from Invitrogen (KHB3442 and KHB3482, Karlsruhe, Germany). Result was 
normalized to the protein concentration of the sample (Bio-Rad Protein Assay, 
Bio-Rad Laboratories, Munich, Germany). 
 
Statistical analysis.  
All statistical analyses were performed using SPSS v16.0 (SPSS Inc. Chicago, IL, 
USA). Resulting data are expressed as mean ± SEM. Differences between 
genotypes and/or aging within multiple ROIs for rCBV measurements and vessel 
density measurements were analysed with multivariate ANOVA’s with Bonferroni 
correction. The one-way ANOVA test was used to evaluate regional differences in 
Aβ- load and in vessel density. If overall analysis revealed a significant difference, 
the separate groups were analyzed post hoc by using Tukey HSD. Other data 
were analyzed with an independent t-test. Correlation analyses were done with 
bivariate Pearson’s correlation method. Statistical significance was established at 
p<0.05. 
 
 
Results 
 
Cerebral blood volume 
To measure changes in rCBV, susceptibility-induced contrast MR imaging was 
used. Relaxation rate maps (ΔR2
*) were obtained from T2
*-weighted images 
before and after i.v injection of USPIO (Figure 1a-c). Histograms of the ∆R2
* maps 
were calculated as described in the Material and Methods section. Overall, the 
whole-brain ∆R2
* histograms showed a right-skewed distribution that consisted 
of two peaks that we associated with contributions of macro- and microvascular 
compartments to the rCBV (Figure 1d and Figure 2). For the voxel-wise 
comparison, we used rCBVmicro maps. For the ROI-based analysis, ∆R2
* maps 
without masking were also considered as measure of rCBV of the total 
vasculature. The 3D representation of rCBVMacro maps showed good agreement 
with the anatomy of major mouse brain vessels (see video, 
http://link.springer.com/content/esm/art:10.1007/s00429-012-0448-
8/file/MediaObjects/429_2012_448_MOESM1_ESM.mpeg) (Dorr, et al., 2007) 
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ROI-based analyses 
The analysis focused on the hippocampus, cerebral cortex and thalamus (see 
Table 1). In 8 months old mice no significant differences were found in the rCBV 
indexes between APPswe/PS1dE9 and wild type mice. In 13 months old mice the 
total rCBV, expressed by ∆R2
*, was lower in the hippocampus of the APPswe/PS1dE9 
compared with non-transgenic littermates, but not reaching a statistical 
significant difference (p=0.081). However, the rCBVmicro was significantly lower in 
the hippocampus of the APPswe/PS1dE9 mice (p=0.024). In the cortex and thalamus 
no significant differences in rCBV between genotypes were found. These results 
suggest that in the hippocampal area of APPswe/PS1dE9 mice a rCBV reduction in 
microvasculature is present that becomes apparent when the contribution of 
large vessels is excluded.  
 
Aging effects 
No significant differences were found between 8 and 13 months old mice, except 
a reduction in hippocampal rCBVmicro in APPswe/PS1dE9 mice (p=0.010, not shown). 
This suggests that the decrease in the hippocampal microvascular rCBV is a 
pathological aging process in the APPswe/PS1dE9 mice.  
 
Voxel-wise differences using SPM  
To determine the location of rCBVmicro impairment at higher spatial resolution, we 
applied a voxel-wise statistical approach with the co-registered brains as 
described in the material and methods section. The analysis of spatially 
normalized rCBVmicro at 8 and 13 months of age exhibits the evolution of the 
vascular impairment in APPswe/PS1dE9 mice. Compared to wild-type littermates, 
some areas with a significant decreased rCBVmicro were found already at 8 months 
of age (figure 3). Voxels of significantly decreased rCBVmicro values were found in 
the cortical infralimbic area (ILA), in the anterior group of the dorsal thalamic 
region and, with smaller amount, also in the hypothalamic lateral zone (LZ), 
medulla, pons and cerebellum (figure 3). 
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Figure 1. a) Representative MRI gradient echo images of 13 months old wild type mouse 
brain before USPIO injection in four coronal slices. The images were acquired using a 3D 
multi GE FLASH sequence. ROIs of the entire brain, cerebral cortex, hippocampus and 
thalamus were selected approximately at 0.38 up to -2.46 posterior to bregma. b) 
Corresponding slices obtained after 1min of i/v USPIO injection c) Relaxation rate images 
(ΔR2
*
) show sensitivity for macro- and microvasculature rCBV. Data are expressed in 
arbitrary units d) Microvasculature rCBV maps (rCBVmicro) are obtained after selective 
thresholding based on the ΔR2
* 
histogram analysis and expressed in arbitrary units. Pixels 
that have anatomical correspondence with major brain arteries and veins are discarded in 
the rCBVmicro maps.  
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 Wild-type APPswe/PS1dE9 Difference (%) p value 
8-month-old  
 
      
Hippocampus        
   ∆R2
*
  0.77±0.07 0.75±0.08 -2.66 % ns 
   rCBVmicro  0.99±0.17 0.98±0.162 -1.01 % ns 
Cerebral cortex     
   ∆R2
*
  0.73±0.16 0.74±0.15 +0.82 % ns 
   rCBVmicro  0.94±0.06 0.95±0.07 +1.67 % ns 
Thalamus      
   ∆R2
*
  1.18±0.23 1.09±0.35 -8.25% ns 
   rCBVmicro  1.17±0.17 1.17±0.63 -0.43% ns 
13-month-old      
Hippocampus      
   ∆R2
*
  0.91±0.16 0.77±0.12 -18.18 % 0.081 
   rCBVmicro  1.03±0.06 0.89±0.02 -16.74 % 0.024 
Cerebral cortex     
   ∆R2
*
 0.71±0.07 0.67±0.12 -5.97 % ns 
   rCBVmicro  0.98±0.15 0.91±0.15 -7.69 % ns 
Thalamus      
   ∆R2
*
  1.11±0.09 1.12±0.03 +0.89% ns 
   rCBVmicro  1.20±0.2 1.04±0.15 -15.34% ns 
 
Table 1. Comparison of normalized blood volume changes between control C57BL6/J mice 
and APPswe/PS1dE9 mice at 8- and 13 months of age. The ∆R2
* 
is considered a measure of 
the total blood volume, while rCBVmicro a measure of the microvascular blood volume. 
Data show hippocampal rCBVmicro decrease at 13 months of age in the APPswe/PS1dE9 mice. 
Values represent mean ± STD 
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Figure 2. Representation of the histogram of the ΔR2
* 
map of the entire brain in 13 months 
old wild type mouse. a) The distribution of ΔR2
* 
intensities consisted of two peaks that we 
associated with contributions of macro- and microvascular compartments to the rCBV. 
From the fist peak of the histogram, point high peak (PHP), full width half maximum 
(FWHM) and maximum value (MV) are determined and used to define thresholds for 
microvasculature rCBV (rCBVmicro ≈ gray area) and macrovasculature rCBV (rCBVMacro ≈ 
dark gray area). b) Representation of the ΔR2
* 
distribution in the hippocampus of one 13-
month-old APPswe/PS1dE9 mouse compared to a wild type littermate. The difference 
between APPswe/PS1dE9 and wild type is more pronounced in the range of low ΔR2
* 
intensities, which is assigned to the microvascular compartment.  
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Figure 3. Normalized rCBVmicro t-value maps superimposed on anatomical images in axial 
and sagittal view revealed the occurrence of early microvascular blood volume reduction 
in the APPswe/PS1dE9 mice at 8 months of age in the infralimbic cortical area (ILA) and in 
the dorsal thalamic regions. Hypothalamic lateral zone, medulla, pons and cerebellum 
seem also partly affected. Voxels showing decreased rCBVmicro corresponding to p values 
<0.01 for a two-tailed test, uncorrected, are shown in the t-maps. 
 
 
At 13 months of age, a more severe decrease in rCBVmicro was detected in 
APPswe/PS1dE9 mice as illustrated in figure 4. At this age, several areas of the 
thalamus, hypothalamus, ventral striatum, medulla, pons, cerebellum and 
hippocampus showed decreased normalized rCBVmicro. In the cortex, clusters of 
significant rCBVmicro decrease were found mostly in the primary somatosensory 
areas (SSp) and in the secondary somatomotor area (MOs). Some clusters were 
also found in the olfactory bulb, superior colliculus and cerebral cortex. Overall, 
the inferior part of the brain seems to be more affected in APPswe/PS1dE9 mice. 
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Figure 4. In 13 month old transgenic APPswe/PS1dE9 mice, normalized rCBVmicro t-value maps 
revealed the evolution of blood volume decrease. A more severe and widespread 
pathology seems to occur in several areas of thalamus, hypothalamus, ventral striatum, 
medulla, pons, cerebellum and hippocampus. The somatosensory areas and the 
secondary somatomotor area appear the most affected cortical regions. Some voxels of 
the olfactory bulb, superior colliculus and cerebral cortex also showed significantly 
decreased rCBVmicro. Voxel showing decreased rCBVmicro in APPswe/PS1dE9 mice and 
corresponding to p values <0.01 for a two-tailed test, uncorrected, are shown in the t-
maps. 
 
 
GLUT-1 density per area  
Immunohistochemical staining with rabbit anti GLUT-1 transporter was used to 
visualize the capillaries and quantify the capillary density per area in percentage 
(see Figure 5a and 5b). Both at 8 and 13 months of age no difference could be 
found in the capillary density between genotypes and ROIs (see Figure 5c-d). In 
order to verify our method, we specifically looked at the relation between 
capillary density measured with GLUT-1 staining and non-normalized 
hippocampal rCBVmicro measured with MRI. A strong positive correlation was 
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found between capillary density and both rCBVmicro and PHP of the hippocampus 
measured in the 13-months-old wild type mice (p=0.003 and p=0.004 
respectively, see Figure 5e). 
 
In the APPswe/PS1dE9 mice a similar but weaker correlation was also found, 
possibly due to the lower number of animals or small variation in the amount of 
CA injected (for p=0.037 and p=0.036, not shown). As we were interested in 
determining the effects of the compartment separation, we further evaluated 
the correlation between capillary density and non-masked rCBV values, and we 
found no significant correlations. These results reflect the dependence between 
rCBVmicro as measured with our technique and capillary density as visualized with 
immunohistochemistry. Moreover, they confirm the use of proper vascular 
compartment masking as a tool to increase the sensitivity of the measure 
towards the capillaries in GE derived images. 
 
Amyloid-β load 
 8-month-old mice  
Aβ deposition was visualized with immunohistochemical staining with mouse 
anti-human Aβ4-10 antibody in CA1, CA3 and DG hippocampal regions and in PL 
and ACg cortex regions (see figure 6a-c). Wild type mice did not shown any 
immunoreactivity with this antibody. As illustrated in figure 6d In the 
APPswe/PS1dE9 mice, most Aβ plaques were present in the DG (4.54±2.0% of total 
area, p<0.001 compared to other areas) and only rare deposits were seen in the 
CA1 and in the CA3 (CA1: 0.69±0.9% and CA3: 0.35±0.6% of total area). In cortical 
areas much less deposits were detected (PL: 1.2±0.5% and ACg: 2.1±0.7% of total 
area).  
 
13-months-old mice  
Transgenic mice showed increased Aβ deposits in the CA1 and CA3 hippocampal 
regions compared to 8 months (CA1: 4.2±1.8%, p=0.001 and CA3: 2.9±3.8% of 
total area p=0.005) and in cortical regions (PL: 5±3.9% and ACg: 7.5±4.1% of total 
area, p=0.002); in the DG the percentage of parenchymal Aβ plaques increased, 
although not significantly (5.6±2.4% of total area, p=0.463). No significant 
regional variation in Aβ plaque burden could be found at this age and no 
correlations were found between Aβ burden in the hippocampus and GLUT-1 
density or rCBVmicro.  
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 Figure 5. Representative images of the bloodvessels stained with glucose transporter-1 
(GLUT-1) in brain regions of 13-month-old wild type mice. A: hippocampal region, 
magnification 5×, Scale Bar=250μm; B: magnification 20×, Scale Bar=50μm; C, D: the area 
covered by GLUT-1 reflect the capillary density in the dentate gyrus (DG), CA1 and CA3. 
No significance genotype difference was found in 8- and 13-month old mice. Values 
represent mean ± SEM. E: Correlation between capillary density and microvasculature 
rCBV measured with the non-normalized peak height position (PHP) of the hippocampal 
ΔR2
* 
in 13 months old wild type mice. The line depicts the linear regression (Bivariate 
Pearson’s = 0.004). 
 
 
Apart from parenchymal Aβ plaque load, we also determined the Aβ deposition 
in the vascular walls of the hippocampus, including vessels in the hippocampal 
fissure. The amount of Aβ was significantly lower than the plaque load in the 
total hippocampus (2.2±1.1% and 4.2±2.2% respectively, p=0.005). No significant 
correlation between Aβ in/around bloodvessels and rCBVmicro could be found.  
 
Soluble amyloid-β concentration  
Presence of oligomeric Aβ and high-molecular weight Aβ aggregates were 
measured in 13 months old APPswe/PS1dE9 mice. Both in TBS-T and guanidine-HCL 
fractions, the concentration of Aβ42 found was significantly higher than the 
concentration of Aβ40 (in TBS-T, Aβ42: 85.7±6 ng/mg brain and Aβ40: 54.9±4 ng/mg 
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brain, p<0.01. In guanidine-HCL Aβ42: 0.10±0.05 ng/mg brain and Aβ40: 0.05±0.02 
ng/mg brain, p<0.01; see figure 6e). 
 
 
The ratio of Aβ40/42 observed was similar in the two fractions (0.66±0.2 and 
0.64±0.01 respectively), as expected from the APPswe/PS1dE9 strain (Garcia-Alloza, 
et al., 2006). Strong positive correlation was found between Aβ40 and Aβ42 
(Bivariate Pearson’s <0.01). No other correlations could be found.  
 
Discussion 
Vascular disorders have been associated with clinical symptoms of AD (Breteler, 
2000,Helzner, et al., 2009,Iadecola, 2010)(Larson and Lesne, 2012). The early 
detection of cerebrovascular pathology in patients with suspected AD is 
therefore of primary importance for the initiation of preventive strategies. 
Because changes in functional physiological parameters, like microvascular 
deficits, can be subtle and region-specific, a methodology that offers sensitive 
quantification together with a high spatial resolution is required for the detection 
of these deficits. 
In this study, a voxel-wise analysis (VBA) approach was applied to the 
microvascular rCBV maps (rCBVmicro) to spatially localize the cerebrovascular 
changes in the APPswe/PS1dE9 mouse model, not limited to predetermined 
neuroanatomical locations. Because of its non-invasiveness, we were able to 
follow rCBVmicro changes longitudinally. We showed some clusters of voxels 
indicating early rCBVmicro impairment in 8 months old APPswe/PS1dE9 mice in 
cortical areas such as the infralimbic area (ILA), in the anterior group of the 
dorsal thalamus and in the hypothalamic lateral zone (LZ). At 13 months of age 
we described a widespread decreased rCBVmicro in several cortical and sub-
cortical brain regions of old APPswe/PS1dE9 mice. These findings were based on the 
analyses of gradient echo (GE) derived ΔR2
* maps combined with a histogram 
analysis developed in this study for the selection of the microvascular 
compartment. For this purpose, a 3D GE sequence was chosen. Because of the 
short repetition time needed, GE sequences offer the possibility to acquire a 
whole-brain volume with a very high isotropic resolution in a reasonable 
acquisition time. This is of particular importance when a voxel-wise approach is 
applied, in order to have a better co-registration of the individual datasets. 
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Figure 6. Parenchymal and soluble β-amyloid pathology in the brains of APPswe/PS1dE9 
mice. Photomicrographs at 5× magnifications show the β-amyloid load in different brain 
regions of 13 months old APPswe/PS1dE9 mice based on the mouse brain atlas of Franklin 
and Paxinos, 1997. Scale bar=250μm. A, B, C: hippocampus was quantified from -2.18 to -
2.46 posterior to bregma and the CA1, CA3 and DG regions were defined. The ACg and 
PLA were quantified at level +1.10 to +0.86 and at level +1.98 up to +1.78 anterior to 
bregma respectively. D: Area covered by β-amyloid increases differently in different brain 
regions due to aging. DG dentate gyrus, PLA prelimbic area, ACg anterior cingulated 
gyrus. E: presence of Aβ40 and Aβ42 in TBS-T and guanidine-HCL fractions in 13 months old 
APPswe/PS1dE9 mice. Result are normalized to the protein concentration of the sample. 
Values represent mean ± SEM. *p<0.05. 
 
 
Moreover, we employed a 3D excitation to minimizes the inflow effect and yields 
a more reliable signal (Wu, et al., 2003). Previous studies demonstrated an equal 
susceptibility weightings for all vessels’ sizes for the ΔR2
* index (Boxerman, et al., 
1995,Dennie, et al., 1998,Tropres, et al., 2001). This feature of ΔR2
* limited its 
use in rCBV evaluation, as the evaluation of capillary rCBV is often preferred in 
neurological studies. For this study, we developed a method to shift the 
sensitivity of ΔR2
* images towards the microvascular compartment based on 
analysis the distribution of ΔR2
* values in the whole brain. Because the capillary 
density in rodents does not differ significantly in distinct brain regions (Weiss, et 
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al., 1982), it is likely that the ΔR2
* will mostly dependent on the percentage of 
macro- and microvessels included in the region of interest selected. For example, 
in a region that contains only capillaries, we observed a normal distribution 
around a mean capillary blood volume fraction (data not shown). In contrast, if a 
voxel partially or totally includes a major artery or vein, the blood volume 
fraction is substantially higher, and the resulting ΔR2
* value can be easily 
separated with a threshold-based approach from the capillary distribution.  
Indeed our analysis for the whole brain showed a distribution of ΔR2
* that 
consisted of two peaks that we associated with contributions of macro- and 
microvascular compartments. In support of our methodology, we found a strong 
positive correlation between the capillary density, as reflected by GLUT-1 
staining, and the rCBV indexes of the microvascular compartment. The major 
surrounding and penetrating brain vessels obtained from the rCBVMacro maps 
were in good correspondence with an anatomical atlas of mouse brain 
vasculature (Dorr, et al., 2007). Hence, the analysis of the ΔR2
* distribution 
provides a useful division of tissue vasculature, that can be employed as an 
attractive tool for noninvasive brain analysis. 
The results obtained in the ROI based approach demonstrated the importance of 
this two compartments separation, as we were able to detect statistical 
significant differences in the hippocampus of 13 months old APPswe/PS1dE9 mice 
only after removing the contribution of the macrovasculature. Cerebral 
macrovascular abnormalities, such as narrowing, vessel voids, constrictions and 
partial occlusions, were also described in AD patients and animal models 
(Beckmann, et al., 2003,El Tayara Nel, et al., 2010,Krucker, et al., 2004). 
However, in this study we decided not to consider the ΔR2
* from the large 
cerebral vessels because of the difficulties with correct quantification and 
determination of rCBVMacro due to partial volume effects, and susceptibility 
artifacts due to the higher concentration of CA. As the brain vascular network 
includes a large variety of vessels such as capillaries, arterioles, venules, arteries 
and veins, each with its own size, the two-component model is an approximation 
of the vessels included in a voxel. 
The reduced microvascular rCBVmicro found in our APPswe/PS1dE9 mice matches 
well with other studies in AD mouse models (Wu, et al., 2004); Hooijmans et al 
2009). The technique developed in our study enabled us to determine maps of 
reduced blood volume with the highest possible spatial resolution – equal to the 
voxel size. From these maps, we could identify several areas of reduced CBV that 
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correspond to AD pathogenesis and relate to areas of spatial memory and 
learning (e.g. hippocampus, primary somatosensory area (SSp) and secondary 
somatomotor area (MOs). Notably, in 2008 Liu and colleagues found robust 
losses (~50%) of monoaminergic (MAergic) neuronal axonal losses in these same 
areas in 12 months old APPswe/PS1dE9 mice (Liu et al 2008).The occurrence of 
axonal degeneration followed the load of Aβ deposits and preceded atrophy of 
cell bodies and loss of MAergic neurons. These results imply an Aβ-dependent 
effect on neuronal degeneration although in absence of precise co-localization.  
To confirm whether the same hypothesis could be applied for the CBV results in 
our study and to analyze the plausible relation between neuronal degeneration 
and decreased CBV, further multi-modal longitudinal analyses will be necessary. 
In this scenario, the use of a voxel-based approach, as presented here, would be 
required to spatially relate multiple parameters and biomarker changes over 
time. 
A significantly reduced rCBVmicro is also apparent in the inferior part of the brain, 
adjacent to the circle of Willis, and following the internal carotid artery (IC), 
anterior cerebral artery (ACA) and the basilar artery (BA). Although these major 
arteries were excluded from the VBA, it is possible that blood flow disturbances 
or structural flaw in these macrovessels could have caused a reduction in blood 
volume in the perfused areas. This hypothesis is in agreement with macroscopic 
vascular alterations in these large arteries that are found in APP×PS1 mice as the 
Aβ pathology progresses (El Tayara Nel et al 2010) 
In general, a decrease in CBV may be caused by vasoconstriction or capillary loss 
or disruption; the last hypothesis, however, is less likely since we did not find any 
difference in the hippocampal capillary density between genotypes after 
quantification of the amount of bloodvessels visualized immunohistochemically 
with GLUT-1 staining in both 8 and 13-month-old groups. Loss of GLUT-1 
transporters in capillary endothelium is mediated by the presence of Aβ and 
visible in APPswe/PS1dE9 mice starting from 18 months of age (Hooijmans, et al., 
2007a); the relatively younger age of the mice used for this study ensure that no 
significant GLUT-1 changes had occurred yet, that could compromise the vessel 
density quantification. Thus, diminished rCBVmicro in our APPswe/PS1dE9 mice is 
more likely caused by vasoactivity impairment of the capillaries and small arteries 
and reduced cerebral blood flow. 
The equilibrium between Aβ production, transport and clearance is dependent 
on lipid and lipoprotein content (Altman and Rutledge, 2010), on the 
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functionality of the blood brain barrier (BBB) (Zlokovic, 2008), and of the 
neurovascular unit, including pericytes, astrocytes and microglia (Iadecola, 
2004,Peppiatt, et al., 2006). Overproduction and neurovascular accumulation of 
Aβ, as occur in APPswe/PS1dE9 mice, are capable to disturb this balance by several 
mechanisms and consequently induce hypoperfusion. 
These include the interaction with receptors for advanced glycation end products 
(RAGE) for the transport of Aß across the BBB and the increased expression of 
proinflammatory cytokines and endothelin-1 (ET-1), that enhances the 
production of superoxide radicals and mediates Aß-induced vasoconstriction 
(Zlokovic, 2008). A reduced vasoactivity in response to endothelium-dependent 
vasodilators, such as acetylcholine and bradykinin has also been shown in mice 
overexpressing Aβ (Iadecola, et al., 1999), suggesting a role of Aβ in inducing 
capillaries endothelial dysfunction. Altered endothelial function and BBB 
disruption therefore amplify the Aβ-induced stress by restricting clearance of Aβ. 
These events may then cause decreased blood flow and hypoxia of the 
neurovascular unit, resulting in accumulation of metabolic waste products and 
changes in brain microenviroment that leads to neurodegeneration. 
Furthermore, deposition of Aβ in bloodvessels walls results in the development 
of cerebral amyloid angiopathy (CAA), which may be the cause of structural 
damage of brain vessels and is reported to be lifelong increasing in APPswe/PS1dE9 
mice (Ghiso and Frangione, 2002). Here, we quantified Aβ in the vessel walls in 
the hippocampus and found no relationship with the decreased rCBVmicro. Levels 
of Aβ in the bloodvessels were significantly lower than plaque burden, with high 
inter-variability between mice. These results are comparable with other studies 
in this mouse strain (Hooijmans et al 2007a; Hooijmans et al 2009). Therefore it 
is unlikely that CAA alone is sufficient to cause the reduction in CBV reserves as 
found in the transgenic mice at this age. Because Aβ accumulation in bloodvessel 
walls is a lifelong process, we believe that CAA could induce severe vascular 
damage in older animals in an advanced stage of the pathology. 
Transgenic mice for β-amyloidosis show also increased levels of soluble forms of 
Aβ1-40 and Aβ1-42. Most studies have demonstrated that the soluble non-fibrillar 
species of Aβ are deleterious to blood vessels and neurons, rather than 
aggregated fibrillar forms (Haass and Selkoe, 2007). In particular, Aβ1-42 oligomers 
are currently suspected to be the cause of synaptic dysfunction and 
neurodegeneration in AD, and were correlated with the severity of cognitive 
impairment in humans (McLean, et al., 1999) and associated with a reduction of 
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the number of synapses (Kamenetz, et al., 2003,Lue, et al., 1999). Instead, Aβ1-40 
have a more pronounced effects on brain vascular activity. A dose-response 
reduced resting CBF has been described in mice due to superfusion of Aβ1-40 on 
the neocortex (Niwa, et al., 2000). Levels of Aβ1-40 and Aβ1-42 in APPswe/PS1dE9 mice 
at 13 months of age were comparable with data from other studies (Hao, et al., 
2011). However, the expected correlation between blood volume changes and 
Aβ1-40 levels was not found, which might be because of Aβ1-40 was analyzed using 
tissue of the half-whole brain and not in co-localized brain structures that 
showed rCBVmicro reduction. 
To summarize, in this paper we described a novel method to characterize 
vascular impairment with a voxel-wise approach, that is based on the analysis of 
ΔR2
* data acquired with a 3D GE sequence into microvasculature CBV maps by 
histogram evaluation. This methodology offers a valid non-invasive tool for the 
identification of early CBV deficits in mouse models for AD, and allows the 
evaluation of future therapeutic strategies targeting microvascular integrity as 
risk factor for neurodegeneration and Alzheimer’s disease with the highest 
possible spatial resolution. 
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Abstract 
In patients with Alzheimer’s disease (AD) the severity of white matter 
degeneration correlates with the clinical symptoms of the disease. In this study, 
we performed diffusion-tensor MRI (DT-MRI) at ultra-high field in a mouse model 
for AD (APPswe/PS1dE9) in combination with a voxel-based approach and 
tractography to detect changes in water diffusivity in both white and gray matter, 
as these reflect structural alterations in neural tissue. We found substantial 
changes in water diffusion parallel and perpendicular to axonal tracts in several 
white matter regions like corpus callosum and fimbria of the hippocampus, that 
match with previous findings of axonal disconnection and myelin degradation in 
AD patients. Moreover, we found a significant increase in diffusivity in specific 
hippocampal sub-regions, which is supported by neuronal loss as visualised with 
the Klüver-Barrera staining. 
This work demonstrates the potential of ultra-high field DT-MRI as a non-invasive 
modality to describe white and gray matter structural changes in mouse models 
for neurodegenerative disorders, and provides valuable knowledge to assess 
future AD prevention strategies in translational research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model 
________________________________________________________________________ 
59 
 
 
Introduction 
Alzheimer’s disease (AD) is the most common type of dementia and is 
characterized by a progressive loss of neuronal function, leading to gradual 
memory impairment, confusion and general withdrawal. Pathological hallmarks 
are the accumulation of extracellular amyloid plaques, caused by amyloid-β 
protein (Aβ) aggregation, and the presence of intracellular neurofibrillary tangles 
(NFTs), formed by aggregates of the hyperphosphorylated tau protein. These 
pathological changes originate in the medial temporal lobe, especially the 
entorhinal cortex and hippocampus, spreading further across the limbic cortex 
and neocortex (Arnold, et al., 1991,Braak and Braak, 1995). Along with Aβ- and 
NFTs gray matter pathology, histological studies identified several changes in 
white matter structures. Over 50% of confirmed cases of AD show white matter 
disease (WMD) in neuropathological examinations, with a widespread 
distribution in patients with moderate- to late-stage dementia (Englund and 
Brun, 1990). Several studies reported a correlation of the incidence of white 
matter lesions with severity of the underlying AD pathology (Bozzali, et al., 2002) 
(Bronge, et al., 2002,de Groot, et al., 2000). The etiology of AD-related white 
matter pathology remains to be fully elucidated, although some underlying 
processes have been proposed, including (1) interhemispheric disconnection 
through Wallerian degeneration (Tomimoto, et al., 2004), 2) axonal damage and 
gliosis following vascular disease (Englund, 1998) and (3) primary myelin 
degradation resulting in axonal disconnection (Medina, et al., 2006,Xie, et al., 
2006). 
Magnetic resonance imaging (MRI) offers tools to measure white and gray matter 
architecture in vivo. Diffusion weighted MRI measures the incoherent motion of 
water molecules for every imaged voxel and provides complementary 
information to conventional MRI on tissue microstructure (Le Bihan, et al., 1986). 
Since its first description (Basser, et al., 1994), diffusion tensor MRI (DT-MRI) has 
been widely used to investigate white matter because of the relatively coherent 
organization of axons in fiber bundles that results in a marked diffusion 
anisotropy, with greater diffusivity occurring along the axonal direction. By 
measurement of the diffusivity in multiple directions, DT-MRI can reconstruct an 
ellipsoid to model the diffusion in every voxel. The diffusion tensor is 
characterized by the magnitude of the diffusivity over its three axes 
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(eigenvectors). The mean diffusivity (MD) is the average of these diffusivities and 
captures the size of the tensor. Other informative measures include the axial 
diffusivity (λ1) aligned to the primary diffusion direction and the radial diffusivity 
(RD) that represent the diffusivity perpendicular to this main direction. The shape 
of the diffusion tensor is often quantified by the fractional anisotropy (FA), which 
is an index between 0 and 1 that indicates to what degree diffusivity is different 
over the three axes of the tensor.  
DT-MRI is particular well suited for studies of neurological disorders, like AD, 
because structural changes in neural tissue, like neuronal cell death and white 
matter microstructural pathology, are reflected in shape and size of the diffusion 
tensor (Kantarci, et al., 2005). In AD patients changes in DT-MRI parameters are 
particularly consistent, showing increased diffusivity with loss of directionality - 
decreased FA - in white matter and increased MD in gray matter regions (Hanyu, 
et al., 1998,Kantarci, 2011,S.-K. Song, et al., 2004). Histological examinations in 
brains of AD mice models suggested that myelin loss, decrease in axonal density 
and axonal disconnection contribute to the diffusion changes in white matter 
(Chen, et al., 2011,S.K. Song, et al., 2004). In gray matter, the increased diffusivity 
has been attributed to neuronal loss, as the diffusivity of water molecules 
increases when less cell membrane restrict their random motion (Sykova, et al., 
2005). Interestingly, changes in gray matter diffusion - e.g. elevated hippocampal 
MD - predicted the conversion from mild cognitive impairment (MCI) to AD 
similarly or even better than hippocampal volumetric changes in two 
independent studies (Fellgiebel, et al., 2006,Kantarci, et al., 2005). These results 
highlight the importance of characterizing the diffusion properties not only in 
white, but also in gray matter structures, as these contain unique and 
complementary information about the progression of the disease.  
For translational research in AD it’s important to perform similar DT-MRI studies 
in animal models of the disease, but only recently the availability of new 
dedicated hardware and methods for acquisition and data analysis enabled the 
study of brain water diffusion in small animals. The results reported in mouse 
models of cerebral amyloidosis showed white matter diffusion changes similar to 
those in human studies, but no further investigation on diffusion in gray matter 
sub-structures has yet been performed (S.K. Song, et al., 2004,Sun, et al., 2005).  
In this study, we aimed to assess water diffusion changes both in white and in 
gray matter in a double transgenic mouse model for AD (APPswe/PS1dE9). We used 
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state-of-the-art methodology for in vivo DT-MRI data acquisition (Harsan et al 
2010b) at ultra-high field (11.7T) with respiratory and cardiac motion correction 
and robust tensor estimation (L.A. Harsan, et al., 2010,Zwiers, 2010). Thereafter, 
we employed both ROI-based and whole-brain voxel-based approaches in 
combination with tractography algorithm to describe genotype differences with 
the highest possible spatial resolution. This enables an innovative and accurate 
description of diffusion changes, for a comprehensive spatial characterization of 
the underlying pathology in our AD mouse model. 
 
Material and methods 
 
Animals 
The APPswe/PS1dE9 founders were obtained from Johns Hopkins University, 
Baltimore, MD, USA (D. Borchelt and J.Jankowsky, Department of Pathology). A 
colony was bred and established at the Central Animal Facility at the Radboud 
University Nijmegen Medical Centre, The Netherlands. The transgenic mice were 
created by co-transfection with chimeric mouse/human amyloid precursor 
protein APPswe (mouse APP695 harboring a human Aβ domain and mutations 
K595N and M596L linked to Swedish familial AD pedigrees) and human presenilin 
1 with deletion of exon 9 (PS1dE9) vectors controlled by independent mouse prion 
protein promoter element (Jankowsky, et al., 2004,Jankowsky, et al., 2001). 
These two genes co-integrate and co-segregate as a single locus. Breeder mice 
were backcrossed to C57BL6/J for 12 generations to obtain the animals for this 
study. Throughout the duration of the experiment the mice were housed in 
groups. Room temperature was kept at 21° C with an artificial 12h light:dark 
cycle. Food and water were available ad libitum. The experiments were 
performed according to Dutch federal regulations for animal protection and were 
approved by the Veterinary Authority of the Radboud University Nijmegen 
Medical Centre.  
 
MR imaging 
Twelve months old male APPswe/PS1dE9 transgenic mice (n=9) and age-matched 
wild type (WT) littermates (C57BL6/J  n=15) were used for DT-MRI. Isoflurane 
(3.5% for induction and ~2% for maintenance) was used for anesthesia. The 
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anesthetic concentration was adjusted during the experiment in order to 
maintain the breathing frequency at 65-85 per minute. The mice were placed in a 
stereotactic device in order to immobilize the head. Body temperature was 
measured using a rectal thermometer and maintained at 37° C using a heated air 
flow device. 
MR measurements were performed on a 11.7 T BioSpec Avance III small animal 
MR system (Bruker BioSpin, Ettlingen, Germany) equipped with an actively 
shielded gradient set of 600 mT/m. We used a circular polarized volume 
resonator for signal transmission and an actively decoupled mouse brain 
quadrature surface coil for signal reception (Bruker BioSpin).  
Gradient echo (GE) images in the axial, sagittal and coronal orientation were 
acquired to visualize the anatomy and the morphology of the mouse brain 
structures. Imaging parameters were: echo time (TE) = 5 ms, repetition time (TR) 
= 630 ms, flip angle = 12 deg, field of view (FOV) = 40×40 mm, matrix size = 
512×512, slice thickness = 0.345 mm. 
Diffusion MRI was performed following a modified protocol of Harsan et al (L.A. 
Harsan, et al., 2010). In short, 31 axial slices covering the whole brain were 
acquired with a spin-echo planar imaging protocol (SE-EPI). B0 shift 
compensation, navigator echoes and automatic ghost correction algorithm were 
implemented to limit the occurrence of ghosts and artifacts. Encoding b-factors 
of 0 s/mm2 (b0 images; 5×) and 1000 s/mm2 were used and diffusion-sensitizing 
gradients were applied along 30 non-collinear directions of three-dimensional 
space. Other imaging parameters were: TE = 21.4 ms, TR = 7750 ms, time 
between the application of diffusion gradient pulses Δ = 10 ms, diffusion gradient 
duration δ = 4ms, number of segments = 4, total resolution 156×156×500 μm. 
This results in a total scan time of 18 minutes for each mouse.    
 
Data preprocessing 
For spatial normalization, a study-specific template was created of all WT and 
transgenic animals using Advanced Normalization Tools (ANTs. V1.9.x, 
http://picsl.upenn.edu/ANTS/). A group-wise normalization procedure (SyGN, as 
implemented in the buildtemplateparallel.sh script V0.0.13) was employed on 
the realigned mean diffusion image of each mouse (Avants et al 2008). The 
default implementation was followed with four iterations using mutual 
information as the initial affine similarity metric and cross-correlation as ‘greedy 
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SyN’ diffeomorphic transformation metric. A mask that included the entire brain 
was manually defined in the normalized coordinate space and transformed to 
each animal’s native space for use in subsequent processing.  
The diffusion tensor was estimated for every voxel using the PATCH algorithm 
(Zwiers, 2010). This method incorporates realignment and is robust against both 
regional (e.g. cardiac motion) and slice-wise (e.g. bulk motion) artifacts by 
providing a weight for every voxel that reflects the probability of being an outlier 
in the tensor fitting. From the eigenvalues of the diffusion tensor, the rotationally 
invariant indices fractional anisotropy (FA), mean diffusivity (MD), radial 
diffusivity (RD) and axial diffusivity (λ1) were calculated. The resulting volumes 
were spatially normalized to the template space using the affine parameters and 
deformation field obtained at template creation. 
 
Voxel-based group comparison 
Regional differences in spatially normalized FA, MD, RD and λ1 maps between 
APPswe/PS1dE9 mice and WT littermates were assessed voxel-wise using MATLAB 
R2008a (Mathworks, Natick, MA, USA) and Statistical Parametric Mapping 5 
(SPM5, Wellcome Department of Clinical Neurology, London, UK) with the 
SPMMouse toolbox (Sawiak, et al., 2009). Two t-tests were performed to identify 
increase (APPswe/PS1dE9 > WT) or decrease (APPswe/PS1dE9 < WT) genotype-wise 
differences in the framework of the general linear model (GLM). Statistical 
significance for an individual voxel was established at p<0.01, uncorrected for 
multiple comparisons. The locations of significant voxels exceeding a minimum 
cluster size of 4 (to achieve cluster size ≈ 0.05 mm3 as in (Dubois, et al., 2008)) 
were determined with an anatomical atlas (Franklin K, 1997,Franklin and Paxinos, 
1997). The contrasts were then color coded and overlaid onto images derived 
from the template image.  
 
ROI-based group comparison 
To compare our results with other studies, the DTI parameter maps FA, MD, RD 
and λ1 were evaluated for significant genotype differences with a region of 
interest (ROI) approach. For the ROI-based approach, ten white matter tracts 
were selected bilaterally across the mouse brain based on the atlas of (Franklin K, 
1997,Franklin and Paxinos, 1997). These regions include the anterior 
commissure, anterior commissure posterior, and genu – body – splenium of the 
Chapter 3 
________________________________________________________________________ 
64 
 
corpus callosum, cerebral peduncle, external capsule, fimbria of the 
hippocampus, fornix and optic tract. The hippocampus and cerebral cortex (all 
cortical areas above the corpus callosum) were also defined approximately at -
1.22 up to -2.54 posterior to bregma. 
 
Image analysis and tractography 
To determine the fiber systems involved in areas of significant difference 
between APPswe/PS1dE9 and WT, we investigated those regions with tractography. 
We used MRtrix' (v.0.2.9) constrained spherical deconvolution (CSD) with 
spherical harmonic order 4, for obtaining fiber orientation distributions (FODs) 
(Tournier, et al., 2007). Deterministic CSD tractography was initiated from the 
VBA clusters of significant FA differences separately for APPswe/PS1dE9 > WT and 
APPswe/PS1dE9 < WT. Fibers were seeded from these regions until 10000 fibers 
with a minimum of 1 mm, maximum length of 20 mm and stepsize 0.02 mm. 
Termination criteria were set at: FA threshold < 0.1 and curvature radius > 0.05. 
 
Histology 
In order to compare the axonal organization in hippocampal and cortical gray 
matter structures with our DT-MRI images and to demonstrate the correlation 
between changes in water diffusion as found with DT-MRI and the degeneration 
of the brain tissue, we performed two staining methods: one for myelin and 
nerve cell bodies (Klüver-Barrera staining) and one for myelinated and 
unmyelinated nerve fibers (Bodian silver staining). These stainings were 
performed on brain tissue of two APPswe/PS1dE9 and two wild type littermates of 
the scanned group of mice. After perfusion with saline the brains were removed 
from the skull and immersion fixated overnight in 4% phosphate buffered 
paraformaldehyde. After fixation, the brain tissue was dehydrated in alcohol 
series, cleared in xylene and embedded in paraffin. Sections of 5 µm were cut on 
a rotary microtome, mounted on albumen-coated glass slides and dried 
overnight at 37 °C. After removing the paraffin by xylene the sections were 
rehydrated in alcohol series and rinsed in distilled water. The brain sections 
(Bregma -2.92 mm, based on the atlas of Franklin and Paxinos, 1997) were 
stained according to Bodian (1936, 1937), or according to Klüver and Barrera 
(1953). After dehydration in alcohol series, sections were cleared with xylol and 
mounted in Entellan.  
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Statistical analysis 
Statistical analyses for the ROI-based approach were performed using SPSS v16.0 
(SPSS Inc. Chicago, IL, USA). Results are expressed as mean ± standard deviation 
(SD). Differences between genotypes in multiple ROIs were analysed with 
multivariate ANOVA’s with Bonferroni correction. Statistical significance was 
established at p<0.05. 
 
Results 
For each mouse, fractional anisotropy (FA), mean diffusivity (MD), radial 
diffusivity (RD) and axial diffusivity (λ1) maps were generated from the DT-MRI 
data (Figure 1-a). The high resolution of the images enabled us to recognize the 
organization of many structures in the mouse brain. This is illustrated in Figure 1-
b for ten slices of color-coded fractional anisotropy (FA) maps of a wild type 
mouse, overlaid with the primary diffusion direction λ1. These composite images 
incorporate in each voxel information from the anisotropy degree and the main 
diffusion orientation, and help to identify several white matter substructures that 
are difficult to distinguish by other image modalities (Jiang and Johnson, 2010). 
For example, neighboring white matter structures like the cerebral peduncle (cp) 
and the optic tract (ot) are readily discriminated from these images (Figure 1-b). 
Other white and gray matter structures are also easily identifiable, like the 
anterior commissure anterior (aca), anterior commissure posterior (acp), genu 
(gcc) – body (bcc) – splenium (scc) of the corpus callosum, external capsule (ec), 
fimbria of the hippocampus (fi) and fornix (f). 
 
Voxel-based analysis and tractography 
An anatomical template was overlaid with p-value maps (p-value with threshold 
at 0.01, minimum voxel cluster size set at 0.05 mm3) in order to visualize the 
distribution of water diffusivity differences between the APPswe/PS1dE9 transgenic 
and wild type mouse brains. Voxels that differ significantly are indicated by the 
colored overlay (Figure 2). Radial diffusivity (RD), mean diffusivity (MD), axial 
diffusivity (λ1) and FA were investigated using this method. The VBA indicates 
several areas of significant differences between the two genotypes. In several 
clusters in the corpus callosum (cc) and external capsule (ec), a decrease in all 
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Figure 1: Coronal images of diffusion parameter maps from a wild-type mouse. Fractional 
anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (λ1) 
maps are shown (a). Regions of interest were selected on a representative series of FA 
maps, color-coded by the diffusion orientation, overlaid with the primary diffusion 
direction λ1 (b). Anterior commissure anterior (aca), anterior commissure posterior (acp), 
cerebral peduncle (cp), optic tract (ot), genu (gcc) – body (bcc) – splenium of the corpus 
callosum (scc), external capsule (ec), fimbria of the hippocampus (fi), fornix (f), 
hippocampus (hc) and cerebral cortex (ct) were defined approximately from bregma 1.10 
mm to -3.16 mm, based on the atlas of Paxinos 1997. 
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Figure 2: Voxel based analysis indicate significant differences in radial diffusivity (RD), 
mean diffusivity (MD), axial diffusivity (λ1) and fractional anisotropy (FA) in transgenic 
APPswe/PS1dE9 mouse brains compared to wild type. Five rostral to caudal axial diffusion 
weighted maps are overlaid with voxels that showed a significant difference (p < 0.01, 
voxel cluster size 0.05 mm
3
). The voxel color indicates a negative or positive change in the 
transgenic mice compared to the wild type mice. VBA results were overlaid on top of a 
template image derived from the dataset. A widespread increase in RD is found in the 
hippocampus and in the fimbria (fi), while decreases are present in the corpus callosum 
(cc), cerebral peduncle (cp) and in the lateral posterior thalamus nuclei (LP). The MD 
decrease is found amongst others in the internal capsule (ic) and in the cc. An increased 
MD in the hippocampus and fi is also present. An increase in λ1 is found along the 
boundaries of the hippocampus, while a decrease is present in the splenium of cc (scc). FA 
reduction was observed in areas such as the scc, fi and cortex. Increases in FA are found in 
the cp, ic LP. 
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DT-MRI parameters (FA, MD, RD & λ1) was visible. The decrease in FA resulted 
from the stronger decrease in λ1 than in RD. In the fimbria of the hippocampus, 
bilateral clusters of voxels showed a large increase in MD, RD and λ1, with 
decreased FA. In the area corresponding to the cerebral peduncles, a decrease in 
RD is notable, together with an increase in FA and a slight decrease in λ1. 
Similar changes were detected in other areas, like the internal capsule (ic) and 
the lateral posterior thalamus nuclei (LP). The fiber tracts of a wild type mouse 
shown in Figure 3 were obtained from seeding fibers in the clusters of significant 
differences in FA from the VBA (overlaid in the pictures). The seeded voxels were 
differentiated in areas where APPswe/PS1dE9 mice showed lower FA values (Figure 
3a, in blue) and higher FA values (Figure 3b, in red) compared to wild type. By 
tracking fibers from voxels of significantly lower FA in the APPswe/PS1dE9 mice, we 
identified several white matter fiber bundles involved in degeneration processes 
in these mice. Among them, the whole corpus callosum with its extensions into in 
the cortex and the fimbria of the hippocampus were the areas most affected 
(Figure 3a). Conversely, the tracts resulting from seed voxels of higher FA in the 
transgenic mice did not form single coherent fiber bundles, but these voxels 
showed a marked co-localization with crossing fibers, originating from the 
thalamus, midbrain and hypothalamus (Figure 3b).  
Interestingly, the VBA indicated clusters of significant genotype differences 
located in gray-matter structures. In both left and right hippocampus, the MD, 
RD and λ1 increased in transgenic mice compared to the control (Figure 2). The 
FA did not change significantly. A closer look at these results shows that most of 
the differences are present in the LMol and in the Mol layers of the hippocampus 
(Figure 2). In some cortical areas, mainly in the visual cortex, a few clusters of 
decreased FA and λ1 were also found. 
 
 Regions of interest (ROI) based analysis 
For a quantitative assessment of genotype differences, we analyzed the DT-MRI 
indices in ROI drawn on several white and (two) gray matter structures. The 
results are shown in Table 1. A significant decrease in diffusion along the main 
fiber orientation (λ1) was seen in the anterior commissure posterior (p=0.030), 
cerebral peduncle (p=0.020), body of corpus callosum (p=0.010) and fornix 
(p=0.025) of transgenic mice. In the latter three regions, this was also associated 
with a decreased MD (p=0.004, p=0.044 and p=0.023 respectively). In the fimbria 
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of the hippocampus, we found a strong increase in RD (p<0.001), linked with a 
decreased FA (p=0.013) and increased MD (p=0.037).  In the total hippocampal 
area, we detected a strong significant increase in MD, RD and λ1 (p=0.001, 
p=0.003 and p=0.002 respectively). In the cerebral cortex, a decrease in FA was 
seen (p=0.035). Overall, diffusion values resemble the results from other similar 
studies (L.-A. Harsan, et al., 2010,Ruest, et al., 2011). 
 
Gray matter diffusion and genotype comparison with histology  
To illustrate the advantage of high resolution MR imaging to assess directional 
diffusivity in grey matter structures, magnifications of the DT-MRI images of 
hippocampal area (Figure 4) and cortical area (Figure 5) were compared with 
stainings for myelin and nerve cells (Kluver-Barrera) and staining for nerve fibers 
(Bodian). The anatomical layers which constitute the hippocampus are 
discernible by the different orientation of their diffusion tensors (Figure 4 a-b): 
two layers of marked anisotropy and medial-lateral orientation, correspond to 
the stratum radiatum (Rad) and the molecular layer of dentate gyrus (Mol), and 
they alternate with two thin layers of more isotropic diffusion: i.e. the lacunosum 
moleculare layer (LMol) and the granular layer of the dentate gyrus (GrDG) / 
polymorph layer of the dentate gyrus (PoDG). The actual orientation of the axons 
is visualized in the hippocampal layers by the Klüver-Barrera staining (Figure 4 c-
d) and by the Bodian staining (Figure 4e). In the latter, the alignment of the fibers 
in the direction radial to the cortical surface is discernible in the Rad and in the 
Mol layers. An incoherent alignment of the nerve fibers is found instead in the 
LMol, GrDG and PoDG. Overall, a good anatomical agreement is found between 
DT-MRI data and nerve fibers directionality and alignment. Sections of the same 
Bregma (-2.92 mm) stained according to Klüver-Barrera, are shown in order to 
demonstrate neurodegeneration in the APPswe/PS1dE9 (Figure 4d) compared 
with wild-type mice (Figure 4c). In the APPswe/PS1dE9, the GrDG layer is 
significantly thinner compared to WT mice due to a marked reduction of neurons 
as shown with the Klüver-Barrera staining (Figure 4d, arrows). In the 
magnification insert of the APPswe/PS1dE9 mouse (Figure 4g) a decreased 
amount of stained healthy neuronal cell bodies is visible in this layer and many 
more pycnotic dark stained cells are shown compared to the WT (Figure 4f), 
suggesting degenerated neurons.Spherical-shaped areas with no staining are 
present in the APPswe/PS1dE9 tissue, most likely related to the presence of Aβ 
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 Figure 3: Example of fiber tracts of a wild type mouse seeded from the clusters of 
significant differences in FA. (a) shows tracts from the voxels where APPswe/PS1dE9 mice 
showed significantly lower FA values (overlaid as blue voxels). The tracts defined in (a) 
suggest the areas that appear to be more affected in transgenic mice, particularly corpus 
callosum, fimbria of hippocampus and fornix. (b) shows tracts from clusters where APP 
mice showed significantly higher FA values (overlaid as red voxels). The tracts in (b) spread 
out in multiple directions, suggesting the presence of crossing fibers. 
 
 
plaque deposits (Figure 4d, asterisks). No major differences in amount of nerve 
fibres between APPswe/PS1dE9 and WT mice were detectable with the Bodian 
staining (not shown). In the cerebral cortex the primary diffusion direction radial 
to the cortical surface can be clearly identified (Figure 5). 
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Figure 4: Diffusion orientations in a representative wild type (WT) mouse hippocampus at 
12 months of age (a, b). The primary diffusion tensor orientation is overlaid on FA maps, 
color-coded by the diffusion orientation (a). The diffusion is shown with fiber orientation 
distribution (FODs) overlaid on the FA (b). In the hippocampus, two layers of marked 
anisotropy and medial-lateral orientation alternate with two layers of more isotropic 
diffusion. The anatomical orientation of the axons is visualized in the hippocampal layers 
Chapter 3 
________________________________________________________________________ 
72 
 
by the Klüver-Barrera staining in a WT and an APPswe/PS1dE9 mouse (c, d respectively, 10× 
magnification) and in a WT mouse by the Bodian staining (e, 5× magnification). In the 
stratum radiatum (Rad) and in the molecular layer of the dentate gyrus (Mol) the fibers 
are oriented in the direction radial to the cortical surface, as visible in the Bodian staining 
(e). A less coherent alignment of the nerve fibers is found instead in the lacunosum 
moleculare layer (LMol), in the granulate layer of the dentate gyrus (GrDG) and in the 
polymorph layer of the dentate gyrus (PoDG). Overall, a good anatomical agreement is 
found between diffusion data and nerve fibers directionality and alignment. The Klüver-
Barrera staining of a WT (c) and of a APPswe/PS1dE9 (d) and their correspondent 
magnifications (f, g, 40× magnification) illustrate neurodegeneration in the transgenic 
mice, with thinner GrDG layer (d, arrows), loss of healthy neurons and many pycnotic dark 
stained cells and spherical-shaped areas with no staining, possibly due to the presence of 
Aβ plaques (d, asterisks). DT-MRI images and staining sections were selected at Bregma -
2.92 mm, based on the atlas of Franklin and Paxinos 1997. C, d, e: scale bar = 250 μm. F, 
g: scale bar = 50 μm. 
 
 
This corresponds well with the axonal orientation, as shown with Klüver-Barrera 
and Bodian staining of the same areas (Figure 5c-d and Figure 5e respectively). 
Comparing APPswe/PS1dE9 (Figure 5d) and WT mice (Figure 5e), the only 
noticeable difference in the cortical tissue was the loss of both neurons and 
fibers in regions that are likely related to presence of the Aβ plaques (Figure 5d, 
asterisks).  
 
Discussion 
DT-MRI has become accepted in clinical practice as preferred tool for 
quantitative assessment of the structural integrity of white matter and, to some 
extent, of gray matter (Basser, et al., 1994,Beaulieu, 2002). Nowadays, it is 
possible to apply water diffusion MRI also in translational research and acquire 
high-resolution DTI images of the mouse brain in vivo (L.A. Harsan, et al., 2010). A 
recent study in rat brain validated the correlation between DTI parameters and 
microstructural tissue properties (Budde and Frank, 2012). This is of particular 
interest in experimental AD research to monitor white and gray matter 
degeneration in AD models for the investigation of new preventive strategies. A 
reduction of the apparent diffusion coefficient was found in neocortical areas of 
25 months old APP23 transgenic mice, which was associated with fibrillar 
amyloid deposits and glial proliferation (Mueggler, et al., 2004). 
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 APPswe/PS1dE9 Wild type p-value 
Anterior commissure    
   RD 0.51 ± 0.03 0.50 ± 0.05 n.s. 
   MD 0.69 ± 0.03 0.70 ± 0.04 n.s. 
   λ1 1.06 ± 0.08 1.08 ± 0.05 n.s. 
   FA 0.45 ± 0.05 0.46 ± 0.06 n.s. 
Anterior commissure posterior    
   RD 0.62 ± 0.08 0.65 ± 0.02 n.s. 
   MD 0.74 ± 0.06 0.77 ± 0.02 n.s. 
   λ1 0.99 ± 0.04 1.02 ± 0.03 0.030 
   FA 0.31 ± 0.11 0.28 ± 0.02 n.s. 
Cerebral peduncle    
   RD 0.42 ± 0.03 0.44 ± 0.03 n.s. 
   MD 0.70 ± 0.02 0.74 ± 0.02 0.004 
   λ1 1.27 ± 0.08 1.33 ± 0.04 0.020 
   FA 0.61 ± 0.04 0.60 ± 0.02 n.s. 
   Corpus callosum - Body    
   RD 0.61 ± 0.05 0.64 ± 0.03 n.s. 
   MD 0.74 ± 0.05 0.78 ± 0.03 0.044 
   λ1 0.99 ± 0.06 1.06 ± 0.04 0.01 
   FA 0.37 ± 0.04 0.39 ± 0.03 n.s. 
Corpus callosum - Genu    
   RD 0.64 ± 0.08 0.59 ± 0.06 n.s. 
   MD 0.82 ± 0.09 0.80 ± 0.05 n.s. 
   λ1 1.18 ± 0.16 1.22 ± 0.05 n.s. 
   FA 0.39 ± 0.06 0.44 ± 0.05 0.058 
Corpus callosum - Splenium    
   RD 0.73 ± 0.11 0.79 ± 0.11 n.s. 
   MD 0.97 ± 0.09 1.03 ± 0.11 n.s. 
   λ1 1.47 ± 0.09 1.52 ± 0.12 n.s. 
   FA 0.44 ± 0.08 0.41 ± 0.04 n.s. 
External capsule    
   RD 0.71 ± 0.07 0.69 ± 0.03 n.s. 
   MD 0.83 ± 0.06 0.81 ± 0.02 n.s. 
   λ1 1.06 ± 0.07 1.06 ± 0.02 n.s. 
   FA 0.29 ± 0.03 0.30 ± 0.02 n.s. 
Fimbria of the hippocampus    
   RD 0.78 ± 0.08 0.65 ± 0.04 0.000 
   MD 1.05 ± 0.09 0.96 ± 0.08 0.037 
   λ1 1.60 ± 0.19 1.58 ± 0.18 n.s. 
   FA 0.45 ± 0.07 0.51 ± 0.05 0.013 
Fornix    
   RD 0.40 ± 0.04 0.42 ± 0.07 n.s. 
   MD 0.64 ± 0.06 0.70 ± 0.05 0.023 
   λ1 1.10 ± 0.18 1.60 ± 0.11 0.025 
   FA 0.55 ± 0.08 0.59 ± 0.08 n.s 
Optic tract    
   RD 0.55 ± 0.06 0.54 ± 0.03 n.s. 
   MD 0.76 ± 0.06 0.77 ± 0.03 n.s. 
   λ1 1.20 ± 0.10 1.24 ± 0.04 n.s. 
   FA 0.48 ± 0.06 0.50 ± 0.03 n.s. 
Hippocampus    
   RD 0.80 ± 0.05 0,75 ± 0.02 0.003 
   MD 0.87 ± 005 0.81 ± 0.02 0.001 
   λ1 1.01 ± 0.06 0.94 ± 0.02 0.002 
   FA 0.16 ± 0.03 0.16 ± 0.03 n.s. 
Cerebral cortex    
   RD 0.70 ± 0.02 0.70 ± 0.02 n.s. 
   MD 0.77 ± 0.02 0.77 ± 0.02 n.s. 
   λ1 0.89 ± 0.02 0.91 ± 0.02 n.s. 
   FA 0.16 ± 0.02 0.18 ± 0.02 0.035 
Table 1. Diffusion tensor parameters of the regions of interest. The mean (MD), radial (RD) 
and axial (λ1) diffusivities are expressed in units of 10
-3
 mm
2
/s. n.s.: non-significant 
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Figure 5. Diffusion orientations in a representative mouse brain cortex at 12 months of 
age (a,b). The primary diffusion direction is overlaid on color-coded FA maps (a). The 
diffusion is shown with FODs overlaid on the FA (b). The diffusion direction well resembles 
the actual axonal orientation radial to the cortical surface, as shown with the Klüver-
Barrera staining of a WT and an APPswe/PS1dE9  mouse (c-d, respectively) and with the 
Bodian staining of a WT (e) in the same areas (boxes in a and b). The Klüver-Barrera 
staining of a APPswe/PS1dE9 mouse (d) revealed the presence of spherical-shaped areas 
characterized by omission of staining, were no fibers and cell bodies are present likely due 
to Aβ plaque deposits in the transgenic animals (d, asterisks). c, d, e: magnification = 10x. 
Scale bar = 250 μm.    
 
 
In DT-MRI studies, changes in fractional anisotropy (FA) and longitudinal 
diffusivity (λ1) were found in 15 months old PDAPP mice and 12 months old 
Tg2576 mice in some white matter areas, including corpus callosum and external 
capsule, followed by an increase in radial diffusivity (RD) as the pathology 
progressed (S.K. Song, et al., 2004,Sun, et al., 2005). Remarkably, the same 
effects were not seen in an ex vivo study with APPswe mice brains, likely due to 
fixation-related alterations in post-mortem analysis (Harms, et al., 2006).  
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In this study, we aimed for a comprehensive analysis of the DT-MRI changes 
occurring not only in white but also in gray matter in 12 months old APPswe/PS1dE9 
mice in vivo. At 12 months of age these transgenic mice already exhibit 
widespread parenchymal deposits of Aβ in several cortical and subcortical 
regions, together with progressive Aβ accumulation in the vascular walls, leading 
to cerebral amyloid angiopathy (CAA) (Garcia-Alloza, et al., 2006,Jankowsky, et 
al., 2004). Furthermore, deficits in learning and memory tasks were described at 
this age in the Morris water maze test, indicating an initial decline of neuronal 
function (Malm, et al., 2011). 
 
White matter 
A histological characterization of white matter degeneration of 24 months old 
APP/PS1 mice (with the Swedish KM670/671NL, and London mutation V717I 
introduced in human sequence APP751 × HMG PS1 M146L) has been recently 
reported (Chen, et al., 2011). This study demonstrated fiber tract volume 
reduction, loss of axonal neurofilaments and myelin breakdown in axonal bundles 
of the corpus callosum (cc) and the anterior commissure. Interestingly, atrophy 
of the corpus callosum is also classically observed in AD patients (Teipel, et al., 
2002). Our DT-MRI results describe in vivo changes in white matter diffusion that 
resemble the fibre tract anomalies reported by Chen et al, including changes in 
the cc. Compared to wild type littermates, the APPswe/PS1dE9 mice display a 
smaller and more isotropic diffusion ellipsoid in some areas of the cc, particularly 
in the body of cc, with the largest reduction occurring in the direction of the fibre 
bundles (λ1). This situation has been associated with a Wallerian-like 
degeneration in the presence of axonal disconnection and volume reduction of 
fiber tracts, as the water molecules have more restricted diffusion mostly along 
the tracts (Sun, et al., 2008). Wallerian-like degeneration and processes of 
retrogenesis are also described in the corpus callosum of mild AD patients (Di 
Paola, et al., 2010). We did not find an increase in RD in the cc, that has been 
linked to myelin degradation of the axonal bundles (Song, et al., 2005), but 
contrarily we found a minor decrease. This same trend has been shown already 
by Sun et al in 12 months old Tg2576 mice. In their experiment, mice were 
measured at multiple time points, and the increase in RD in the cc was detected 
only after 16 months of age (Sun, et al., 2005). Together these findings indicate 
that myelin degradation in the cc occurs in an advanced stage of the pathology. 
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This corresponds with histological findings, in which volume reduction of the 
corpus callosum in APP/PS1 mice – at 24 months of age – appeared to be largely 
caused by atrophy of fiber bundles, loss of axonal neurofilaments and only partly 
by myelin breakdown (Chen, et al., 2011). In our staining on myelin and nerve 
fibers, we could not detect well-defined differences in cc between APPswe/PS1dE9 
and WT mice. However, the lack of staining in some areas of the cc and the 
external capsule in the transgenic mice are likely related to deposits of Aβ, which 
could interfere with the shape and the integrity of the axonal bundles (Sun, et al., 
2005). The presence of Aβ in white matter regions of APPswe/PS1dE9 mice already 
has been reported at this age by ex vivo histopathological studies (Zerbi et al 
2012). Contrary to what we expected, the VBA showed also regions of co-
localized increased FA and decreased RD in the APPswe/PS1dE9, e.g. in the cerebral 
peduncles and thalamic areas below the hippocampus. This would suggest that in 
these regions wild type mice and not APPswe/PS1dE9 mice show signs of white 
matter pathology and myelin degradation. However, as highlighted by our 
tractography images, in these regions the white matter is not coherently aligned 
as in the cc, ec or ac and crossing fibers are frequent. The FA in such regions is 
naturally lower than would be the case in any one of these bundles separately.  In 
the depicted thalamic regions, the higher FA and lower RD that we found in 
APPswe/PS1dE9 mice could therefore be caused by a degeneration of one fiber 
tract, in voxels that normally include more fibers with different orientations. This 
event would cause one fiber group to dominate in the diffusion quantification, 
resulting in a voxel with higher FA and lower RD. This concept has been discussed 
recently for AD patients, where the increase of FA in crossing-fiber areas was 
associated with early white matter alterations (Douaud, et al., 2011). A recent 
study on stained rat brain slices further demonstrated that these regions are 
likely to include multiple fibre populations (Budde and Frank 2012). 
 
Gray matter 
The interpretation of the data from gray matter diffusion imaging requires 
distinct considerations. Whereas the white matter consists of relatively coherent 
bundles of myelinated axons, in gray matter regions like cortex or hippocampus, 
the constituents are far more heterogeneous in size, shape and orientation. The 
larger volume fraction of cell bodies of neurons and glial cells compared to white 
matter fibre bundles yield an increased isotropic diffusion. As the dendrites are 
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only partially coherently organized and the axons are not homogeneously 
distributed and may be myelinated or unmyelinated, their contribution to the 
diffusion signal is uncertain and may vary in different substrate regions. Hence, if 
the analysis of FA do not account for these contributions, it may lose its 
descriptive meaning. Instead, other parameters like the averaged diffusivity along 
all the diffusion directions (MD) are considered more informative. There is 
growing evidence that the increased MD in the hippocampus is associated with 
loss of neurons and can be used as a good predictor of AD progression 
(Carlesimo, et al., 2010,Fellgiebel, et al., 2006); In the present study, a marked 
increase in MD was seen in the hippocampus of APPswe/PS1dE9 mice, suggesting 
neurodegeneration. With the increased spatial sensitivity of the VBA, we were 
able to further circumscribe these changes to the lacunosum moleculare layer 
(LMol) and the molecular layer of the dentate gyrus (Mol). To the best of our 
knowledge, this is the first study that reports diffusion changes in AD models in 
specific sub-regions of the hippocampus, which is a key-area in AD pathogenesis, 
related to spatial memory and learning and among the earliest and most severely 
affected regions in AD pathology in these mice (Braak and Braak, 1991,Garcia-
Alloza, et al., 2006). 
The increase of MD in gray matter has been described in several human AD 
studies, and is often explained to be caused by neuronal degeneration and cell 
loss, resulting in less hindered water diffusion (Fellgiebel, et al., 2004). Although 
reports about neuronal loss in mice expressing APP mutations are still 
controversial, this explanation for our results is supported by histological analysis. 
In the Klüver-Barrera staining for myelin and nerve cells, we showed clear 
evidence of neuronal loss with thinning of the whole GrDG layer of the 
hippocampus in APPswe/PS1dE9 mice compared to the WT.  Interestingly, the 
neurodegeneration seems to occur adjacently to the Mol layer of the DG, where 
we demonstrated higher MD in APPswe/PS1dE9 mice with DT-MRI.  
Similar findings have been found in other studies in APP/PS1 double transgenic 
mice. Two studies reported a substantial age-related neuronal loss in the 
hippocampal pyramidal cell layer of APP/PS1 mice that could relate to our results 
(Ramos, et al., 2006,Schmitz, et al., 2004). Lower levels of glucose uptake were 
measured with fluoro-D-glucose PET (FDG-PET) in APP/PS1 mice compared to PS1 
mice in the LMol and in the stratum radiatum of the hippocampus (Dubois, et al., 
2010). Moreover, in 12 months old APPswe/PS1dE9 mice, robust axonal loss (~50%) 
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of monoaminergic neurons in hippocampal and cortical regions was observed, 
which was correlated with progressive atrophy of cell bodies and loss of 
monoaminergic neurons (Liu, et al., 2008).  
Vascular alterations are closely associated with amyloid angiopathy, and could 
contribute to a progressive neuronal loss due to chronic hypoperfusion and/or 
ischemia (de la Torre, 2002). Many reports, including some from our group, 
described a reduction in cerebral blood volume in the hippocampus of APP/PS1 
mice (Hooijmans, et al., 2009,Wu, et al., 2004,Zerbi, et al., 2012). Furthermore, 
several changes in behavior and memory impairment are known in these mice, 
and suggest hippocampal neuronal malfunction or loss (Hooijmans, et al., 2009). 
The histological staining methods did not reveal neuronal loss in the cerebral 
cortex of APPswe/PS1dE9 mice. However in this area, the absence of staining of 
neurons and nerve fibres in the spherically shaped areas is likely due to a severe 
cortical Aβ plaque load. The presence of Aβ plaques might result in a more 
isotropic diffusion on the voxel level, because the structure of the Aβ is unlikely 
to contribute to anisotropy. This is in agreement with the reduction in cortical FA 
in our DT-MRI results for the APPswe/PS1dE9 mice compared to WT. 
 
Methodological considerations 
For achieving fast and high-resolution EPI images with a good signal-to-noise 
ratio (SNR), the use of ultra-high field magnet strength coupled with powerful 
gradients and highly sensitive radiofrequency coils are prerequisites. Especially at 
ultra-high field (> 7T), susceptibility inhomogeneities that can cause image 
distortion must be properly adjusted by careful shimming. Furthermore, 
respiration and head movement must be avoided during the acquisition (e.g. by 
using a stereotactic holder) and should be further corrected with post-processing 
methods (Zwiers, 2010). All these criteria were fulfilled in this study. 
The advantages in SNR allowed us to acquire high spatial resolution data in a 
short acquisition time. The use of high resolution is necessary to describe 
diffusion proprieties in small brain structures, and is particularly important to 
reduce the partial volume effect in structures neighboring cerebrospinal fluid 
(CSF) or at the interface between GM and WM. In these areas, the presence of 
different structures in one voxel can bring about an erroneous evaluation of DT-
MRI parameters. In AD patients with brain atrophy the enlargement of cerebral 
ventricles might contribute to an increased MD (Kwong, et al., 1991). An increase 
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of the CSF area has also been observed in APP/PS1 mice by high-resolution MRI 
volumetry (Delatour, et al., 2006). From our VBA, we detected an increase in MD 
and RD and a decrease in FA in voxels along the hippocampal CA3 region and left 
and right ventricles. It is possible that the increase in ventricle size and atrophy of 
the fimbria of the hippocampus might have influenced these results, due to 
partial volume effects. The anatomical differences between groups and the 
influence of image deformation was however reduced by the use of a study-
specific template and by the non-linear diffeomorphic transformation applied for 
the spatial normalization of the individual datasets. This makes it unlikely that 
partial volume effects near CSF areas have influenced the results in the 
hippocampal sub-regions.  
In conclusion, in this paper we describe a method to acquire and process high-
resolution DT-MRI images in mice with a voxel-based approach. This 
methodology was applied to evaluate changes in water diffusivity in both white 
and gray matter occurring in 12 months old APPswe/PS1dE9 mice, with a spatial 
characterization of the effects not limited to predetermined neuroanatomical 
locations. As changes in DT-MRI parameters have been associated with 
progression in neuronal and myelin damage, the methodology and results 
presented here provide the basis both for further studies on the biological cause 
of diffusion changes and for evaluation of the efficiency of future treatment 
strategies in mice models for AD and other neurodegenerative disorders.  
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Abstract 
It is well-established that the cholesterol-transporter apolipoprotein ε (apoE) 
genotype is associated with the risk of developing neurodegenerative diseases. 
Recently, brain functional connectivity (FC) in apoE-ε4 carriers has been 
investigated by means of resting-state fMRI, showing a marked differentiation in 
several functional networks at different ages compared to carriers of other apoE 
isoforms. The causes of such hampered FC are not understood, but it has been 
suggested that vascular function and synaptic repair processes, which are both 
impaired in carriers of apoE-ε4, can trigger loss of FC during aging. To test this 
hypothesis, we integrated several different MRI techniques and 
immunohistochemical staining in a translational study using aging apoE-ε4 and 
apoE-knockout (-ko) mice. Compared to wildtype mice, we detected profound FC 
reduction in adult and elderly apoE-ko mice, concomitant with strongly reduced 
brain perfusion. In apoE-ε4 mice perfusion deficits appear only later in life, and 
no significant changes of FC were seen. In both mouse models, water diffusion 
changes commonly associated to axonal disconnection and disorganization are 
found in hippocampal areas, in agreement with reduced post synaptic density 
levels at different ages. In conclusion, we provide new evidence for a relation 
between apoE and brain connectivity, possibly mediated by vascular risk factors 
and by the efficiency of apoE as synaptic modulator in the brain. Our results show 
that FC assessment by resting-state fMRI is an excellent tool to investigate 
neuropathology and aging effects in translational research. 
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Introduction 
The only gene that currently is associated to sporadic Alzheimer’s disease (AD) is 
the ε4 allele of the apolipoprotein E (apoE) (Corder, et al., 1993,Mahley and Rall, 
2000,Strittmatter, et al., 1993). Several mechanisms by which the apoE-ε4 
promotes AD have been proposed; one of these states that, compared to the 
other isoforms, the ε4 confers impairment in cerebrovascular function, which in 
turn alters synaptic and neuronal health (Liu, et al., 2013,Zlokovic, 2013). In the 
brain, apoE is produced after injury to transport cholesterol to the damaged 
neuronal and synaptic membranes; however, apoE4-ε4 carriers seem to be more 
susceptible to vascular brain damages (eg. stroke, brain haemorrhage (Zlokovic, 
2011)); at the same time, the repair and remodelling of damaged synapses 
appears to be less effective by apoE-ε4 than other isoforms (Mahley, et al., 
2006,Verghese, et al., 2011). This, in the end, can result in a permanent loss of 
synaptic contacts, with gradual loss of neuronal connectivity (Bu, 2009,Verghese, 
et al., 2011). This abnormal connectivity in apoE-ε4 carriers has recently been 
investigated by resting-state functional magnetic resonance imaging (rsfMRI).  
RsfMRI examines the temporal correlations of blood oxygen level dependent 
(BOLD) fluctuations between brain different regions during a resting condition, 
thought to reflect resting neuronal activity (Damoiseaux, et al., 2006,De Luca, et 
al., 2006). The temporal correlation of neuronal activity among different brain 
regions is often referred as functional connectivity (FC) (Biswal, et al., 1995). This 
MR technique has generated a great deal of interest among neuroscientists and 
has been widely used to investigate neurological disorders (Greicius, 2008). 
Many studies have reported on a correlation between apoE-ε4, AD, and 
abnormalities in functional connectivity measured with rsfMRI; cognitively 
normal young apoE-ε4 carriers showed elevated resting-state activity in the 
default mode network and high hippocampal activation during memory tasks; 
both areas that are preferentially affected in early AD (Bookheimer, et al., 
2000,Filippini, et al., 2009). This hippocampal hyper-activation is thought to 
represent a compensatory response, in which increased cognitive effort is 
required to achieve an equal level of performance to that of non-ε4 carriers 
(Bondi, et al., 2005). Such hyper-activation is followed by a rapid decline in FC 
and structural interconnectivity between several cortical regions at older age 
(Brown, et al., 2011,Machulda, et al., 2011,O'Brien, et al., 2010). In elderly apoE-
ε4 carriers a reduced FC in brain networks compared to apoE-ε3 carriers is 
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shown, even in the absence of amyloid-β plaques (Sheline, et al., 2010). Despite 
an increasing amount of evidence for an association between apoE genotype and 
FC, the mechanisms underlying this relationship remain elusive (Verghese, et al., 
2011).  
Here we investigate, in a translational study, functional connectivity in relation 
with cerebral perfusion, brain tissue microstructure, analyzed by diffusion tensor 
MRI (DT-MRI), and staining for post synaptic density. We used target-
replacement apoE-ε4 mice, as a model for hypercholesterolemia and AD vascular 
risk factors, and apoE-ko mice, as model for severe atherosclerosis. We 
hypothesize that a decrease in FC can be caused by cerebrovascular impairments 
due to the apoE-ε4 (or its absence), which subsequently triggers neuronal and 
synaptic dysfunction.  
 
 
Materials and methods 
 
Animals 
The ApoE-ε4 founder mice were originally obtained from Taconic Transgenic 
Models (Hudson, NY, USA) and a colony was established at the Radboud 
University Nijmegen Medical Centre (RUNMC). ApoE-ε4 mice were created by 
targeting the murine APOE gene for replacement with the human apoE-ε4 alleles 
cultured in E14TG2a Embryonic Stem (ES) cells as described previously (Sullivan, 
et al., 1997). Resulting chimeras were backcrossed to C57BL/6J (B6) mice for 8 
generations. The line was derived by embryo transfer and is maintained by 
incrossing homozygous mice. For the present study, male and female apoE-ε4 
breeder mice were used to generate homozygous apoE-ε4 offspring (3rd 
generation). 
The ApoE-deficient (B6,129P2-Apoetm1Unc/J) founders were originally obtained 
from Jackson Laboratories (Bar Harbor, ME, USA) and a colony was established at 
the RUNMC. In ApoE KO mice the APOE fragment was targeted with an apoE-
specific probe (a Sac I/Bgl II fragment) isolated from a mouse apoE cDNA clone. 
The strongly hybridizing phage clones obtained in this screening, a 7.8-kilobase 
(kb) EcoRI fragment was isolated and compared with the restriction map. 
Subsequently these targeted cells were cultured in E14TG2a Embryonic Stem (ES) 
and injected into C57BL/6J (B6) mice. Resultant chimeras were backcrossed for 
11 generations and intercrossed to homozygosity. The line was derived by 
Resting-state functional connectivity changes in aging apoE-ε4 and apoE-ko mice 
________________________________________________________________________ 
85 
 
embryo transfer and is maintained by incrossing homozygous mice (Piedrahita, 
Zhang et al. 1992). For the present work, male and female ApoE knockout (apoE-
ko) breeder mice were used to generate homozygous apoE-ko offspring (3rd 
generation). 
C57BL6/JOlaHsd wild-type mice, obtained from our colony at the RUNMC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
were used as controls. Throughout the experiment animals were housed in 
groups of 2-7 mice per cage in a controlled environment, homogenously 
illuminated by normal fluorescent room light at 60 lux, with room temperature at 
21ºC, and an artificial 12:12h light:dark cycle (lights on at 7 a.m.). Food and water 
were available ad libitum.  
The experiments were performed according to Dutch federal regulations for 
animal protection. The Veterinary Authority of the Radboud University Nijmegen 
Medical Centre (RUNMC), the Netherlands, approved all the protocols within this 
study. 
 
MR imaging 
Two cohorts of apoE-ε4, apoE-ko and wildtype male mice of 12 months of age 
(number of animals for each genotype (n) = 8, 10 and 9, respectively) and of 18 
months of age (n= 12, 9, 10, respectively) were used for this study. To study 
genotype and aging related differences in brain function and structure, resting 
state functional MRI (rsfMRI), cerebral blood flow (CBF) and diffusion tensor 
imaging (DT-MRI) were measured in each cohort.  
MRI measurements were performed on an 11.7 T BioSpec Avance III small animal 
MR system (Bruker BioSpin, Ettlingen, Germany) equipped with an actively 
shielded gradient set of 600 mT/m and operated by a Paravision 5.1 software 
platform. We used a circular polarized volume resonator for signal transmission 
and an actively decoupled mouse brain quadrature surface coil for signal 
reception (Bruker BioSpin). During the MR experiments mice were anesthetized 
with isoflurane (3.5% for induction and ~1.5% for maintenance). The mice were 
placed in a stereotactic device in order to immobilize the head. Body 
temperature was measured using a rectal thermometer and maintained at 37° C 
using a heated air flow device. 
 
After standard adjustments, gradient echo (GE) T2
*-weighted images covering the 
entire mouse brain were acquired for anatomical reference. Subsequently, 
rsfMRI datasets were acquired using a single shot spin echo sequence combined 
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with echo-planar imaging (SE-EPI) sequence. Six hundred repetitions with a 
repetition time (TR) of 1.8s and echo time of 11.8ms were recorded for a total 
acquisition time of 17 minutes.  
 
To study brain perfusion under resting conditions, a flow-sensitive alternating 
inversion recovery arterial spin labelling (FAIR ASL) technique was used (Kim, 
1995). Fifteen images with increasing inversion times (TIs) (40 ms - 3000 ms) 
were obtained for the T1 calculations, amounting to a total scan time of 12 
minutes. Inversion recovery data from the imaging slice were acquired after 
selective inversion interleaved with non-selective inversion.  
 
Diffusion of water was measured as described previously (Harsan, et al., 
2010,Zerbi, et al., 2013). In short, 31 axial slices covering the whole brain were 
acquired with a four-shot SE-EPI protocol. B0 shift compensation, navigator 
echoes and an automatic correction algorithm to limit the occurrence of ghosts 
and artefacts were implemented. Encoding b-factors of 0 s/mm2 (b0 images; 5×) 
and 1000 s/mm2 were used and diffusion-sensitizing gradients were applied 
along 30 non-collinear directions in three-dimensional space. All other imaging 
parameters are listed in Table 1. 
 
Table 1. Parameters used in each MR scan 
 
 Imaging sequence 
 
Anatomical images Resting-state fMRI Cerebral blood flow 
Diffusion tensor 
imaging 
Method Gradient echo Spin Echo EPI FAIR-ASL 4-shot Spin Echo EPI 
Echo time (TE) 5 ms 16.9 ms 11.8 ms 20 ms 
Repetition time (TR) 630 ms 1.8 s 13.75 s 7.55 s 
Image matrix 512×512 96×96 128×128 128×128 
Field of view 4×4 cm 25×25 mm 30×30 mm 20×20 mm 
Spatial resolution 78×78×34 μm/pixel 
260×260×500 
μm/pixel 
234×234×1000 
μm/pixel   
156×156×500 
μm/pixel 
Acquisition time ~8 min ~18 min 2 x 12 min ~18 min 
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Functional connectivity measurements 
The rsfMRI datasets were first realigned using a least squares method and rigid-
body transformation with Statistical Parametric Mapping (SPM) mouse toolbox 
(SPM5, University College London, http://www.fil.ion.ucl.ac.uk/spm/)(Sawiak, et 
al., 2009). Individual EPI datasets were then spatially normalized to a study-
specific template through linear affine and non-linear diffeomorphic 
transformation (ANTs. V1.9, http://picsl.upenn.edu/ANTS/). Briefly, a group-wise 
normalization procedure was employed on the mean SE-EPI image of each 
mouse. The default implementation was followed with four iterations, using 
mutual information as the initial affine similarity metric and cross-correlation as 
‘greedy SyN’ diffeomorphic transformation metric.  
 In plane spatial smoothing (0.4×0.4mm) and temporal high-pass filtering (cut-off 
at 0.01Hz) were applied to compensate for small across-mouse misregistration 
and temporal low frequency noise. Functional connectivity (FC) maps were 
calculated using total correlation analysis implemented in the REST Matlab 
toolkit (Song, et al., 2011). Sixteen seeds (2×2 pixel in plane) were selected in left 
and right cornus ammonis 1 and 3 (CA1, CA3), dentate gyrus (DG), thalamus (Th), 
visual cortex (Vctx), auditory cortex (Auctx), motor cortex (Mctx) and 
somatosensory cortex (SSctx). For each animal, correlation analyses of the BOLD 
time series were carried out between the seeds and the whole brain and 
Pearson’s correlation values were Fisher transformed to Z-scores. 
 
Cerebral blood flow calculation 
For each mouse, the FAIR images with different TIs were realigned over the first 
TI using a rigid-body model, implemented in SPM. Determination of T1 selective and 
T1 non-selective was performed by fitting the averaged signal intensities in each region 
of interest (ROI) with a three-parameters monoexponential T1 relaxation curve. 
CBF was determined in cortex, hippocampus, and thalamus using the following 
equation:  
 
   
 
 
                 
        
 
 
            
 
 
                
  
 
where λ is the blood/tissue partition coefficient for water, assumed to be 0.9 
ml/g (Herscovitch and Raichle, 1985,Leithner, et al., 2010) and T1 blood was 
assumed to be 2.75s at 11.7T (Lin, et al., 2012).  
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Diffusion tensor MRI parameter estimation and group comparisons 
The calculation of the two commonly used DT-MRI parameters, mean diffusivity 
(MD) and fractional anisotropy (FA), was performed following a protocol as 
described previously (Zerbi, et al., 2013). Briefly, the diffusion images were first 
realigned with SPM mouse toolbox, and then spatially normalized to a study-
specific template through linear affine and non-linear diffeomorphic 
transformation using ANTs. Following these pre-processing steps, the diffusion 
tensor was estimated for every voxel using the PATCH algorithm (Zwiers, 2010).  
Regional differences between apoE-ε4 mice and wildtype, and between apoE-ko 
and wildtype in spatially normalized FA and MD maps were assessed voxel-wise 
using SPM5 with the SPMMouse toolbox. In both 12-month-old mice and 18-
month-old mice, two t-tests were performed to identify genotype differences in 
the framework of the general linear model (GLM). Statistical significance for 
voxels exceeding a minimum cluster size of 4, to achieve cluster size ≈ 0.05 mm3 
as in (Dubois, et al., 2008), was established at p<0.05, uncorrected for multiple 
comparisons. The contrasts were then colour coded and overlaid onto averaged 
FA and MD images derived from the template image. In addition, ROI of several 
white matter (WM) and gray matter (GM) areas were drawn on the template 
image based on an anatomical atlas (Paxinos, 1997) and the resulting FA, MD, 
radial diffusivity (RD) and first eigenvalue (λ1) were measured for further 
statistical analyses. Only significant differences between mice groups are 
reported.  
 
Immunohistochemistry  
Directly following the MR measurements at 12 and 18 months of age, mice were 
sacrificed by transcardial perfusion with 0.1M phosphate buffered saline (PBS). 
The perfused brains were collected and postfixed for 15h at 4°C in 4% 
paraformaldehyde fixative and thereafter stored in 0.1M PBS with 0.01% sodium 
azide at 4°C for immunohistochemical staining. Eight series of 30 µm coronal 
sections were cut through the brain using a sliding microtome (Microm HM 440 
E, Walldorf, Germany) equipped with an object table for freeze sectioning at -
60°C. The tissue was stained for postsynaptic density with PSD95 antibody using 
one complete series of brain sections. Immunohistochemistry was performed 
using standard free-floating labeling procedures, as described previously (Jansen, 
et al., 2013).  
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PSD95  
Polyclonal rabbit anti-PSD95 (1:2000; Abcam) was used as a primary antibody. 
The sections were first pre-treated with 0.9% H2O2 in PBS to block endogenous 
peroxidise and then incubated overnight at room temperature on a shaker table. 
After incubation, the sections were rinsed three times with 0.1M PBS and 
incubated with the secondary antibody, donkey anti-rabbit biotin (1:1500; 
Jackson Immuno Research). After 90 minutes, the sections were rinsed three 
times again and transferred to a solution containing Vector ABC-elite (1:800; 
Vector Laboratories) for 90 minutes. Thereafter, visualization of postsynaptic 
density was achieved by incubation with DAB-Ni solution. Stained sections were 
mounted on gelatin-coated glass slides, dried overnight in a stove at 37 °C, 
dehydrated in alcohol series, cleared with xylol and mounted in Entellan. 
 
Quantification 
The stained sections were analyzed using a Zeiss Axioskop microscope equipped 
with hardware and software of Microbrightfield (Williston, VT, USA). Brain 
regions were based on the mouse brain atlas of Franklin & Paxinos (third edition, 
2008) and quantified in five regions of the hippocampus: the inner molecular 
layer (IML), outer molecular layer (OML), cornus ammonis 1 (CA1), CA2 and CA3. 
Additionally, two regions in the cortex corresponding to the visual and 
somatosensory cortex were analyzed. The relevant regions were digitized at 100 
times magnification with immersion oil using Stereo Investigator. The 
quantification of the photographs was performed using Image J (Image J, U. S. 
National Institutes of Health, Bethesda, Maryland, USA). Images were converted 
to 8-bit gray scale, followed by conversion to 16-bit gray scale; subsequently, the 
contrast was enhanced and the amount of tissue stained was measured with a 
threshold-based approach.  
 
Statistics 
For the statistical analysis, IBM SPSS 20 software (IBM Corporation, New York, 
NY, USA) was used. Since the setup of the current study was designed to 
determine the effect of aging and the extent to which apoE-ε4 and apoE-ko mice 
develop neuropathological traits of AD and not to study the effects of the apoE 
allele itself, statistical analyses were performed separately for the apoE-ε4 and 
apoE-ko mice (apoE-ε4 versus wild-type, and apoE-ko versus wild-type). 
Multivariate ANOVA (MANOVA) with Bonferroni corrections was conducted with 
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between-group-factors genotype and age of the animals. If the Bonferroni post 
hoc test indicated a significant interaction between genotype and age, the data 
were split for the concerning factor and thereafter analyzed again with the 
MANOVA. Statistical significance was set at p ≤ 0.05. Correlation analyses 
between region-specific FC, perfusion, diffusion and post-synaptic density 
parameters were performed with the bivariate Spearman’s correlation method. 
To avoid false positive correlation, the statistical significance for the correlation 
analyses was set at p ≤ 0.01. All values used are expressed as mean ± SEM.  
 
Results 
 
Resting-state fMRI - Functional connectivity 
Averaged functional connectivity (FC) patterns in wildtype mice from seeds in 
DG, thalamus, auditory cortex, visual cortex, motor cortex and somatosensory 
cortex of the left hemisphere are shown in Figure 1b. Several differences can be 
observed in the FC patterns for each seed ROI; particularly, a strong bilateral 
connectivity is notable when seeding in hippocampal regions. Moreover, a 
widespread FC was measured between hippocampal and thalamic regions, across 
the whole brain. In the cortex, we detected a single band covering 
somatosensory, auditory and visual cortices, with highest degree of connectivity 
closely located to the seed region. Functional correlations between several areas 
are shown as functional connectivity matrices, colour-coded for Z-fisher values, 
which represent the correlation between 16 defined ROI (Figure 2 and Figure 3). 
 
ApoE-ε4 vs wildtype  
In both apoE-ε4 and wildtype mice, 18-month-old animals showed decreased FC 
levels compared to 12-month-old mice. Most striking aging differences are the 
decrease in FC between the motor cortex (left and right), the left visual, auditory 
and somatosensory cortex and the hippocampus (left and right) (Figure 2). 
Despite that FC values were visibly lower in apoE-ε4 compared to age-matched 
wildtype mice, the MANOVA revealed no significant overall genotype nor 
genotype×age interactions in all the ROI. 
 
ApoE-ko vs wildtype  
The multivariate ANOVA showed overall significant genotype and aging effects 
when comparing apoE-ko with wildtype mice. The pairwise comparison revealed 
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significant lower FC in apoE-ko mice, independent of age; this reduction affected 
the connectivity between auditory cortex and somatosensory cortex with the 
hippocampus and thalamus, bilaterally (Figure 3). A reduced FC was also found as 
an effect of age, independent of genotype, in the visual, auditory and 
somatosensory cortices, particularly in the left-brain hemisphere. 
 
 
 
Figure 1. Averaged functional connectivity Z-Fisher maps in wildtype animals. a) 
Anatomical reference based on T2-weighted images. b) Comparison of averaged Z-maps 
of the different seeds positioned in the left hemisphere revealed functionally connected 
areas. The spatial colour-coded Z-maps are overlaid on the SE-EPI image template. A 
higher z-score (yellow) represents a higher correlation between the time course of the 
seed voxel and the other voxels in the brain.  In particular, a strong bilateral connectivity 
between right and left hippocampus is notable. In the thalamus, the highest degree of 
connectivity was unilaterally distributed and extended to the hippocampal area. In the 
cortex, high connectivity was found between auditory, visual and somatosensory cortices. 
In the latter, high connectivity with the hippocampus is also seen.  
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Figure 2. Functional connectivity (FC) group differences between selected areas in apoE-ε4 
and wildtype mice. On the vertical axe, the region of interest in which the seed is placed is 
shown with its correlation between the other areas shown on the horizontal side. 
Connectivity matrices show strong FC reduction due to age in both genotypes, particularly 
between the hippocampus and the visual, auditory and motor cortex. No significant 
genotype differences could be detected instead. b indicates significant aging effects, 
p<0.05.  
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Figure 3. Functional connectivity (FC) group differences between selected areas in apoE-ko 
and wildtype mice. On the vertical axe, the region of interest in which the seed is placed is 
shown with its correlation between the other areas shown on the horizontal side. 
Connectivity matrices revealed reduced FC due to overall genotype and aging effects in 
these mice. Specifically, apoE-ko mice showed impaired FC between auditory and 
somatosensory cortex and hippocampal and thalamic regions. Aging effects were 
detected as a reduced FC, particularly evident between the visual, auditory and 
somatosensory cortex and hippocampus. a indicates significant genotype differences; b 
indicates significant aging effects; c indicates significant genotype and aging effects, 
p<0.05. 
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Cerebral blood flow 
To study group-related differences on cerebrovascular health, we measured 
cerebral blood flow (CBF) with a flow-sensitive MRI technique (FAIR ASL). Three 
regions of interest (ROI) on the left and right brain hemispheres were analysed: 
cortex, hippocampus and thalamus. Since no intra-individual differences in CBF 
between right and left hemispheres were detected between mice groups (data 
not shown), values from both sides were averaged.  
 
ApoE-ε4 vs wildtype  
In the comparison of apoE-ε4 with wildtype, the MANOVA revealed a 
genotype×age interaction in the cortex and in thalamus (p=0.027 and p=0.026, 
respectively); after splitting the data for age and for genotype, we found that 18-
month-old apoE-ε4 mice have significantly lower CBF in these ROI compared with 
wildtype at the same age (p=0.005 for the cortex and p=0.002 for the thalamus) 
and also compared with 12- month-old apoE-ε4 animals (p=0.005 and p=0.002, 
respectively)(Figure 4). In the 12-month-old mice we did not detect any 
difference between wildtype and apoE-ε4. 
 
ApoE-ko vs wildtype  
Compared to wildtype, the apoE-ko mice showed a significant lower CBF in the 
cortex (p=0.022), independent of age. In the hippocampus and in the thalamus a 
slight reduction of CBF was also seen, although it did not reach statistical 
significance (p=0.117 and p=0.084, respectively). No aging effects were seen in 
both genotypes. 
Figure 4. Cerebral blood flow (CBF) was measured in apoE-ε4, apoE-ko and wildtype mice 
at 12 and 18 months of age in three different regions of interest (ROI): cortex, 
hippocampus and thalamus. To measure the CBF we employed a FAIR ASL MRI technique. 
A reduced CBF was found in the cortex in 18-month-old apoE-ε4 mice and in 12 and 18-
month-old apoE-ko mice compared to wildtype. A similar trend was observed in the 
thalamus, although it was not significant for the apoE-ko mice. No significant differences 
were seen in the hippocampus. 
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Diffusion tensor magnetic resonance imaging (DT-MRI) 
In DT-MRI the water diffusivity, assessed in multiple directions, is used to 
reconstruct an ellipsoid for every voxel to model the diffusion. The mean 
diffusivity (MD) describes the size of the ellipsoid, while its shape is quantified by 
the fractional anisotropy (FA). Because the water diffusion in the brain is 
restricted by cell membranes, microtubules and myelin sheaths, changes in size 
and shape of the diffusion ellipsoid may reveal unique details about tissue micro-
architecture in both white matter (WM) and gray matter (GM) (Zerbi, et al., 
2013). Differences of diffusion tensor derived indices were determined 
separately in each age group with an explorative voxel-based approach (VBA) 
and, with the MANOVA for age and genotype with a ROI-based approach. The 
VBA can detect the occurrence of diffusion changes at higher spatial resolution 
and is the option of choice when there is no prior knowledge about the expected 
changes; however, these changes must then be confirmed by a proper statistical 
analysis in a ROI-based approach. For the VBA, t-value maps (for a p-value < 0.05, 
and minimum voxel cluster size set at 0.05 mm3) were overlaid with FA and MD 
template images (Figure 5 and 6).  
 
ApoE-ε4 vs wildtype  
Several differences in diffusion parameters were detected from the VBA in apoE-
ε4 mice compared to wildtype (Figure 5). Voxels of the internal capsule (ic), the 
anterior commissure (aca), the cerebral peduncle (cp) and the posterior 
hypothalamic area displayed significantly lower FA at both ages compared to 
wildtype. In the cp and in other white matter areas such as the corpus callosum 
(cc) an increase in MD was also seen, particularly in the 18-month-old mice. The 
VBA demonstrated the presence of significant genotype differences also in gray-
matter structures; in the dentate gyrus of the hippocampus, the FA was highly 
reduced in apoE-ε4 compared to the wildtype at both ages, while the MD did not 
change significantly. An increase of MD was seen instead in several cortical and 
thalamic areas, and this was more apparent in the 18-month-old animals. 
Furthermore, in the lateral ventricles several clusters of reduced MD and 
increased FA were found in the apoE-ε4 mice in both age groups. The MANOVA 
for the selected ROI confirmed these findings; an overall reduction in FA, 
independent of age, was found in the apoE-ε4 mice compared to wildtype in the 
aca (0.38 ± 0.01 vs 0.44 ± 0.01, p=0.027), cp (0.65 ± 0.01 vs 0.68 ± 0.01, p=0.044), 
dentate gyrus (DG) (0.14 ± 0.01 vs 0.16 ± 0.01, p=0.004), cornu ammonus 1 (CA1) 
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(0.18 ± 0.01 vs 0.2 ± 0.01, p=0.016) and cornu ammonis 3 (CA3) (0.17 ± 0.01 vs 
0.19 ± 0.01, p=0.001). This decreased FA is driven by a reduced diffusion along 
the axons in aca, cp and in CA3, and by an increased radial diffusivity in DG and 
CA1 (data not shown). In addition, an increased FA was found as a result of aging, 
independent of genotype, in the body of corpus callosum (bcc) (0.52 ± 0.01 vs 
0.54 ± 0.01, p=0.003), genu of cc (gcc) (0.35 ± 0.01 vs 0.37 ± 0.01, p=0.016), 
splenium of cc (scc) (0.53 ± 0.01 vs 0.56 ± 0.01, p=0.034), and fimbria (fi) (0.43 ± 
0.01 vs 0.47 ± 0.01, p=0.006). This increased FA is mainly driven by a reduced 
diffusivity across the axons (or radial diffusivity (RD); data not shown). A reduced 
MD was also found as an effect of age in fi (8.64 ± 0.16 vs 8.14 ± 0.13, p=0.024) 
and in the visual cortex (vctx) (7.36 ± 0.08. vs 7.10 ± 0.07, p=0.030). 
 
ApoE-ko vs wildtype  
When comparing apoE-ko mice with wildtype we found a different pattern of 
changes in the VBA concerning the two ages analysed (Figure 6); at 12 months of 
age, apoE-ko displayed an increased FA and reduced MD in some white matter 
structures including the cc, the external capsule (ec) and the ic. A widespread 
reduction of MD is also found in other cortical and thalamic regions in the apoE-
ko. In the hippocampus, a reduction of FA was also visible. In 18-month-old 
animals, the increased FA in the ec, in the fi and in some thalamic and 
hypothalamic areas was still visible in the apoE-ko, but no other major 
differences were detected in the cc. Similarly to the apoE4, also the apoE-ko at 
18 months of age showed increased MD in some cortical areas, and a markedly  
increased FA and reduced MD in the lateral ventricle areas. The MANOVA for the 
selected ROI showed an overall reduced MD in the apoE-ko in the CA3, 
independent on the age (7.93 ± 0.12 vs 8.28 ± 0.13, p=0.044), caused by a strong 
reduction in λ1 (data not shown). Similarly to the comparison with apoE4 mice, 
also in apoE-ko we found an increased FA due to age in the bcc (0.54 ± 0.01 vs 
0.56 ± 0.01, p=0.023), scc (0.54 ± 0.01 vs 0.57 ± 0.01, p=0.020) and aca (0.42 ± 
0.01 vs 0.45 ± 0.01, p=0.044), mainly due to a reduction of RD (data not shown). 
 
Postsynaptic density protein 95 (PSD-95) 
Levels of postsynaptic density were measured with polyclonal rabbit anti-PSD95 
and are shown as relative values compared to wildtype mice (Figure 7). In the 12-
month-old animal group, we did not detect differences in PSD-95 levels between 
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Figure 5. Voxel based analysis (VBA) indicate significant differences in fractional 
anisotropy (FA) and mean diffusivity (MD) in apoE-ε4 mouse brain compared to wild type 
at 12 and 18 months of age. Seven rostral to caudal averaged FA and MD maps are 
overlaid with voxels that showed a significant difference (p < 0.05, minimum voxel cluster 
size 0.05 mm
3
). The voxel colour indicates a negative or positive change in the apoE-ε4 
mice compared to the wild type mice. At both ages, apoE-ε4 mice showed a widespread 
reduced FA in some white matter regions and in the hippocampus. An increase in MD is 
found amongst others in the corpus callosum (cc), in the cerebral peduncle (cp) and in the 
cortex. Increases in FA and reduced MD are found in the ventricle area. 
 
 
apoE-ε4 and wildtype mice in any of the selected regions. Instead, we did find a 
significant reduction of PDS-95 staining in apoE-ko mice compared to wildtype in 
the IML (p=0.005) and in the CA3 (p=0.046) (Figure 7, c). In 18-month-old 
animals, reduced PSD-95 levels in both apoE-ko and apoE-ε4 mice compared to 
wildtype were seen in the IML and OML; however, these differences were 
significant only in the apoE-ε4 group (p=0.043 and p=0.039, respectively) (Figure 
7, d). Because the staining of the two groups was not performed at the same 
time, we could not assess aging effects on the different genotypes. The two-
tailed Spearman’s correlation test revealed a strong positive correlation between 
PDS-95 levels and CBF in both the hippocampal region (p=0.003) and in the 
cortex (p=0.006).  
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Figure 6. Voxel based analysis (VBA) indicate significant differences in fractional 
anisotropy (FA) and mean diffusivity (MD) in apoE-ko mouse brain compared to wild type 
at the two ages. Seven rostral to caudal averaged FA and MD maps are overlaid with 
voxels that showed a significant difference (p < 0.05, minimum voxel cluster size 0.05 
mm
3
). The voxel colour indicates a negative or positive change in the apoE-ko mice 
compared to the wild type mice. At 12 months of age, apoE-ko showed concomitant 
increased FA and reduced MD in some white matter structures including the corpus 
callosum (cc), the external capsule (ec) and the internal capsule (ic). A small reduction of 
FA was also visible in the hippocampus. In 18-month-old animals, the increased FA in the 
ec, in the fimbria (fi) and in some thalamic and hypothalamic areas was still visible in the 
apoE-ko, but not in the cc. Moreover, an increased MD in some cortical areas was 
detected. Similarly to apoE-ε4 mice, increased FA and reduced MD were found in the 
ventricle area. 
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Figure 7. Post-synaptic density 95 (PSD-95) staining performed on brain sections of apoE-
ε4, apoE-ko and wild-type mice. a, b) Representation of PSD-95 immunoreactive staining 
in hippocampal and cortical areas at two different magnifications (5× and 100×, 
respectively). c) In 12-month-old animals we detected a significant decrease in PSD-95 
levels in apoE-ko mice compared to wildtype in the inner molecular layer (IML) and CA3 of 
hippocampus. d) In 18-month-old animals we show reduced PSD-95 levels in the apoE-ε4 
animals in the outer molecular layer (OML) and in the inner molecular layer (IML), while 
no significant differences were seen between wildtype and apoE-ko mice. Values 
represent the mean and SEM; CA = cornus ammonis. SC=somatosensory cortex; VC=visual 
cortex. 
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Discussion 
In the present study, we assessed resting-state functional connectivity (FC) in 
combination with perfusion, diffusion and synaptic density measurements in 
aging wildtype, apoE-ε4 and apoE-ko mice. Target-replacement apoE-ε4 and 
apoE-ko mice are attractive models to investigate the role of vascular risk factors 
in relationship with AD-like pathological features, such as changes in brain FC. 
However, the technical challenges to obtain good-quality MR images and the lack 
of knowledge in the murine brain network system have been a strong limiting 
factor for these studies. Only recently, new dedicated hardware and methods for 
acquisition and data analysis enabled the analysis of resting-state fMRI in mice 
(Jonckers, et al., 2011). In the present study, a particular attention was given to 
the anaesthetic used; some studies in rats have used analgesic muscle relaxants, 
such as dexmedetomidine (Lu, et al., 2012) or medetomidine (Zhao, et al., 2008), 
to limit the sedation levels of the animals. More recently, a study demonstrated 
that reliable FC measures in mice could be detected using a regime of low-dose 
isoflurane (Guilfoyle, et al., 2013). For our experiments, low-dose isoflurane was 
used, lightly adjusted throughout the experiment to maintain a fast and stable 
breathing frequency (>130 bpm), minimizing  the impact of anaesthesia on the 
resting-state fMRI signal. Despite the limited literature about resting-state FC in 
murine brains, the correlation maps obtained for wildtype animals match 
previous findings very well. Our results exhibited many similarities with the 
resting-state networks described in mice by means of independent component 
analysis (Jonckers, et al., 2011); in particular, we show the presence of strong 
bilateral hippocampal connectivity, while a unilateral component was seen in the 
thalamus. Furthermore, we revealed a high correlation between somatosensory, 
auditory and visual cortices; a similar network has been found in rats and 
identified as the default mode network (Lu, et al., 2012).  
A significant result of our study was a reduced FC in the old animals (18-month-
old) compared to adults (12-month-old). Interestingly, we saw this pattern in all 
the genotypes. Resting-state fMRI and FC measurements have been increasingly 
used as a tool for investigating the aging human brain in vivo. With the exception 
of few studies reporting no or little changes in FC due to aging, most of the 
rsfMRI studies reported aging-related decrements in FC, which have been 
recently reviewed (Ferreira and Busatto, 2013). Since normal aging is also 
associated with decline in cognition, the reduction in FC is thought to correlate 
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with a disruption of neuronal connections and a deterioration of brain 
functioning in elderly people (Hedden and Gabrieli, 2004,Whalley, et al., 2004). It 
is therefore plausible that the results obtained here reflect similar changes in the 
aging mice. To the best of our knowledge, this is the first report of age-related 
differences in FC in mice and might represent a novel way to study the 
neurobiology of aging. 
 
Resting-state FC and perfusion changes 
Cerebral blood flow (CBF) was measured to test whether changes in perfusion 
occur before, simultaneous or after alterations in FC. CBF is closely coupled with 
brain metabolism (Raichle, 1998) and is commonly used as an indirect measure 
of brain energy demand, also during resting state (Roy and Sherrington, 1890).  
 
ApoE-ε4 
Cross-sectional studies in young, middle-aged, and elderly human apoE-ε4 
carriers have reported reductions in regional CBF and regional cerebral glucose 
metabolism over time, particularly significant in brain regions susceptible to 
pathological changes in AD (Scarmeas and Stern, 2006). In apoE-ε4 subjects, a 
faster decline of regional CBF during aging has been shown compared to apoE-
ε3, suggesting its contribution to the increased risk of developing AD (Wierenga, 
et al., 2013). In good agreement with these human studies, we demonstrated 
that apoE-ε4 mice suffer from decreased cortical CBF at 18 months of age 
compared to wildtype, while no differences in CBF were seen at 12 months of 
age. By hypothesizing a correlation between CBF and FC, we would have 
expected to see a similar decline in cortical connectivity in the 18-month-old 
apoE4 mice. However, despite that the FC was lower in apoE-ε4 mice between all 
selected ROI, this was not significantly different from wildtype mice. Similarly, the 
reduction of FC due to aging seems to be stronger in the apoE-ε4 mice than in 
the wildtype, but again this was not significantly different between the groups. 
These results indicate that, despite the rapid decline of cerebral perfusion during 
aging from adult to senile, neural connectivity is not severely compromised in 
apoE-ε4 mice. Therefore it seems that in apoE-ε4 mice cerebrovascular 
impairments occur before FC changes, and might trigger brain connectivity 
disruption only in a later stage, as the pathology progresses. Future studies in 
older mice are warranted to validate this hypothesis.  
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ApoE-ko 
In apoE-ko mice we found a concomitant reduction in CBF and resting-state 
connectivity at both ages. These mice develop abdominal aortic aneurysm and 
atherosclerotic plaques starting in the aorta from 3 months of age; the amount 
and the severity of the plaques spread in other arteries throughout their life, 
including in the carotids. Furthermore, the size of atherosclerotic plaques in the 
aorta has been associated to the development of endothelial dysfunction 
(Crauwels, et al., 2003), making the apoE-ko a commonly used model for severe 
atherosclerosis and vascular pathology (Trollope, et al., 2011). No investigations 
on resting-state fMRI were previously performed in apoE-ko mice; however, it is 
known that, together with vascular deficits, these mice also develop a 
compromised synaptic plasticity (Blain, et al., 2006,Masliah, et al., 1995a), and 
defective cognitive performances (Gordon, et al., 1995,Krzywkowski, et al., 
1999,Masliah, et al., 1995b,Oitzl, et al., 1997). We therefore hypothesise that the 
severe vascular pathology, which these mice spontaneously develop at early age, 
could have accelerated the occurrence of brain injuries by an overexposure to 
stress factors, such as cerebral hypoperfusion; the absence of apoE would have 
further aggravated the synaptic repair processes, leading to a permanent loss of 
neuronal connectivity. In support of this hypothesis, we found a positive 
correlation in cortex and hippocampus between CBF and averaged post-synaptic 
density (measured in sampled regions). Although the correlation of these two 
measures do not imply a cause-effect mechanism, it reinforces the idea that 
neuronal and vascular health are tidily interdependent. Indeed, the role of 
vascular defects in neurodegenerative processes is vastly described, and a direct 
causal relation between hypoperfusion and neurodegeneration, including AD, 
has been also suggested by many (Altman and Rutledge, 2010,de la Torre, 
2000,Iadecola, 2004). Changes in cerebrovascular dynamics, such as an impaired 
coupling between neural activity and hemodynamic response, might have 
directly influenced BOLD signal fluctuations and consequently FC changes (Liu, 
2013). However, the lack of direct correlations between FC measures and post-
synaptic density and CBF suggests instead a non-uniform contribution of both 
neurovascular coupling and neural activity to the changes in connectivity.  
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Structural changes revealed by DT-MRI 
In order to find a possible relation between FC changes and structural differences 
in the brain of apoE-ε4 and apoE-ko mice, we measured diffusion tensor MRI 
(DT-MRI).  
 
ApoE-ε4 
In this study we showed altered WM microstructure in apoE-ε4 mice compared 
to wildtype, specifically manifested as reduced FA and increased MD (due to 
increased radial diffusivity (RD)) in the anterior commissure (aca), corpus 
callosum (cc) and cerebral peduncle (cp). We also demonstrated that apoE-ε4 
mice displayed significant FA reduction in the hippocampus and a sparse 
increased MD in the cortex. Most of these changes occurred similarly in both age 
groups. Despite the lack of DT-MRI studies in apoE-ε4 mice, similar findings have 
been described in human studies, where significant FA reductions in WM of 
apoE-ε4 carriers are shown (Heise, et al., 2011,Honea, et al., 2009,Nierenberg, et 
al., 2005); increased MD and RD have also been reported for analogous WM 
regions, particularly in the cc. In agreement with our study, these dissimilarities 
were consistent across different ages, suggesting that APOE affects WM 
microstructure proprieties from early adulthood, without directly reflecting the 
associated risk of developing AD (Westlye, et al., 2012). Two studies also 
reported diffusion differences in hippocampal structures in apoE-ε4 carriers, 
specifically as a reduction in FA in the left hippocampus (Persson, et al., 2006) 
and in the parahippocampal gyrus (Nierenberg, et al., 2005). These changes have 
been related to regional atrophy and to disruption of white matter integrity 
within the medial temporal lobe (e.g., hippocampal–parahippocampal 
connectivity). When considered together with evidence from previous studies, 
the pattern of changes observed here suggests that apoE-ε4 mice develop early 
in life alterations in neuronal architecture and organization. These structural 
modifications are therefore not related to the occurrence of vascular 
impairment, but may be linked to the role of apoE in synaptic development, 
dendrite formation and axonal guidance. However, these changes do not seem 
to induce drastic abatements in functional connectivity.   
 
ApoE-ko 
In the apoE-ko mice, we found different changes in diffusion proprieties for WM 
and GM structures; one unanticipated finding was the increased FA and the 
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reduced MD in the cc and external capsule (ec) of the apoE-ko mice, particularly 
at 12 months of age. Because it is unlikely that the apoE-ko mice have better 
white matter integrity (to which these diffusion changes are often referred to), 
these differences may be explained by a local reduction of crossing fibres and in 
fibres spreading from the cc towards cortical and subcortical regions. However, 
most of the differences seen in the VBA were not confirmed by the MANOVA 
analysis for selected ROI. Interestingly, the strongest result was a reduced 
diffusivity along the axons (λ1) in the CA3 region in both age groups, suggesting a 
lack of axonal organization in the hippocampus. In accordance with these 
findings, one study demonstrated that adult apoE-ko mice show a reduction in 
number and an irregular shape in unmyelinated peripheral axons, while 
myelinated fibres were structurally normal (Fullerton, et al., 1998). A decrease in 
spine density and dendritic length is also reported in 12-month-old apoE-ko mice 
(Ji, et al., 2003). These studies together suggest that lack of apoE leave 
unmyelinated axons especially vulnerable to injury. This also is in agreement with 
our observations of FC and perfusion deficits in the apoE-ko mice. However, 
other studies did not show differences in neuronal morphology and spine density 
in adult apoE-ko mice compared to wildtype or apoE3 mice (Anderson, et al., 
1998,Klein, et al., 2010). It is possible that changes in other protein levels and the 
severe hyperlipidemic phenotype of apoE-ko mice may have a role in 
compensating the lack of apoE, making it difficult to interpret and to compare 
the changes seen in different studies. 
 
Post-synaptic density 
Synaptic loss and disconnection are strongly correlated with cognitive decline in 
AD and may influence FC (Selkoe, 2002,Serrano-Pozo, et al., 2011). Compared to 
wildtype, we found reduced PSD-95 levels in 12-month-old apoE-ko mice, and 
also in the 18-month-old apoE-ε4 mice. While in the apoE-ε4 mice these changes 
mirror the hypoperfusion deficits observed, in the apoE-ko our results seem 
rather contradictory. Since cholesterol released from apoE-containing lipoprotein 
particles is used to support synaptogenesis and the maintenance of synaptic 
connections (Mauch, et al., 2001,Pfrieger, 2003,Poirier, et al., 1995), a decrease 
in postsynaptic density in apoE-ko mice was expected in older animals as well as 
in the adults. A relative increase in synaptic density might therefore reflect a 
compensatory mechanism in the apoE-ko mice in response to early functional 
synaptic failure or insults to the brain, like stroke, ischemia, or the measured 
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hypoperfusion (Arendt, 2001,Jansen, et al., 2012,Jin, et al., 2004,Li, et al., 
2010,Mu and Gage, 2011,Wang, et al., 2008). This also accords with earlier 
observations, which showed enhanced neurogenesis in apoE-ko mice (Levi and 
Michaelson, 2007). Unfortunately, we could not analyse aging effects with these 
data to confirm this effect. Nevertheless, this compensatory mechanism does not 
seem to restore or improve FC in these mice. 
 
In conclusion, with this study we provide new evidence for a relation between 
vascular risk factors, the apoE genotype and functional connectivity; we propose 
that vascular deficits are the triggering events that lead to synaptic disruption, 
and that both these factors contribute to resting-state functional connectivity 
changes. Despite the limitations and technical challenges, we demonstrate that 
rsfMRI can be used as a powerful tool to investigate neuropathology and aging 
effects in translational research.  
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Abstract 
Lipid metabolism and genetic background together strongly influence the 
development of both cardiovascular and neurodegenerative diseases like 
Alzheimer’s disease (AD). A non-pharmacological way to prevent the genotype-
induced occurrence of these pathologies is given by dietary behavior. In the 
present study, we tested the effects of long term consumption of a specific multi-
nutrient diet in two models for atherosclerosis and vascular risk factors in AD: the 
apolipoprotein ε4 (apoE4) and the apoE knockout (apoE ko) mice. This specific 
multi-nutrient diet was developed to support neuronal membrane synthesis and 
was expected to contribute to the maintenance of vascular health. At 12 month 
of age, both genotypes showed behavioral changes compared to control mice 
and we found increased neurogenesis in apoE ko mice. The specific multi-
nutrient diet decreased anxiety-related behavior in the open field, influenced 
sterol composition in serum and brain tissue, and increased the concentration of 
omega-3 fatty acids in the brain. Furthermore, we found that wild-type and apoE 
ko mice fed this multi-nutrient diet showed locally increased cerebral blood 
volume and decreased hippocampal glutamate levels. Taken together, these data 
suggest that a specific dietary intervention has beneficial effects on early 
pathological consequences of hypercholesterolemia and vascular risk factors for 
AD.  
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Introduction 
Diseases related to a sedentary lifestyle with high-fat dietary intake become a 
major problem in our aging western society. For example cardiovascular 
diseases, like coronary heart disease (CHD), and neurodegenerative disorders, 
like Alzheimer’s disease (AD), are the most described in the current literature and 
share many risk factors such as obesity, diabetes mellitus and 
hypercholesterolemia (Breteler, 2000,Kivipelto, et al., 2001,Kivipelto, et al., 
2005,LaRosa, et al., 1990,Skoog and Gustafson, 2006). Despite the growing 
awareness of the impact of a sedentary lifestyle and high-fat dietary intake, these 
risk factors are likely to increase in the future and extend to developing 
countries, which will have a huge impact on the global economy because of costs 
associated with screening, treatment and daily care services. These same risk 
factors are modifiable by the management of hypercholesterolemia; this reduces 
the risk of developing cardiovascular-related pathologies, including CHD (Gupta, 
et al., 2010). Epidemiological studies have associated the use of cholesterol 
lowering agents (statins) with diminished prevalence of AD (Haag, et al., 
2009,Jick, et al., 2000) and with preserved cognitive functions (Sparks, et al., 
2005), although more recent studies have shown no beneficial effects of statins 
on dementia or AD (Kandiah and Feldman, 2009,McGuinness, et al., 2009,Zhou, 
et al., 2007).  
To which extent a compromised cholesterol homeostasis in the vascular system 
and in the brain is able to trigger cerebrovascular and neurodegenerative 
pathologies is still under debate. A potential key-factor in the relationship 
between lipid metabolism and vascular and neurodegenerative disorders is the 
cholesterol transporter apolipoprotein ε4 (apoE-ε4), which is a major genetic risk 
factor for hypercholesterolemia, vascular dementia and sporadic AD (Hirsch-
Reinshagen, et al., 2009,Huang, 2006,Kim, et al., 2009). ApoE is the most 
prevalent brain lipoprotein and plays a fundamental role in neuronal 
maintenance and repair. In the human population three common isoforms 
termed apoEε2, apoEε3, and apoEε4 are expressed, which differ from each other 
in one to two amino acids (Weisgraber, 1994). ApoE has several functions in the 
body and in the brain, including anti-inflammation and antioxidation (Huang, 
2010,Lynch, et al., 2001,Miyata and Smith, 1996), but especially functions as a 
ligand in receptor-mediated endocytosis of lipoprotein particles, such as 
cholesterol. Cholesterol released from apoE-containing lipoprotein particles is 
Chapter 5 
________________________________________________________________________ 
110 
 
used to support synaptogenesis and the maintenance of synaptic connections 
(Mauch, et al., 2001,Pfrieger, 2003). Compared to the apoEε2 and apoEε3 
isoforms, apoEε4 is a less functioning cholesterol transporter contributing to 
hypercholesterolemia and atherosclerosis (Davignon, et al., 1988,Mahley, 1988). 
Interestingly, while in the general population 10-15% carries one ε4 allele, the 
occurrence in AD patients is 40-65%. In addition, ε4 allele carriers develop AD at 
a younger age than non- ε4 allele carriers (Corder, et al., 1993), and ε4-positive 
AD patients display higher levels of AD pathological hallmarks, such as amyloid-β 
(Aβ) plaques and neurofibrillary tangles (NFTs), than do corresponding non-ε4 AD 
patients (Nagy, et al., 1995,Ohm, et al., 1999,Schmechel, et al., 1993). 
The non-pharmacological management of cholesterol levels by means of specific 
diets containing fish oil has been recently proposed to prevent and treat the 
negative effects of the apoE4 genotype in AD (Cole, et al., 2009,Schipper, 2011). 
Recent experiments on young apoE4- target replacement mice suggest a positive 
influence of fish-oil containing diets on behavioral and cognitive performances 
(Kariv-Inbal, et al., 2012). These beneficial effects have been explained by the 
capacity to prevent arrhythmias (Leaf, et al., 2003), lowering plasma 
triacylglycerols (Harris, 1997a,Harris, 1997b,Sacks and Katan, 2002), decreasing 
blood pressure (Geleijnse, et al., 2002), improving vascular reactivity 
(Goodfellow, et al., 2000,Harris, 1997b) and decreasing atherosclerosis (Okuda, 
et al., 2005) and inflammation (Calder, 2001). Furthermore, high levels of omega-
3 (n-3) long-chain polyunsaturated fatty acids (lc-PUFAs) replace omega-6 (n-6) 
fatty acids and cholesterol from cell membranes leading to increased fluidity of 
the membrane, increased number of receptors, enhanced receptor binding and 
affinity, and better ion channel functionality (Bourre, et al., 1991,Bourre, et al., 
1989,Farkas, et al., 2002). As a result, this leads to improved neurotransmission 
and signalling (Bourre, et al., 1989), which is important for optimal cognitive 
functioning (Fontani, et al., 2005). Other dietary components like B-vitamins and 
antioxidants have been shown to protect the brain from oxidative and 
inflammatory damage (Guerrero, et al., 1999,Joseph, et al., 1998,Socci, et al., 
1995,Yamada, et al., 1999), and synaptic and neuronal loss (Fujii, et al., 
1996,Shrivastava, et al., 2005).  
Based on these findings, a specific multi-nutrient diet has been developed for the 
dietary management of AD’s risk factors (Scheltens, et al., 2010). To date, two 
randomized, double-blind controlled clinical trials demonstrated improved 
memory performance in patients with mild AD, taking this multi-nutrient 
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component diet supplementation on a daily base (Kamphuis, et al., 
2011,Scheltens, et al., 2010,Scheltens, et al., 2012). The mechanisms by which 
these dietary nutrients influence the cholesterol metabolism and have protective 
properties against AD traits yet need to be elucidated. In this study, we 
investigate the extent to which a specific multi-nutrient diet, containing 
docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), phospholipids, uridine 
monophosphate (UMP), choline, B-vitamins and antioxidants, which are 
precursors and co-factors for membrane synthesis and maintenance (Kamphuis 
and Scheltens, 2010) and may help to support vascular health, may inhibit 
cerebrovascular flaws and neuronal and synaptic loss in apoE4-carrier and apoE 
knockout mice. ApoE4-carrier and apoE knockout mice represent relevant 
models to study the effects of compromised cholesterol homeostasis on the 
development of CHD and AD. While apoE4 carrier mice exhibit an increased risk 
of vascular disorders due to altered cholesterol metabolism, apoE knockout mice 
spontaneously develop severe hypercholesterolemia and atherosclerosis 
(Breslow, 1996,Knouff, et al., 1999).   
 
 
Materials and methods 
 
Animals, dietary intervention and housing conditions 
The apoE4 founder mice were originally obtained from Taconic Transgenic 
Models (Hudson, NY, USA) and a colony was established at the Radboud 
University Nijmegen Medical Centre (RUNMC), the Netherlands. In short, mice 
were created by targeting the murine APOE gene for replacement with the 
human APOE4 alleles (4/4) in 129P2/OlaHsd-derived E14TG2a ES cells and 
injecting the targeted cells into blastocysts. Resultant chimeras were backcrossed 
to C57BL/6J for 8 generations. The line was derived by embryo transfer and is 
maintained by incrossing homozygous mice. For the present study, male and 
female apoE4 breeder mice were used to generate homozygous apoE4 offspring 
(1st generation at the RUNMC).  
 
The apoE-deficient (B6,129P2-Apoetm1Unc/J) founders were originally obtained 
from Jackson Laboratories (Bar Harbor, ME, USA) and a colony was established at 
the RUNMC. In short, mice were created by targeting the apoE gene in 
129P2/OlaHsd-derived E14TG2a ES cells and injecting the targeted cells into 
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C57BL/6J blastocysts. Resultant chimeras were backcrossed to C57BL/6J for 11 
generations. The line was derived by embryo transfer and is maintained by 
incrossing homozygous mice (Piedrahita, et al., 1992).  For the present work, 
male and female apoE knockout (apoE ko) breeder mice were used to generate 
homozygous apoE ko offspring (1st generation at the RUNMC).  
C57BL/6J wild-type mice, which were the non-transgenic wild-type littermates of 
our colony of AβPPswe-PS1dE9 mice, were used as controls. In short, the AβPP-
PS1swe-PS1dE9 founders were originally obtained from John Hopkins University, 
Baltimore, MD, USA (D. Borchelt and J. Jankowsky, Dept. of Pathology) and a 
colony was established at the RUNMC (Jankowsky, et al., 2004,Jankowsky, et al., 
2001). The AβPPswe-PS1dE9 line (line 85) was originally maintained on a hybrid 
background by backcrossing to C3HEJ×C57BL/6J F1 (so-called pseudo F2 stage). 
For the present work, male AβPPswe-PS1dE9 breeder mice were backcrossed to 
female C57BL/6JOlaHsd (Harlan Laboratories, Inc., Horst, the Netherlands) for 10 
generations, and the non-transgenic C57BL/6J wild-type offspring were used for 
the current study.  
Throughout the experiments animals were housed in groups of 2-7 mice per cage 
in a controlled environment, homogenously illuminated by normal fluorescent 
room light at 60 lux, with room temperature at 21ºC, and an artificial 12:12h 
light:dark cycle (lights on at 7 a.m.). Food and water were available ad libitum.  
 
Male apoE ko, apoE4 and wild-type mice were fed either a standard Control diet 
(CO diet), or a specific multi-nutrient diet, called Fortasyn® Connect (FC diet). The 
diets differed in composition with regard to the fat blends used, as well as the 
number of supplemented nutrients as indicated in Table 1. Diets were isocaloric 
and were manufactured by Research Diet Services (Wijk bij Duurstede, the 
Netherlands). In order to minimize oxidation of the lc-PUFAs, the experimental 
diets were stored at -20°C in 2-day supply aliquots. At 2 months of age the mice 
were put on the diets for the remainder of the experiment. Animals underwent 
behavioral testing at 9 ± 1 month of age and MRI measurements at 11 ± 1 month 
of age (Fig. 1). In total 84 mice were used. Table 2 describes the number of mice 
in each experimental group. The experiments were performed according to 
Dutch federal regulations for animal protection and were approved by the 
Veterinary Authority of the Radboud University Nijmegen Medical Centre.  
  
Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity 
________________________________________________________________________ 
113 
 
Behavioral analyses 
Behavioral testing was performed at 9 ± 1 months of age, in the following order: 
First open field, followed by Morris water maze (MWM), and finally the reversal 
MWM (Fig. 1). All testing sessions were performed during the light phase 
(between 9 a.m. and 5 p.m.) and were recorded for computer-assisted analysis 
using Ethovision 7.0 software (Noldus Information Technology B.V., Wageningen, 
the Netherlands). All behavioral testing was performed in the same room, 
homogenously illuminated by normal fluorescent room light at 60 lux. 
 
Open field 
To analyze explorative and anxiety-related behavior mice were placed 
individually in the center of a square open field (50×50×50 cm) with white 
Plexiglas walls, and were observed for 30 min. The duration (seconds) of walking, 
wall leaning, rearing, sitting and grooming were scored and analyzed. These open 
field parameters were defined as described previously (Hooijmans, et al., 
2009,Streijger, et al., 2005). In addition, total walking distance, mean velocity, 
and the time spent in the corners respectively the center of the open field were 
obtained from the recorded sessions. The center of the open field was defined as 
a square measuring 20×20 cm, and the corners of the open field were defined as 
the sum of all four 10×10 cm squared corners.  
 
Morris water maze (MWM) 
To investigate spatial learning abilities, mice were tested in the Morris water 
maze (MWM). Mice were placed in a pool (104 cm diameter) filled with water 
(21-22°C; made opaque by the addition of milk powder) at different starting 
positions and trained to find a submerged platform by using distant visual cues 
present on the four walls of the test room at a distance of 0.5 meter. The 8 cm 
diameter round platform was submerged 1 cm below the water surface and 
placed in the middle of the northeast (NE) quadrant at a distance of 26 cm from 
the wall. During all trials the researcher was present and always located at the 
same location in the room (close to the SW quadrant). 
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 Dietary groups 
Source Control (CO) Fortasyn
®
 Connect (FC) 
Corn starch 35.57 33.12 
Casein  14.00 14.00 
Corn dextrin 15.50 15.50 
Sucrose 10.00 10.00 
Dextrose 10.00 10.00 
Fibers 5.00 5.00 
Mineral mix (AIN-93M-MX) 3.50 3.50 
Vitamin mix (AIN-93-VX) 1.00 1.00 
Soy oil 1.900 - 
Coconut oil 0.900 0.100 
Corn oil 2.200 1.870 
Fish oil - 3.030 
Additions:   
L-cysteine 0.180 0.180 
Choline bitartrate  0.250 0.250 
Tert-butylhydroquinone 0.0008 0.0008 
Pyridoxine-HCL - 0.00328 
Folic acid (90%) - 0.00067 
Cyanocobalamin (0.1% in mannitol) - 0.00350 
Ascorbic acid (100% pure) - 0.160 
dl-α-tocopheryl acetate  - 0.4650 
UMP disodium (24% H2O) - 1.0 
Choline chloride (74.576%) - 0.402 
Soy lecithin - 0.402 
Sodium selenite (46% min) - 0.00023 
Energy (kcal/100g chow): 376.9 367.1 
% Fatty acids:   
Total n3  2 22 
Total n6 44 22 
Ratio n6/n3 20.3 1.0 
SFA 27 24 
MUFA 21 24 
PUFA 46 44 
 
Table 1. Compositions of the experimental diets used, based on AIN-93M (Reeves, et al., 
1993) with minor revisions.All diets were isocaloric, contained 5% fat and standard 
vitamin and mineral premix, providing recommended daily amounts of these nutrients. All 
amounts of nutrients are indicated in g/100g of diet. UMP = uridine monophosphate; SFA 
= saturated fatty acids; MUFA = mono unsaturated fatty acids; PUFA = poly unsaturated 
fatty acids. 
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Genotype Diet Total 
Open 
Field 
(r)MWM MRS CBV IHC BCH 
Wild-type CO 17 8 8 8 8 7-8 8 
 FC 16 8 8 8 10 8-9 7 
apoE4 CO 13 8 8 9 9 7 5-6 
 FC 13 8 6 8 7 7 5-6 
apoE ko CO 13 8 8 8 9 5-7 6 
 FC 12 8 8 8 10 5-6 6 
 
Table 2. Overview of the number of mice used in each experimental group. CO = Control 
diet; FC = Fortasyn
®
 Connect diet; (r)MWM = (reverse) Morris water maze; MRS = 
magnetic resonance spectroscopy; CBV = cerebral blood volume; IHC = 
immunohistochemistry; BCH = biochemistry. 
 
 
 
 
 
Figure 1. Time line of experimental design. At 2 months of age, the mice were put on 
either control or Fortasyn
® 
Connect diet for the remainder of the experiment. Behavioral 
testing was performed at 9±1 months of age. In the first week of behavioral testing, 
animals were exposed to the open field once for 30 minutes. In the second week, animals 
were trained in the Morris water maze (MWM) for 4 days. In the third week, animals were 
trained in the reverse Morris water maze (rMWM) for 2 days. MR imaging was performed 
at 11±1 months of age. Animals were sacrificed immediately after MR imaging. 
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Acquisition (spatial learning): Mice were trained to find the location of the 
submerged escape platform in 4 acquisition trials (maximal swimming time 120 s; 
30 s on the platform; inter-trial interval 60 min) per day during 4 consecutive 
days. The latency time (seconds) to find the hidden platform was scored. Starting 
positions during the 4 trails/day were: S, N, E, W. After the 2 min swim the mice 
were placed back in their home cage, and a paper towel was available inside the 
cage for additional drying.  
 
Probe (spatial memory): All mice performed a single probe trial 60 min after the 
last trial on day 4, in which the platform was removed from the swimming pool. 
Mice were allowed to swim for 60 s and the time spent swimming and searching 
in the former platform quadrant and former platform location), total swimming 
distance, and mean velocity were recorded.  
 
Reverse Morris water maze (rMWM) 
Four days after the standard MWM probe trial, a simplified reversal MWM 
(Hooijmans, et al., 2009) was performed in which the platform location was 
changed to the southwest (SW) quadrant. In this procedure, earlier platform 
location needs to be encoded in the long-term memory. Memory retrieval needs 
to be selective for the most recently learned location, introducing an episodic like 
component in the spatial memory task (de Bruin, et al., 1994). Acquisition and 
probe sessions were performed similar to the standard MWM sessions, except 
that starting positions were E, W, S, and N, the target quadrant was SW, and 
training lasted only 2 days (4 trials/day).  
 
Magnetic resonance imaging and spectroscopy 
MRI measurements were performed at 11 ± 1 month of age on a 7T/300mm 
horizontal-bore magnet interfaced to a ClinScan console (Bruker Biospin, 
Ettlingen, Germany). An integrated circular polarized transmit 1H volume coil 
(200mm/154mm outer/inner diameter) was used for signal transmission and 
combined with a circular polarized mouse brain 1H surface coil for signal 
reception. Before the MR measurements, all mice received an intravenous tail 
vein catheter. During the experiments, mice were anesthetized with 2% 
isoflurane (Abott, Cham, Switzerland) in a mixture of oxygen and N2O (2:1) 
through a nose cone and placed in a stereotactic holder. Body temperature was 
maintained at physiological levels with heated airflow and monitored with a 
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rectal optical temperature probe. Respiration of the animal was monitored using 
a pneumatic cushion respiratory monitoring system (Small Animal Instruments 
Inc, NY, USA). Initially, multislice turbo spin echo images in the coronal, 
transversal and longitudinal orientations were acquired to visualize the anatomy 
and the morphology of the mouse brain structures. Imaging parameters were: 
field of view (FOV) = 25×25 mm, matrix size = 256×256, slice thickness = 0.5 mm, 
echo time (TE) = 46 ms, and repetition time (TR) = 3500 ms.  
 
 
Magnetic resonance spectroscopy (MRS) 
Metabolite concentrations in the hippocampus were determined using 1H MRS. A 
volume of interest (VOI) of 1.0×1.0×2.0 mm was positioned inside the left 
hippocampus between -2.18 and -2.46 posterior to bregma, according to the 
mouse brain atlas of Franklin and Paxinos (Franklin and Paxinos, 1997). 1H-MRS 
spectra were acquired with stimulated echo acquisition mode (STEAM) sequence 
with imaging parameters: TR = 1500 ms, TE = 13 ms, and 1024 signal averages. 
Water suppression was performed with variable pulse power and optimized 
relaxation delays (VAPOR). For each 1H MRS spectrum, a water reference 
spectrum was acquired without water suppression in the same VOI with the 
same imaging parameters and 32 signal averages. Total acquisition time for 1H 
MRS was 27 min per animal.  
 
Quantification of the metabolite concentration was performed using the Linear 
Combination model software package (LCModelTM, S. Provencher, Oakville, 
Canada). Model metabolite spectra were simulated to match the magnetic field 
strength, sequence type and sequence parameters used for data acquisition. 
Metabolite concentrations are given as absolute values using the water signal in 
non-water suppressed spectra as a reference. The criteria to select the reliable 
metabolite concentrations were based on the Cramér-Rao lower bounds (CRLB), 
which are measures of the minimum standard deviation of the fit for each 
metabolite (Cavassila, et al., 2001) and are also determined by LCModelTM. Only 
metabolites that had a CRLB ≤ 20% in more than 80% of the spectra were 
included. Five metabolites or metabolite combinations fulfilled the criteria: 
creatine + phosphocreatine (tCre), glutamate (Glu), myo-Inositol + glycine 
(mI+Gly), N-acetylaspartate (NAA) and taurine (Tau).  
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Relative cerebral blood volume (rCBV) 
To assess differences in microvascular brain blood volume reserves, relative 
cerebral blood volume (rCBV) was determined with a susceptibility contrast 
enhanced MRI technique as described previously, with modifications (Zerbi, et 
al., 2012). In short, a multi GE FLASH sequence was performed prior to and 1 min 
after administration of an intravenous bolus injections of ultra small particles of 
iron oxide  (USPIO – AMI-277, Sinerem®, Guerbet Laboratories, France) at the 
dose of 140µg Fe/mouse. The USPIO is a contrast agent that provides a valuable 
tool to characterize tissue vascularity since it remains intravascular for a 
prolonged period of time and strongly enhances the transverse water proton MR 
relaxation rate (R2
*). Previous studies have shown an approximately linear 
relationship between the increase of relaxation rate (ΔR2*) and rCBV fraction 
over the physiologically relevant range (Belliveau, et al., 1990,Boxerman, et al., 
1995). This technique has been widely used to assess rCBV in mice (Dennie, et al., 
1998,Kennan, et al., 1994). Imaging parameters were: FOV = 303014 mm, 
matrix size = 19219288, total resolution = 0.16×0.16×0.16 mm, TEs = 5.13 – 
7.28 – 9.40 ms, TR = 50 ms, resulting in a total scan time of 35 min per mouse.  
 
Data pre-processing and cerebral blood volume calculation 
For spatial normalization, the GE images before and after USPIO of all mice were 
co-registered with a study-specific template created from the averaged GE 
images of all animals using Advanced Normalization Tools (ANTs. V1.9.x, 
http://picsl.upenn.edu/ANTS/). Spatial normalization was achieved by using 
mutual information as the initial affine similarity metric and cross-correlation as 
‘greedy SyN’ diffeomorphic transformation metric (Avants, et al., 2008). Spatially 
normalized and masked datasets were then imported in MatLab (R2008a, 
Mathworks, Natick, MA, USA) and, for each mouse, a pixel-by-pixel delta 
relaxation rate ΔR2
* map was obtained using the formula: 
Δ  
  
 
  
     
    
    
  
where S is the signal amplitude before-USPIO (Sbef ) and after-USPIO (Saft). Image 
sets from the three TEs were used for the calculation of three ΔR2
* values and 
thereafter these values were averaged for ∆R2
* maps. Histogram analysis of the 
ΔR2* images was used to mask voxels containing pial and large perforating 
arteries and veins and focus on the microvasculature compartment (rCBVmicro) as 
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described in detail elsewhere (Zerbi, et al., 2012). The analysis of genotype-wise 
and diet-wise differences in rCBVmicro was performed with a voxel-based and 
regions of interest (ROIs)–based approaches. 
 
Voxel-based and ROI-based group comparisons 
Normalized rCBVmicro values were measured in several ROIs drawn based on the 
atlas of Franklin and Paxinos (Franklin and Paxinos, 1997). These ROIs include: 
hippocampus, cerebral cortex (all cortical areas above the corpus callosum), 
olfactory bulb, cerebellum and thalamus. For the ROI-based approach, we 
evaluated significant interactions between genotype and diet. Significant 
differences in rCBVmicro maps were additionally assessed voxel-wise using the 
SPMMouse toolbox within statistical parametric mapping 5 (SPM5, Wellcome 
Department of Clinical Neurology, London) (Sawiak, et al., 2009). Spatially 
normalized rCBVmicro datasets were smoothed with a 500μm isotropic Gaussian 
kernel to correct for imperfect registration and subsequently a two-group t test 
was performed to identify genotype-wise and diet-wise differences in the 
framework of the general linear model (GLM). Statistical significance for an 
individual voxel was established at p<0.01, uncorrected for multiple comparisons 
(Ashburner and Friston, 2000).  
 
Tissue sampling 
Directly following the MR measurements at 11 ± 1 months of age, half of the 
number of mice was sacrificed by cervical dislocation to collect brain tissue for 
biochemical analyses, and the other half was sacrificed by transcardial perfusion 
fixation with Somogyi’s fixative (4% paraformaldehyde, 0.05% glutaraldehyde and 
0.2% picric acid in 0.1M phosphate buffer, PB, pH=7.3). Blood samples were 
collected via eye extraction, and subsequently processed to obtain blood serum. 
Blood serum was stored at -80°C before further biochemical processing. Non-
perfused brains were snap frozen in liquid nitrogen and then stored at -80°C, 
before further biochemical processing. Perfused brains were collected and 
postfixed for 15h at 4°C in Somogyi’s fixative and subsequently stored in 0.1M 
PBS with 1% sodium azide at 4°C for immunohistochemical stainings.  
 
Immunohistochemistry 
Before cutting, the brain tissue was cryoprotected by immersion in 30% sucrose 
in PB. Six series of 40 µm coronal sections were cut through the brain using a 
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sliding microtome (Microm HM 440 E, Walldorf, Germany) equipped with an 
object table for freeze sectioning at -60°C. Presynaptic boutons were visualized 
with anti-synaptophysin antibody (monoclonal rabbit anti-synaptophysin clone 
EP1098Y, Abcam Inc., Cambridge, UK). Synaptophysin is localized in small 
synaptic vesicles of the presynaptic terminal and functions in the regulation of 
exocytosis (Jahn and Sudhof, 1993). Newly formed immature neurons were 
visualized with anti-doublecortin antibody (polyclonal goat anti-doublecortin 
(C18): sc-8066, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). 
Doublecortin is a microtubule-associated protein that is exclusively found in 
somata and processes of migrating and differentiating neurons (Francis, et al., 
1999,Gleeson, et al., 1999). Immunohistochemistry was performed using 
standard free-floating labeling procedures, and was carried out on a shaker table 
at room temperature as described in detail elsewhere (Jansen, et al., 2012). One 
complete series of brain sections, with 240 µm distance between the sections, 
was used for each staining. Brain sections were incubated overnight with either 
monoclonal rabbit anti-synaptophysin (1:20,000), or polyclonal goat anti-
doublecortin (1:3000) as primary antibody. Either donkey anti-rabbit biotin 
(1:1500) or donkey anti-goat biotin (1:1500) was used as a secondary antibody 
(Jackson ImmunoResearch, West Grove, PA, USA).  
Quantification of presynaptic boutons and doublecortin-positive newly formed 
immature neurons was performed using a Zeiss Axioskop microscope, equipped 
with hardware and software from Microbrightfield (Williston, VT, USA). 
Appropriate sections were digitized and photomicrographed using a computer-
assisted analysis system (Stereo Investigator). Brain regions were based on the 
mouse brain atlas of Franklin and Paxinos (Franklin and Paxinos, 1997). All 
quantifications were performed by two independent raters who were blind to 
the experimental groups. Measurements were averaged to obtain a single value 
per animal for every region of interest (ROI).  
 
Quantification of synaptophysin-immunoreactive presynaptic boutons 
To determine the amount of synaptophysin-immunoreactive boutons (SIPBs), 
appropriate sections were digitized and photomicrographed at 100× 
magnification using an 100× oil immersion objective. SIPBs were analyzed in the 
hippocampus (cornu ammonis (CA)1, CA3 and dentate gyrus (DG) regions), and in 
the cortical regions prelimbic area (PLA) and anterior cingulate gyrus (ACg). 
These regions were chosen because of their large amyloid load in AD patients 
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and transgenic mouse models for AD and their importance in learning and 
memory (Irizarry, et al., 1997,Shukla and Bridges, 1999). In the hippocampus, 
SIPBs were analyzed in the stratum radiatum of the CA1 area (SR), stratum 
lucidum of the CA3 area (SL), and the inner molecular layer (IML) and outer 
molecular layer (OML) of the DG using one section per animal at -2.18 mm 
posterior to bregma. The ACg was quantified at level +0.98 mm anterior to 
bregma using one section per animal. The PLA was quantified at +1.94 mm 
anterior to bregma using one section per animal. For every ROI, two 
photomicrographs were taken at 100× magnification by each independent rater. 
Images were further processed using ImageJ software (U.S. National Institutes of 
Health, Bethesda, MD, USA) for the quantification of the amount of SIPBs. All 
settings were kept identical for all analyses and background levels were equalized 
using a threshold. Shading correction was performed before measurement to 
correct for irregularities in illumination in the microscopic field. A differential 
contrast enhancement filter was applied to selectively enhance weak differences 
in contrast. To eliminate noise signal and to differentiate between possible 
artifacts and specific SIPBs, particles were classified based on size. Particles 
ranging between 0.1-4.5 µm2 were considered to be normal sized SIPBs (Mulder, 
et al., 2007), and were included for statistical analyses. The amount of SIPBs was 
defined as the total number of SIPBs per µm2.  
 
Quantification of doublecortin-positive cells 
For the assessment of the amount of newly formed immature neurons in the 
subgranular zone of the hippocampus as a measure for neurogenesis, three 
sections per animal (at -1.70, -2.18 and -2.46 posterior to bregma) were digitized 
and contours were drawn along the borders of the hippocampus at 5× 
magnification using Stereo Investigator software. These three sections were 
selected as representative slices containing the subgranular zone of the 
hippocampus. Doublecortin-positive (Dcx+) cells were counted at 20× 
magnification, and the values of the three sections were averaged to obtain a 
single value per animal.  
 
Biochemical analyses 
Serum and brain sterol analysis 
Serum cholesterol levels and the cholesterol precursor lathosterol and its 
oxidative brain specific metabolite 24S-hydroxycholesterol were measured by 
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gas-chromatography-mass-spectrometry-selected ionmonitoring (GC-MS-SIM) as 
described in detail previously (Lutjohann, et al., 2002,Lutjohann, et al., 
2004,Thelen, et al., 2006). Brains were homogenized and sterols were extracted 
overnight by chloroform/methanol trimethylsilylated prior to GC-MS-SIM analysis 
(Lutjohann, et al., 2002,Thelen, et al., 2006). 
 
Brain fatty acid analysis 
Fatty acid analyses were performed with a part of the homogenate (described 
above). Total lipid was extracted from brain homogenates by methanol and 
chloroform. Subsequently, samples were centrifuged at 3000 rpm for 10 min and 
the lower phase (chloroform and lipids) was removed. Chloroform was added to 
the upper phase, samples were centrifuged again at 3000 rpm for 10 min and the 
lower phase was combined with the first one. The chloroform fractions were 
dried in a SpeedVac® and 2 ml methanol and 40 μl concentrated sulfuric acid 
were added to the dried extract. The samples were heated at 100°C for 60 min, 
and 2 ml hexane and 0.5 ml 2.5M sodium hydroxide solution were added. After 
vortexing and centrifuging the samples for 5 min at 3000 rpm, the upper layer 
was collected and evaporated in a SpeedVac®. The fatty acids (FAs) were 
dissolved in 125 μl iso-octane and analyzed on a GC-FID with a CP-SIL88 column 
(50 m × 0.25 mm id. 0.22 film thickness). The n6/n3 ration was calculated as a 
sum of analyzed n6 FAs divided by the sum of n3 FA.  
 
Statistical analysis 
Data are expressed as mean ± SEM and were analyzed with SPSS for windows 
16.0 software (SPSS Inc. Chicago, IL, USA). Since the setup of the current study 
was designed to determine the effect of diets and the extent to which apoE4 and 
apoE ko mice develop behavioral and neuropathological traits of AD and not to 
study the effects of apoE itself, statistical analyses were performed separately for 
the apoE4 and apoE ko mice (apoE4 versus wild-type, and apoE ko versus wild-
type). The repeated measures ANOVA was used for the acquisition phase of the 
MWM and rMWM (with the repeated measure: trial block), followed by a 
Bonferroni post hoc to analyze possible interactions between trial block, 
genotype and/or diet. If interactions between trial block, genotype or diet 
(between-group-factors) were present, the data were split for the concerning 
factor and thereafter analyzed again with the repeated measures ANOVA. 
Multivariate ANOVAs (MANOVA) were conducted with between-group-factors 
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genotype and diet, to analyze possible differences between wild-type, apoE4 and 
apoE ko mice, and between the CO and FC diets in the open field parameters, the 
probe trials of the MWM and rMWM, the body weight, brain weight, metabolite 
concentrations, rCBV, immunohistochemical stainings and biochemical analyses. 
If the Bonferroni post hoc test indicated a significant interaction between 
genotype and diet (between-group-factors), the data were split for the 
concerning factor and thereafter analyzed again with the MANOVA. For clarity 
reasons, F-values are not displayed. Furthermore, only between-group 
interactions that reached statistical significance are specified in detail. Statistical 
significance was set at p≤0.05.  
 
 
Results 
 
Body and brain weight 
All mice were weighed one week before starting the behavioral tests at the age 
of 9 ± 1 months and again on the day of the MR measurements at the age of 11 ± 
1 months. Body weight was not affected by genotype or diet when animals were 
measured one week before starting the behavioral tests (p>0.05). Overall mean 
body weight was 34.8 ± 0.8 g in the apoE ko mice, 33.8 ± 0.5 g in the apoE4 mice 
and 32.6 ± 1.0 g in the wild-type mice. Body weight was affected by genotype, 
but not by diet when animals were measured on the day of the MR 
measurement. At scanning, ApoE ko mice were significantly heavier than wild-
type mice (p<0.001), independent of diet. Overall mean body weight was 36.5 ± 
0.7 g in the apoE ko mice, 33.3 ± 0.7 g in the apoE4 mice and 31.7 ± 0.8 g in the 
wild-type mice. Since absolute brain weight was not affected by genotype or diet 
(p>0.05), we expect no confounding effects of the increased body weights in 
ApoE ko mice on the MR parameters measured. Overall mean brain weight was 
0.49 ± 0.01 g in apoE ko mice, 0.48 ± 0.01 g in both apoE4 and wild-type mice.  
 
Behavioral analyses 
Open Field 
In the open field, locomotion activity and active exploration parameters (walking, 
sitting, wall leaning, rearing) and grooming are scored for 30 minutes. In 
addition, total walking distance, mean walking velocity, and the time spent in the 
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corners respectively the center of the open field were obtained from the 
recorded sessions.  
ApoE4 mice, but not apoE ko mice, were more active in the open field than wild-
type mice. ApoE4 mice walked more (Fig. 2A; p=0.016) and sat less (Fig. 2B; 
p=0.004), although the total distance moved (Fig. 2F; p=0.140) and mean walking 
speed (p=0.141; wild-type 6.1 ± 0.3 cm/s, apoE4 7.0 ± 0.5 cm/s, apoE ko 6.3 ± 0.4 
cm/s) did not differ significantly between apoE4 and wild-type mice. Dietary 
intervention with the FC diet had no effect on these parameters (p>0.05). There 
was a significant genotype×diet interaction for the time spent grooming 
(p=0.032). ApoE4 mice on CO diet spent slightly less time grooming than wild-
type mice on CO diet (Fig. 2E; p=0.062), whereas no difference was found 
between apoE4 and wild-type mice on the FC diet, or between apoE ko and wild-
type mice (p=0.411). No differences were observed between the apoE4, apoE ko 
and wild-type mice in the time spent rearing (Fig. 2C) and wall leaning (Fig. 2D). 
ApoE ko animals spent significantly less time in the center (Fig. 2G; p=0.001) and 
significantly more time in the corners of the open field (Fig. 2H; p=0.025) than 
wild type mice, independent of diet. Overall MANOVA analysis revealed 
significant genotype×diet interactions for the time spent in the center (p=0.007) 
and corners (p=0.015) of the open field when comparing apoE4 and wild-type 
mice. Only in wild-type mice, the FC diet increased the time spent in the center 
(p=0.001), and decreased the time spent in the corners (p=0.002) of the open 
field compared to the CO diet (Fig. 2G, H). The FC diet had no effect on these 
parameters in the apoE4 mice (p=0.360 and p=0.532 respectively). Furthermore, 
an overall effect of the FC diet on time spent in the center (p<0.001) and corners 
(p<0.001) was found comparing the apoE ko and wild-type mice. Again, the FC 
diet increased the time spent in the center and decreased the time spent in the 
corners of the open field compared to the CO diet (Fig. 2G, H).  
 
Altogether these data show increased activity in apoE4 mice, whereas the apoE 
ko mice did not differ from the wild-types on the parameters related to 
locomotion. Instead, apoE ko mice show increased anxiety-related behavior, 
indicated by the increased time spent in the corners and decreased time spent in 
the center of the open field (Hooijmans, et al., 2009,Simon, et al., 1994). The FC 
diet decreased anxiety-related behavior in both apoE ko animals and wild-type 
mice. 
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Morris water maze (MWM) 
The Morris water maze is designed to test spatial learning by training the mice to 
find a hidden platform (acquisition phase). Spatial memory is tested in a trial in 
which the platform is removed from the maze (probe trial) directly following the 
acquisition phase. ApoE4, apoE ko and wild-type mice showed a decrease in 
escape latency during training (Fig. 3A; p<0.001). No significant trial 
block×genotype, trial block×diet or trial block×genotype×diet interaction was 
observed, indicating that all animals learned the position of the hidden platform 
equally well. Escape latencies did not differ between apoE4, apoE ko and wild-
type mice, nor did they differ between the CO and FC diet (p>0.05).  
During the probe trial, apoE4 mice spent less time in the target NE quadrant (Fig. 
3C; p=0.020) than wild-type mice. Furthermore, both apoE ko and wild-type mice 
performed well above 25% chance level, indicating good memorization of the 
platform quadrant, whereas the apoE4 mice did not significantly deviated from 
25% chance performance (p=0.057). However, no differences were observed 
between apoE4, apoE ko and wild-type mice in the time spent in the exact 
platform area (Fig. 3D), reflecting good memorization of the platform location. 
The FC diet had no effect on the spatial acquisition and the spatial memory 
parameters. Overall analysis comparing apoE4 and wild-type mice indicated no 
effects of the FC diet on swim distance (p=0.402) and velocity (p=0.403). 
However, when comparing apoE ko and wild-type mice, the FC diet significantly 
decreased swim distance (Fig. 3B; p=0.049) and swim velocity (p=0.049; CO diet 
18.2 ± 0.6 cm/s, FC diet 16.3 ± 0.8 cm/s), suggesting that the effects of the FC 
diet on those parameters are found mainly in the apoE ko mice.  
 
Reverse Morris water maze (rMWM) 
In the reverse Morris water maze, mice have to learn to find a novel position for 
the hidden platform. This task is considered to be a test for new learning abilities, 
in which a previous successful strategy must be discarded and a new strategy 
should be developed. ApoE4, apoE ko and wild-type mice showed a decrease in 
escape latency during training (Fig. 4A; p<0.001). 
 
No significant trial block×genotype, trial block×diet or trial block×genotype×diet 
interaction was observed, indicating that all animals learned the new position of 
the hidden platform equally well. Escape latencies did not differ between apoE4, 
apoE ko and wild-type mice, nor did they differ between the CO and FC diet.  
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Figure 2. Open Field behavior in 9 ± 1 months old apoE4, apoE ko and wild-type mice on 
control (CO) and Fortasyn (FC) diet. Different open field parameters were measured within 
a 30 min period. A) duration of walking, B) duration of sitting, C) duration of rearing; i.e. 
standing on the hind paws and exploring the environment, D) duration of wall leaning, E) 
duration of grooming, F) total distance moved, G) duration spent in the center of the open 
field, and H) duration spent in the corners of the open field. Values represent the mean 
and SEM. a * different from wild-type mice p<0.05; b # different from wild-type CO 
p=0.062; c * different from control (CO) diet p<0.05.  
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Figure 3. Spatial learning and memory in the Morris water maze (MWM). Spatial learning 
was measured in a 4 day acquisition phase in 9 ± 1-month-old apoE4, apoE ko and wild-
type mice on control (CO) and Fortasyn (FC) diet, by determining the latency to find a 
hidden platform (A). The spatial memory was tested in the probe phase in which the % of 
time spent in the north east (NE) target quadrant was measured (C), the % of time spent 
in the platform area (where formerly the platform had been located; D), and the total 
distance moved (B). Values represent the mean and SEM.  a * different from wild-type 
mice p<0.05.  
 
 
During the probe trial, no differences were observed between the groups in the 
swim distance (Fig. 4B) or in the mean swim velocity (wild-type 18.5 ± 0.5 cm/s, 
apoE4 18.5 ± 0.9 cm/s, apoE ko 17.9 ± 1.0 cm/s). No differences were observed 
between the groups in time spent in the exact platform area (Fig. 4D) or in the 
target SW quadrant (Fig. 4C). All animals spent well above 25% chance level in 
the SW target quadrant, indicating good memorization of the platform quadrant.  
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 Figure 4. Spatial learning and memory with an extra episodic memory component in the 
reversal Morris water maze (rMWM). Spatial learning was measured in a 2 day 
acquisition phase in 9 ± 1-month-old apoE4, apoE ko and wild-type mice on control (CO) 
and Fortasyn (FC) diet, by determining the latency to find a hidden platform in the south 
west (SW) quadrant (A). The spatial memory was tested in the probe phase in which the % 
of time spent in the SW target quadrant was measured (C), the % of time spent in the 
platform area (where formerly the platform had been located; D), and the total distance 
moved (B). Values represent the mean and SEM.  No significant differences were 
observed.   
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Magnetic resonance imaging and spectroscopy 
Magnetic resonance spectroscopy (MRS) 
To determine the effects of the FC diet on hippocampal metabolite 
concentrations, 1H MRS with a single voxel acquisition method (i.e. STEAM) was 
used in wild-type, apoE4 and apoE ko mice (Fig. 5). ApoE4 mice showed 
significantly higher levels of taurine (Tau) compared to wild-type animals, 
independent of diet (p=0.030). All the other metabolites levels showed no 
genotype differences or diet effects (p>0.05). In apoE ko and wild-type mice on 
FC diet, a significant decrease in glutamate (Glu) was observed compared to the 
same groups on CO (p=0.021). No genotype or diet effects were seen in other 
hippocampal metabolites levels (p>0.05). 
 
 
Figure 5. Hippocampal metabolite levels measured with 
1
H MRS. Multivariate ANOVA 
revealed an overall increase in taurine (Tau) in apoE4 mice compared to wild-type, 
independent of dietary intake. Compared to control (CO) diet, wild-type and apoE ko 
animals fed the Fortasyn (FC) diet showed an overall reduction in glutamate (Glu) levels. 
Values represent the mean and SEM. a* different from wild-type mice CO p<0.05, b* 
different from apoE ko CO p<0.05, c* different from wild-type FC p<0.05. 
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Relative cerebral blood volume (rCBV) 
To measure changes in rCBV, susceptibility-induced contrast MR imaging was 
used. Relaxation rate maps were obtained from T2
*-weighted images before and 
after i.v. injection of USPIO. The contribution of large cerebral vessels was 
excluded by histogram analysis, to shift the sensitivity of ΔR2
* images towards the 
microvascular compartment (rCBVmicro) (Zerbi, et al., 2012).   
 
 
Figure 6. Measurement of the microvascular cerebral blood volume (rCBVmicro) in several 
ROIs revealed no significant genotype differences between wild-type, apoE4 and apoE ko 
mice at 12 months of age. Values represent the mean and SEM (A). In (B) and (C), VBA 
results are shown superimposed on anatomical images. Voxels with decreased/increased 
rCBVmicro, corresponding to p<0.01for a two-tailed test, are highlighted in the t-maps. No 
relevant differences between the three genotypes were detected. 
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Figure 7. VBA was assessed between the two diet groups, split by genotypes, to reveal 
possible diet×genotype interactions not seen in the ROI analysis. No significant effects 
were seen in wild-type and apoE4 mice in response to dietary intervention (A). Instead, in 
wild-type and apoE ko the Fortasyn diet significantly increased the rCBVmicro in a relatively 
large area of the midbrain, in anatomical correspondence to the small branches of the 
circle of Willis, and in other cortical areas (B). Voxels showing decreased and increased 
rCBVmicro due to dietary treatment correspond to p<0.01 for a two-tailed test. 
 
ROI-based analyses. The analysis focused on the hippocampus, cerebral cortex, 
olfactory bulb, cerebellum and thalamus. No significant differences between 
genotypes or diet (p>0.05) were found in any ROIs between apoE4, apoE ko and 
wild-type mice (Fig. 6A). 
Voxel-based analyses. To determine the occurrence of rCBVmicro changes at 
higher spatial resolution, we applied a voxel-wise statistical approach to the co-
registered brains. No clear dissimilarities in rCBVmicro were seen between all the 
genotypes, with few voxels indicating significant positive or negative differences 
sparse throughout the brain (Fig. 6B,C). In wild-type and apoE ko mice on FC diet, 
several voxels in the midbrain – at the anatomical location of the first and second 
branches of the circle of Willis and of the posterior cerebral artery - revealed a 
significantly increased rCBVmicro compared to their respective control diet groups. 
A moderate increase in rCBVmicro was also seen in the parieto-temporal cortex for 
the same groups on FC diet (Fig. 7). No distinct effects of FC diet were detected 
for the apoE4 mice. 
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Immunohistochemistry 
Immunohistochemical stainings were performed using standard free-floating 
labeling procedures on brain sections from 11 ± 1 month-old transgenic apoE4 
and apoE ko, and wild-type mice fed either the CO diet or the FC diet for 9 ± 1 
months.  
 
Synaptophysin-immunoreactive presynaptic boutons (SIPBs) 
The amount of presynaptic boutons (size ranging from 0.1-4.5 µm2) was 
visualized using a monoclonal antibody against synaptophysin (Fig. 8A, B). 
Synaptophysin-immunoreactivity was determined in cortical regions prelimbic 
area (PLA) and anterior cingulate gyrus (ACg), and in hippocampal regions 
stratum radiatum of area CA1 (SR), stratum lucidum of area CA3 (SL), and inner 
(IML) and outer (OML) molecular layer of the dentate gyrus.  No significant 
differences were found in the amount of SIPBs between apoE4, apoE ko and 
wild-type mice (Fig. 8C) in any of the regions analyzed (p>0.05). Furthermore, the 
FC diet had no effect on the amount of presynaptic boutons (p>0.05).  
 
Doublecortin-positive immature neurons 
Newly formed immature neurons were visualized with a polyclonal antibody 
against doublecortin (Fig. 9A). Doublecortin-positive (Dcx+) cells were counted in 
the subgranular zone of three alternating hippocampal sections as a measure for 
neurogenesis.  
ApoE ko mice showed increased amount of Dcx+ cells in the hippocampus 
compared to wild-type mice (Fig. 9B; p=0.045), independent of diet, suggesting 
increased neurogenesis in apoE ko animals. ApoE4 mice did not differ from wild-
types (p=0.163). Furthermore, the FC diet had no significant effect on the 
amount of newly formed immature neurons (p>0.05). However, it appears that 
the FC diet increased the amount of Dcx+ cells in apoE4 animals, but due to the 
large variation within this group, it did not reach statistical significance in the 
overall analysis (p=0.087), and no genotype×diet interactions were found.  
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Figure 8. Synaptophysin immunohistochemical staining performed on brain sections from 
11±1 month-old apoE4, apoE ko and wild-type mice on control (CO) and Fortasyn (FC) 
diet. A) Representative image of the synaptophysin-immunoreactive presynaptic boutons 
(SIPBs) in the hippocampus. Image taken using an 5× objective. Scale bar=100 µm.  B) 
Representative image of the SIPBs in the stratum radiatum (SR). Image taken using an 40× 
objective. Scale bar=100 µm. C) Amount of SIPBs (between 0.1-4.5 µm
2
) per µm
2
 in 
hippocampal and cortical areas. Multivariate ANOVA did not reveal any significant 
differences between the different genotype and diet groups. Values represent the mean 
and SEM. IML=inner molecular layer, and OML=outer molecular layer (of the dentate 
gyrus); SR=stratum radiatum (CA1 area); SL=stratum lucidum (CA3 area); PLA=prelimbic 
area; ACg=anterior cingulate gyrus.  
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Figure 9. Doublecortin immunohistochemical staining performed on brain sections from 
11±1 month-old apoE4, apoE ko and wild-type mice on control (CO) and Fortasyn (FC) 
diet. A) Representative image of the doublecortin-positive (Dcx+) cells in the subgranular 
zone of the hippocampus. Image taken using an 10× objective. Scale bar=100 µm. B) 
Amount of Dcx+ cells in the subgranular zone of the hippocampus. Multivariate ANOVA 
revealed an overall increase in the amount of newly formed immature neurons in apoE ko 
mice compared to wild-type animals. Values represent the mean and SEM. a* different 
from wild-type mice p<0.05. 
 
 
Biochemical analyses 
Serum and brain sterol analysis 
As shown in Table 3, brain cholesterol levels did not change due to genotype or 
the FC diet (p>0.05). However, serum cholesterol levels were approximately 5.5× 
higher in apoE ko mice than in wild-type animals (p<0.001), whereas no 
differences were found between apoE4 and wild-type mice (p=0.917). 
Furthermore, serum cholesterol levels decreased due to the FC diet in wild-type 
and apoE4 animals (p=0.002). Overall analysis did not reveal such an effect of the 
FC diet comparing apoE ko and wild-type mice (p=0.112). In addition, serum 
lathosterol, a main cholesterol precursor in the “de novo” synthesis pathway, 
significantly decreased in FC fed wild-type and apoE4 mice (p=0.046). Again, 
overall analysis did not reveal such an effect of the FC diet comparing apoE ko 
and wild-type mice (p=0.833). Serum lathosterol levels were approximately 30× 
higher in apoE ko mice than in wild-type animals (p<0.001), and approximately   
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1.5× higher in apoE4 animals compared to wild-type mice (p=0.005), 
independent of diet. In contrast, brain lathosterol levels were decreased in apoE 
ko animals (p=0.001), whereas no differences were observed between apoE4 and 
wild-type mice (p=0.771). 
The cholesterol elimination rate from the brain, measured by serum 24S-OH-
cholesterol levels decreased in FC fed wild-type and apoE4 mice (p=0.001). No 
diet effects were found on serum 24S-OH-cholesterol levels when comparing 
apoE ko and wild-type mice (p=0.380). ApoE ko animals displayed a 5-fold 
increase in serum 24S-OH-cholesterol levels (p<0.001), whereas no differences 
were observed between apoE4 and wild-type mice (p=0.304). In contrast, brain 
24S-OH-cholesterol levels did not change between apoE ko and wild-type mice 
(p=0.755), whereas apoE4 animals showed increased brain 24S-OH-cholesterol 
levels compared to wild-type mice (p=0.001), independent of dietary intake. 
The relative concentrations of different fatty acids (FA) in brain tissue of 12-
month-old wild-type, apoE4 and apoE ko mice are shown in Table 4. Wild-type, 
apoE4 and ApoE ko mice fed the FC diet showed a shift in the balance between 
n3 and n6 fatty acids. The relative amount of n3 FA in FC fed mice increased 
compared to the CO diet (p<0.001), independent of genotype, whereas the 
relative amount of n6 decreased (p<0.001), resulting in a pronounced shift in the 
n3/n6 ratio in FC fed mice in favor of the n3 FA (p<0.001). The reduction of the 
relative n6 content was mainly caused by a decrease in arachidonic acid (20:4n6; 
p<0.001), while the higher n3 content originated from an increase in relative DHA 
(22:6n3; p<0.001) in all genotypes. Furthermore, the relative concentration of OA 
(18:1n9) was increased in the FC fed mice compared to the CO diet (p<0.001), 
independent of genotype. 
Overall analysis comparing apoE4 and wild-type mice indicated that the FC diet 
decreased the relative concentration of PUFA (p=0.020), which was not observed 
when comparing apoE ko and wild-type mice (p=0.112), suggesting that this 
effect of the FC diet is found mainly in the apoE4 mice. 
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 Serum Brain 
 Cholesterol 
(mg/dl) 
Lathosterol 
(μg /dl) 
24S-OH-chol. 
(ng/ml) 
Cholesterol 
(μg /mg) 
Lathosterol 
(ng/mg) 
24S-OH-chol. 
(ng/mg) 
Wild-type       
Control (CO) 122.9±11.4 14.2±1.6 36.89±2.8 59.1±5.7 63.6±2.9 123.1±12.8 
Fortasyn (FC) 72.5±9.1
a
 10.8±1.8
a
 26.52±1.4
a
 62.9±2.8 65±4.1 124.1±17.0 
       
apoE4       
Control (CO) 108.4±10.5 21.3±2.5
a
 39.28±3.1 64.1±1.8 70.3±3.5 192.5±6.4
a
 
Fortasyn (FC) 85.2±8.4
c
 16.3±2.1
c
  29.60±2.1
c
 60.9±0.6 60.5±3.6 175±20.0
b
 
       
apoE ko       
Control (CO) 566.3±59.3
a
 367.3±84
a
 139.44±13.2
a
 67.2±2.4 49.9±3.6
a
 114.3±25.1 
Fortasyn (FC) 517.4±26.7
b
 388.1±34.5
b
 175.75±29.5
b
 62.7±2.0 51.8±3.9
b
 145.2±24.9 
 
Table 3. Serum and brain concentration of sterols. a=different from wild-type (CO); 
b=different from wild-type (FC); c=different from apoE4 (CO) 
 
 
 
 
 SFA MUFA PUFA Σn3 Σn6 n3/n6 DHA AA OA 
Wild-type          
Control 37.0±1 27.2±1 23.5±0 12.6±0 10.9±0 1.15±.01 11.5±0 7.6±0 16.7±0 
Fortasyn 37.2±1 27.8±1 22.8±1 14.9±0a 7.9±0a 1.91±.05a 13.4±0a 5.6±0a 18.0±0a 
          
apoE4          
Control 38.4±1 26.2±1 24.0±1 12.3±0 10.7±0 1.15±.05 11.2±0 8.1±0 16.6±0 
Fortasyn 37.2±1 28.7±1b# 22.1±0b 14.4±0b 7.6±0b 1.93±.09b 12.9±0b 5.4±0b 18.5±0b 
          
apoE ko          
Control 36.4±1 27.0±1 23.9±1 12.6±0 11.3±1 1.13±.02 11.5±0 7.7±0 16.6±1 
Fortasyn 36.6±0 27.8±1 22.8±0 15.1±0c 7.4±0c 2.05±.05c 13.6±0c 5.3±0c 18.2±0c 
Table 4. Relative fatty acid composition % of the lipid fraction of brain homogenates of 12-
month-old wild-type, apoE4 and apoE ko mice on Control (CO) and Fortasyn (FC) diet. SFA 
= saturated fatty acids; MUFA = mono unsaturated fatty acids; PUFA ; poly unsaturated 
fatty acids; DHA = docosahexaenoic acid; AA = arachidonic acid; OA = oleic acid. 
a=different from wild-type (CO); b=different from apoE4 (CO); c=different from apoE ko 
(CO); # trend, p=0.058. 
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Discussion 
The present study aimed to investigate the extent to which a specific multi-
nutrient diet can modulate cerebral hemodynamics, behavior, cognition, brain 
metabolism, and plasticity in the apoE4-carrier and apoE-knockout mice, which 
are models for risk factors in cardiovascular disorders and Alzheimer’s disease. To 
this end, we performed behavioral testing, MRI and MRS approaches and 
immunohistochemical stainings to determine to which extent these transgenic 
animal models develop behavioral and neuropathological traits of AD and to 
determine the effect of dietary intervention. An overview of the main results 
found in the current study is shown in Table 5.  
 
ApoE4 mice were hyperactive in the open field, while apoE ko mice showed more 
anxiety-related behavior. The FC diet appears to have a general anxiolytic effect on 
open field behavior 
Our results show that while apoE4 mice are more active in the open field, apoE 
ko mice show more anxiety-related behavior, as indicated by the increased time 
spent in the corners (i.e. anxious mice prefer the borders of the open field) and 
decreased time spent in the center of the open field (Hooijmans, et al., 
2009,Pugh, et al., 2007,Simon, et al., 1994). These findings are in line with 
previous studies in adult (6-13 months old) apoE4 and apoE ko mice showing 
increased measures of anxiety in the elevated plus maze and higher acoustic 
startle responses to unavoidable anxiety-provoking stimuli compared to wild-
type mice (Hartman, et al., 2001,Raber, et al., 2000,Robertson, et al., 2005). 
Furthermore, both apoE4 and apoE ko mice required more time to habituate to a 
novel environment compared to wild-type mice, suggesting increased “emotional 
reactivity” (Hartman, et al., 2001,Raber, et al., 2000). Consistent with their 
transgenic apoE mouse data, Robertson and colleagues also reported higher 
anxiety scores in probable AD patients with ε4/ε4 compared to those with ε3/ε3 
(Robertson, et al., 2005). Anxiety symptoms and restlessness may occur in up to 
70% of AD patients during the course of their illness and are significantly 
correlated with impairments in activities of daily living (Ferretti, et al., 
2001,Grossberg, 2003,Patterson, et al., 1990,Teri, et al., 1999). Furthermore, our 
results might suggest that the FC diet could have an anxiolytic effect, since it 
increased the time spent in the center and decreased the time spent in the 
corners of the open field in both apoE ko animals and wild-type mice. 
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Effects of genotype: Compared to wild-type mice 
 apoE4 mice apoE ko mice 
Open field Behavior & activity Increased activity Increased anxiety 
Morris water maze Learning & memory Decreased memory n.s. 
reverse MWM Learning & memory n.s. n.s. 
Hippocampal 1H MRS Metabolite levels Increased taurine n.s. 
rCBV (microvasculature) Blood volume n.s. n.s. 
Presynaptic boutons Hippocampus /Frontal cortex n.s. n.s. 
Immature neurons Hippocampus n.s. Increased amount of  
   immature neurons 
Sterol analyses Serum n.s. Increased cholesterol  
  Increased lathosterol Increased lathosterol 
  n.s. Increased 24-OH- 
   cholesterol 
 Brain n.s. Decreased 
lathosterol 
  Increased 24-OH- n.s. 
  cholesterol  
Fatty acid analysis Brain n.s. n.s. 
    
Effects of the FortasynTM Connect (FC) diet: Compared to littermates on control (CO) diet 
 apoE4 mice apoE ko mice 
Open field Activity Decreased anxiety Decreased anxiety 
Morris water maze Learning & memory n.s. n.s. 
reverse MWM Learning & memory n.s. n.s. 
Hippocampal 1H MRS Metabolite levels n.s. Reduced glutamate 
rCBV (microvasculature) Blood volume n.s. Increased rCBV 
Presynaptic boutons Hippocampus /Frontal cortex n.s. n.s. 
Immature neurons Hippocampus n.s. n.s. 
Sterol analyses Serum Decreased cholesterol n.s. 
  Decreased lathosterol n.s. 
  Decreased 24-OH- n.s. 
  cholesterol  
 Brain n.s. n.s. 
Fatty acid analysis Brain Increased n3 content Increased n3 content 
  Decreased n6 content Decreased n6 
content 
  Increased OA content Increased OA 
content 
 
Table 5. Overview of the main results found in the current study in 12-month-old apoE4 
and apoE ko mice supplemented with a specific multi-nutrient diet for 10 months. 
1
H MRS 
= proton magnetic resonance spectroscopy; rCBV = relative cerebral blood volume; n3 = 
omega-3 fatty acids; n6 = omega-6 fatty acids; OA = oleic acid (18:1n9);  n.s. = not 
significant. 
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This is in line with studies showing that rats fed an n-3 PUFA deficient diet display 
increased anxiety-related behavior in the open field and elevated plus maze tasks 
as compared to animals fed an n-3 PUFA adequate diet (Bhatia, et al., 
2011,Takeuchi, et al., 2003). Supplementation with n-3 PUFAs led to substantial 
reduction in the anxiety levels of n-3 PUFA deficient mice (Carrie, et al., 2002) 
and rats (Naliwaiko, et al., 2004,Takeuchi, et al., 2003). Schipper et al. showed 
that the combination of n-3 lc-PUFAs, phospholipids and B-vitamins (similar to 
our FC diet) completely abolished anxiety-related behavioral responses, 
increased social behavior and facilitated fear extinction recall in serotonin 
transporter knockout (SERT-ko) rats (Schipper, et al., 2011). Supplementation 
with n-3 lc-PUFAs has also shown beneficial effects on depressive symptoms and 
agitation in patients with mild to moderate AD (Chiu, et al., 2008,Freund-Levi, et 
al., 2008).  
 
Spatial learning in the MWM and rMWM was unaffected, although apoE4, but not 
apoE ko mice, showed impaired spatial memory in the MWM. The FC diet had no 
effect on spatial learning and memory performance 
In line with results from previous studies (Bour, et al., 2008,Grootendorst, et al., 
2005), no differences were observed between apoE4, apoE ko and wild-type 
mice in their ability to learn the position of a submerged platform during 
acquisition training in the MWM and rMWM. However, the performance of the 
apoE4 mice during the MWM probe trial was worse than the performance of 
wild-type and apoE ko mice, independent of diet. The time apoE4 mice spent in 
the target quadrant did not exceed chance level, and was significantly shorter 
compared to wild-type mice, indicating spatial memory impairment. These 
results are consistent with previous reports of impaired memory retention 
performance in apoE4 mice in several spatial memory tasks (Bour, et al., 
2008,Grootendorst, et al., 2005,Hartman, et al., 2001,Raber, et al., 1998). 
Moreover, several studies have shown a direct correlation between the apoEε4 
allele and cognitive decline in healthy elderly individuals (Caselli, et al., 
1999,Mayeux, et al., 2001,Savitz, et al., 2006).  
 
Contrary to expectations, no cognitive impairment could be observed in the apoE 
ko mice in the current study. Previous studies have shown that under basal naive 
conditions, apoE ko mice are severely impaired in water maze performance 
(Gordon, et al., 1995,Krzywkowski, et al., 1999,Masliah, et al., 1995,Oitzl, et al., 
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1997). However, this cognitive deficit was abolished when apoE ko mice were 
repeatedly exposed to stressful stimuli. Stressed apoE ko mice performed the 
MWM tasks as good or even better than stressed wild-type mice, and this effect 
appeared to be mediated by corticosterone (Grootendorst, et al., 
2001a,Grootendorst, et al., 2001b,Grootendorst, et al., 2002,Zhou, et al., 1998). 
In the current study, animals were not experimentally exposed to repeated 
stressful stimuli. However, the normal daily care, like handling the animals, 
cleaning cages and transport for behavioral testing, can activate the stress 
responsive system especially in the apoE ko mice, and might have positively 
affected their performance in the MWM task (Claassen, 1994,Holscher, 
1999,Kaneto, 1997).  
 
Previous studies have shown that n-3 lc-PUFA intake may improve cognition in 
both mice and rats (Fedorova and Salem, 2006,Hooijmans, et al., 2009,Tanabe, et 
al., 2004). Besides n-3 lc-PUFAs, other nutrients can also affect spatial memory 
performance. Supplementing CDP-choline or UMP and choline to rats improved 
spatial memory in the water maze (De Bruin, et al., 2003,Teather and Wurtman, 
2003). In addition, transgenic mice fed vitamin E (Conte, et al., 2004) or vitamin 
B3 (Green, et al., 2008) showed normalized escape latency in the water maze. 
However, in agreement with our current results, there are also some reports 
showing no effect of n-3 PUFA intake and other nutrients on learning and 
memory performance (Arendash, et al., 2007,Fedorova and Salem, 
2006,Oksman, et al., 2006). Moreover, most intervention studies based on 
supplementation with n-3 PUFAs have failed to show any protective effect on AD 
(Chiu, et al., 2008,Jicha and Markesbery, 2010,Kotani, et al., 2006) or cognitive 
decline (Dangour, et al., 2010,Rogers, et al., 2008,van de Rest, et al., 2008), 
except in some AD patients with very mild cognitive impairment (Freund-Levi, et 
al., 2006,Kotani, et al., 2006,Yurko-Mauro, et al., 2010). Furthermore, apoE4 
carriers have been reported to lack risk reduction from n-3 PUFA consumption 
(Barberger-Gateau, et al., 2011,Huang, et al., 2005,Schaefer, et al., 2006,Whalley, 
et al., 2008), and to be less sensitive to the protective effects of n-3 PUFA 
supplementation on cognition (Cole and Frautschy, 2010,Jicha and Markesbery, 
2010), although the exact mechanisms underlying this gene-by-diet interaction 
remain unclear. Further research is needed to explain the differential effect of n-
3 PUFA on AD according to apoE genotype.  
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The amount of presynaptic boutons was unaffected by genotype and dietary 
treatment. The amount of newly formed immature neurons was increased in apoE 
ko mice, which might reflect a compensatory mechanism in response to functional 
synaptic and neuronal failure or insults to the brain. Neurogenesis appeared 
unaffected by the FC diet 
Synaptic loss is a pathological hallmark of AD, and it is the best correlate of 
cognitive impairment (DeKosky, et al., 1996,Scheff and Price, 2003,Selkoe, 
2002,Terry, et al., 1991). However, synaptic loss does not appear to correlate 
with the APOE genotype (ε2, ε3, ε4) (Scheff, et al., 2007,Scheff, et al., 2006). 
Synaptophysin is a widely used marker for quantification of presynaptic 
terminals, but conflicting results have been reported on synaptophysin 
immunoreactivity (SYN-IR) both in AD patients (Hamos, et al., 1989,Leuba, et al., 
2008,Scheff and Price, 1998,Scheff, et al., 1996) and AD mouse models. SYN-IR in 
transgenic mice that develop Aβ plaques has been reported to decline, increase, 
or not change, apparently depending on the interplay of mouse strain, 
transgene, age, and disease progression (Dong, et al., 2007,Jansen, et al., 
2012,King and Arendash, 2002,Masliah, et al., 1996,Mucke, et al., 2000,Rutten, 
et al., 2003,Yao, et al., 2005). In the current study, no changes were found 
between apoE4, apoE ko and wild-type mice in the amount of presynaptic 
boutons in hippocampal and cortical regions, which is in line with previous 
studies (Levi, et al., 2005,Rijpma, et al., 2013), reporting no differences in 
presynaptic density in the hippocampus of male apoE4, apoE ko and wild-type 
mice. Veinbergs and colleagues did find a decrease in presynaptic density in the 
hippocampus and frontoparietal cortex of 12-month-old apoE ko mice as 
compared to wild-type mice, while presynaptic density was preserved in 12-
month-old apoE4 mice (Veinbergs, et al., 1999). Since cholesterol released from 
apoE-containing lipoprotein particles is used to support synaptogenesis and the 
maintenance of synaptic connections (Mauch, et al., 2001,Pfrieger, 2003,Poirier, 
et al., 1995), a decrease in presynaptic density in apoE ko mice could be 
expected. However, no differences in brain cholesterol levels between wild-type, 
apoE4 and apoE ko were observed in the current study, which might explain the 
lack of differences in amount of presynaptic boutons. It should be noted that we 
used female C57BL/6J breeder mice from Harlan Laboratories, Inc. (Horst, the 
Netherlands) to generate male wild-type offspring for the current study. It is 
known that these mice carry a gene mutation resulting in an alpha-synuclein 
gene deletion(Specht and Schoepfer, 2001). The alpha-synuclein deletion has 
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some effects on synapse function related to neurotransmitter mobilization 
(Gureviciene, et al., 2007,Yavich, et al., 2006,Yavich, et al., 2004). However, basal 
synaptic neurotransmission is unimpaired (Gureviciene, et al., 2007), and there 
are no indications of an altered number of (pre)synapses or neurogenesis in 
C57BL/6JOlaHsd mice. Furthermore, alpha-synuclein is not essential for spatial 
learning tasks, such as the Morris water maze (Chen, et al., 2002). Thus, although 
we should keep this limitation in mind when interpreting our results, the use of 
the C57BL/6J wild-type offspring as control mice is not expected to significantly 
alter the outcomes of the experiments.  
 
In line with a previous study by Levi and Michaelson, (Levi and Michaelson, 
2007), apoE ko mice displayed enhanced neurogenesis, which might reflect a 
compensatory mechanisms in response to functional synaptic failure or insults to 
the brain, like stroke or ischemia. (Arendt, 2001,Jansen, et al., 2012,Jin, et al., 
2004b,Li, et al., 2010,Mu and Gage, 2011,Wang, et al., 2008). Both in AD patients 
and in AD and apoE mouse models, conflicting results have been found regarding 
neurogenesis. Most studies showed a decrease in neurogenesis in both AD 
patients (Boekhoorn, et al., 2006,Lazarov and Marr, 2010,Lazarov, et al., 2010) 
and in APP and PS1 mouse models (Demars, et al., 2010,Hamilton and Holscher, 
2012,Taniuchi, et al., 2007). In contrast, some studies found an increase in AD 
patients (Jin, et al., 2004b) and in AD transgenic animal models (Jin, et al., 
2004a,Yu, et al., 2009). It has been suggested that neurogenesis, as well as 
synaptogenesis, may have a compensatory role in the early stages of AD which 
can counteract the effect of impaired synaptic and neuronal function, 
neurodegeneration and cell death (Abrous, et al., 2005,Gould, et al., 1999,Jin, et 
al., 2004b,Mu and Gage, 2011). Accordingly, activation of apoptotic mechanisms 
and neuronal death during acute and chronic insults, such as ischemia, 
Huntington’s disease and AD, is indeed accompanied by compensatory increases 
in hippocampal neurogenesis (Briones, et al., 2005,Curtis, et al., 2003,Greenberg 
and Jin, 2006,Kee, et al., 2001,Li, et al., 2010,Mu and Gage, 2011,Sutula, et al., 
1989,Wang, et al., 2008,Yagita, et al., 2001).  
 
In the current study, the FC diet had no significant effect on the amount of 
presynaptic boutons or the amount of newly formed immature neurons, 
although in the latter case one might notice the slight, but non-significant, 
increase in the amount of newly formed immature neurons in the apoE4 animals 
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on the FC diet. In line with our results, previous studies failed to demonstrate an 
effect of n-3 PUFA diets on synaptophysin levels; instead, n-3 PUFAs seem to 
exert their beneficial effects more by improving synaptic function rather than by 
synaptogenesis (Arsenault, et al., 2011,Cole and Frautschy, 2006,Kariv-Inbal, et 
al., 2012,Savelkoul, et al., 2012). Other studies have shown that omega-3 fatty 
acids (Crupi, et al., 2012,Dyall, et al., 2010,Kawakita, et al., 2006,Valente, et al., 
2009), folic acid (Das, 2008,Zhang, et al., 2012), and vitamins and antioxidants 
(Bonnet, et al., 2008,Cuppini, et al., 2002) may promote neurogenesis. However, 
the majority of the studies reporting a positive effect of n-3 PUFAs, folic acid, and 
vitamins and antioxidants on neurogenesis were conducted in nutrient-deficient 
animals (Bonnet, et al., 2008,Kawakita, et al., 2006). These results could imply 
that beneficial effects of dietary interventions might become apparent only when 
neurogenesis is severely compromised in response to a dietary deficiency. Since 
our apoE4 and apoE ko mice were not nutrient-deficient and did not show 
compromised neurogenesis at 11 ± 1 months of age, this might explain the lack 
of differences due to dietary intervention in the current study.  
 
ApoE4 and apoE ko mice did not show differences in CBV compared to wild-type 
mice. The FC diet increased CBV in wild-type and apoE ko mice next to the brain 
feeding arteries 
Among other proprieties, apolipoprotein is very important in the maintenance of 
brain vascular health, and in the repair of blood brain barrier (BBB) after injury. A 
list of studies reported a number of neurovascular pathologies associated with 
apoE4 genotype, such as increased small vessel arteriolosclerosis and micro 
infarcts of the deep nuclei (Yip, et al., 2005), cerebral amyloid angiopathy 
(Premkumar, et al., 1996) and inflammation triggering blood brain barrier (BBB) 
breakdown (Bell, et al., 2012). These pathologies, together with gross 
cardiovascular problems, are present in higher extent in mice lacking apoE, and 
their conditions are worsened if the animals were fed a high fat / high cholesterol 
diet (Methia, et al., 2001,Nakashima, et al., 1994). Vascular defects in apoE4 and 
apoE ko mice are shown to precede neuronal dysfunction and can initiate 
neurodegenerative processes (Bell, et al., 2012). We tested here if brain vascular 
pathology is detectable in apoE4 and apoE ko mice with MR imaging and if the 
specific multi-nutrient diet has beneficial effects on the neurovascular system. 
Our analysis revealed an increased rCBV due to the FC diet in apoE ko and wild-
type mice in the midbrain and in the parieto-temporal cortex.  
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The lack of genotype differences is in contrast with our initial expectations of a 
diminished cerebral blood volume due to atherosclerosis in apoE4 and in apoE ko 
mice (Plump, et al., 1992). However, a micro-CT imaging study showed that apoE 
ko mice from 16 to 80 weeks develop atherosclerotic plaques in the aorta, 
pulmonary artery and carotid artery, but not in cerebral arteries (Langheinrich, et 
al., 2007). The presence of atherosclerosis in the systemic circulation may have a 
detrimental effect on the cerebral perfusion, without directly compromising the 
brain vascular structure. The absence of genotype differences found in this study 
seems to confirm this hypothesis. Microcirculation deficits would then be 
triggered by a direct interaction between apoE and the neurovascular unit, 
rather than from the accumulation of atherosclerotic plaques in cerebral vessels. 
A recent study proposed the proinflammatory cyclophilin-a as a possible 
mediating factor between apoE genotype and brain microcirculation (Bell, et al., 
2012). 
 
In the mid-brain, adjacent to the circle of Willis and the posterior cerebral artery, 
we found voxels of increased rCBV in apoE ko and wild-type mice fed with the 
multi-nutrient FC diet, which may reflect an improvement in brain perfusion. 
Such improved cerebrovascular circulation is possibly influenced by both the n-3 
PUFA components and by the B-vitamins in the FC diet and is consistent with 
other animal studies (Hooijmans, et al., 2009,Tsukada, et al., 2000). The 
beneficial effects on the cardiovascular system by n-3 lc-PUFAs, important 
components in our FC diet, have been widely demonstrated in the last decade. 
Several epidemiological studies and controlled trials showed a correlation 
between n-3 PUFA and improvement in autonomic function, lowered blood 
pressure, reduced atherosclerosis and enhanced microvasculature endothelium-
dependent vasodilation processes (Artham, et al., 2008,Lavie, et al., 2009). All 
these factors may have contributed to improve the functionality of the brain 
vascular system, particularly in apoE ko mice, where these pathologies are 
accelerated. Furthermore, it has been shown that deficiency of folate and B-
vitamins, which are  instead supplemented in the FC diet, reduced brain capillary 
density in mice (Troen, et al., 2008). Finally, all mice fed with FC diet showed 
significantly decreased serum total cholesterol levels, which may have an 
additional effect on the fluid dynamics of the blood, lowering plasma viscosity 
and facilitating blood perfusion (Ercan, et al., 2003,Isik, et al., 2012,Tous, et al., 
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2004). A direct measure of the cerebral blood flow with other techniques (e.g. 
arterial spin labeling MRI) would help to quantitatively determine perfusion 
deficits in these mice and the effects of diets on brain hemodynamics. 
 
ApoE4 mice displayed increased levels of Tau in the hippocampus. The FC diet 
reduced the hippocampal Glu levels in all genotypes 
1H hippocampal MR spectroscopy revealed increased Tau levels in the apoE4 
mice and a decrease in Glu levels in wild-type and apoE ko mice by 
supplementation with the FC diet. Tau is an amino acid that is reported to have a 
number of physiological and pharmacological functions, including 
osmoregulation, cell volume adjustment, antioxidation and modulation of the 
action of neurotransmitters (Oja and Saransaari, 1996). Although the effects of 
taurine on brain metabolism are still unclear, some studies reported beneficial 
effects of taurine on brain function (Ito and Azuma, 2004). Moreover, it has been 
reported that taurine prevents the formation of atherosclerotic plaques in apoE 
ko mice (Kondo, et al., 2000). Taurine is mainly obtained by dietary intake, but it 
can also be synthesized in the brain from other sulphur-containing amino acids in 
response to stressful events. Taurine levels increases in both rats and mice as a 
consequence of various cell-damaging conditions, including ischemia (Lekieffre, 
et al., 1992,Saransaari and Oja, 1997). The increase in taurine in the apoE4 mice 
may therefore reflect a spontaneous response of the brain cells to an increased 
stress conditions / pathological status in these mice. The mechanism by which 
apoE4 genotype, and not the absence of apoE, induces excessive taurine 
production is however far from being clear and requires further studies.  
 
In our experiment, we found decreased levels of Glu due to the specific multi-
nutrient diet supplementation. Glutamate, and glutamate receptors, play a 
fundamental role in neuronal grown and differentiation, synaptic plasticity and in 
regulating neurotransmission, by being the major mediator of excitatory signals 
in the central nervous system. However, excess in glutamate production is 
potentially harmful due to its neurotoxic proprieties. In many neurodegenerative 
diseases, such as AD, glutamate levels are found to be higher than in normal 
aging. Amyloid-β peptides have been shown to increase glutamate release, 
inhibit clearance of glutamate by astrocytes and affect glutamate receptor 
activity (Revett, et al., 2013). Furthermore, glutamate is the major mediator of 
excitotoxic neuronal death following cerebral ischemia. Under hypoxic or 
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ischemic conditions, glutamate transporters can functionally reverse to release 
glutamate, thereby inducing further neuronal injury (Kato and Kogure, 
1999,Noga, et al., 1997,Wang, et al., 2013). Although the interpretation of these 
data need needs to be made carefully, our results suggest that the FC diet can 
modulate the production / uptake of glutamate, and this is possibly linked to a 
better brain perfusion with an amelioration of neuronal function.  
 
Conclusion  
The multi-nutrient Fortasyn Connect® (FC) diet consists of nutrients which are 
precursors and co-factors for membrane synthesis and maintenance, and also 
contains various nutrients that may be expected to support cardio- and 
cerebrovascular health. In the present study, we showed that the 
supplementation of FC diet is able to change fatty acid composition in the brains 
of all our mice. We showed that 11 month-old apoE4 mice display increased 
activity and slightly reduced memory compared to wild-type mice, which may be 
a consequence of hypercholesterolemia and AD. The lack of substantial 
pathological status in these mice may explain why we could detect only minor 
effects of the specific multi-nutrient diet. Instead, in the apoE ko mice, a more 
severe model for atherosclerosis and hypercholesterolemia, we measured 
several beneficial effects due to the FC diet: decreased anxiety-related behavior, 
a reduction in hippocampal glutamate levels, and increased rCBV. We 
hypothesize that these features reflect a better response from neuronal cells to 
sustain ischemic driven events, due to an amelioration of cardiovascular health 
and possibly due to improving the cell membrane properties. Taken together, 
these results suggest that this specific multi-nutrient diet has the potential to 
ameliorate AD-related and ischemia-related pathologies, by positively influencing 
both the vascular system and the cell membrane composition. 
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Abstract 
Nutritional intervention may retard the development of Alzheimer’s disease (AD). 
In this study we tested the effects of two multinutrient diets in an AD mouse 
model (APPswe/PS1dE9). One diet contained membrane precursors such as omega-
3 fatty acids and uridine monophosphate (DEU), while another diet contained co-
factors for membrane synthesis as well (Fortasyn); the diets were developed to 
enhance synaptic membranes synthesis, and contain components that may 
improve vascular health. We measured cerebral blood flow (CBF) and water 
diffusivity with ultra-high-field MRI, as alterations in these parameters correlate 
with clinical symptoms of the disease. APPswe/PS1dE9 mice on control diet showed 
decreased CBF and changes in brain water diffusion, in accordance with findings 
of hypoperfusion, axonal disconnection and neuronal loss in AD patients. Both 
multi-nutrient diets were able to increase cortical CBF in APPswe/PS1dE9 mice and 
Fortasyn reduced water diffusivity, particularly in the dentate gyrus and in 
cortical regions. We suggest that a specific diet intervention has the potential to 
slow AD progression, by simultaneously improving cerebrovascular health and 
enhancing neuroprotective mechanisms. 
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Introduction 
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. The disease 
is clinically characterized by cognitive impairment, memory loss, anomia, apraxia, 
anosognosia and alteration of personality. Pathological hallmarks of AD include 
the presence of neurofibrillary tangles (NFTs), amyloid-beta (Aβ) plaque 
formation and neurodegeneration (Sennvik, et al., 2000). The development of AD 
also involves several associated processes all of which are described in AD 
pathophysiology, such as: synaptic loss, chronic brain inflammation, white matter 
degeneration, mitochondrial dysfunction and cerebrovascular defects. After 
many years of extensive research, the idea that a single event can trigger AD 
pathogenesis is fading, replaced by the belief that all these events combined lead 
to a progressive damage of neuronal function, loss of synaptic integrity and 
cognitive decline. The failure of several anti-AD drugs in phase 3 clinical trials has 
been related to the fact that these medicines targeted a single trait of the 
disease, already in a stage when neuronal damage had become too widespread 
(Kozauer and Katz, 2013); this emerging idea emphasizes the importance of 
combining new therapeutic approaches that act in parallel on multiple AD risk 
factors in an early stage of the disease (Iqbal and Grundke-Iqbal, 2010). One such 
approach currently available is the use of nutrients and dietary modifications. 
 
Aside from aging, many risk factors of AD, including atherosclerosis and 
hypercholesterolemia, seem to be related to the development of a less healthy 
lifestyle in the western population. The consumption of high cholesterol and high 
caloric food typical of the western diet, resulting in overweight with its 
associated disorders, is proposed as one of the main causes of the increased AD 
prevalence, largely because of their negative effect on the vascular system 
(Puglielli, et al., 2003)(Casserly and Topol, 2004,Luchsinger, et al., 2005)(Wolozin, 
et al., 2006)(Canevari and Clark, 2007). A beneficial impact on AD onset and 
development has been suggested via healthy dietary behaviour instead. Among a 
long list of nutrients that are considered potential candidates for interventions to 
delay AD, omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA) from 
fish oil are the most studied. With the discovery of the therapeutic effects of n-3 
LCPUFA supplementation against cardiovascular pathologies (Lee, et al., 2008), 
the idea arose about influencing AD development by attenuating vascular risk 
factors. Furthermore, high levels of n-3 LCPUFA replace omega-6 (n-6) fatty acids 
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and cholesterol from cell membranes leading to increased fluidity of the 
membrane, increased number of receptors, enhanced receptor binding and 
affinity, and improved neurotransmission and signalling (Bourre, et al., 1989), 
which is important for optimal cognitive functioning (Bourre, et al., 1991,Farkas, 
et al., 2002,Fontani, et al., 2005). Several epidemiological studies associated a 
reduced risk of developing dementia, including AD, with an increased dietary 
intake of n-3 LCPUFA from fish oil, particularly docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) (Kalmijn, et al., 1997,Schaefer, et al., 
2006),(Barberger-Gateau, et al., 2007,Beydoun, et al., 2008,Eskelinen, et al., 
2008). However, evidence from clinical randomized controlled trials failed to 
confirm the promising findings of their efficacy as AD treatment (Cunnane, et al., 
2009,Yurko-Mauro, et al., 2010,Quinn, et al., 2010).  
 
One of the reasons behind these inconclusive results may lie in the concomitant 
presence of multiple phenotypic traits in AD. While n-3 LCPUFA alone improve 
the functionality of the neural and vascular system and have a beneficial effect 
on cardiovascular disease prevention, this might not be sufficient to avert 
neurodegenerative processes and synaptic loss as occurring in AD. Several 
preclinical studies showed that specific combinations of nutrients, rather than a 
single component, can synergistically act to express a better therapeutic 
outcomes; animals fed with a combination of uridine monophosphate (UMP), 
DHA and choline, which are key nutritional precursors to form phosphatidyl-
choline (Kennedy and Weiss, 1956), but not DHA alone, showed increased levels 
of brain phospholipids, dendritic spines and neurite outgrowth, with beneficial 
effects on cognition (Cansev and Wurtman, 2007,Sakamoto, et al., 
2007,Wurtman, et al., 2006). Recently, a novel combination diet that also 
includes other precursors and cofactors in membrane synthesis (such as 
phosphatidylcholine, B-vitamins and antioxidants), called Fortasyn, has been 
proposed for the dietary management of AD (Kamphuis and Scheltens, 2010). To 
date, two randomized controlled clinical trials have shown improvements in the 
delayed verbal recall task and better cognitive performance in mild AD patients 
supplemented with a Fortasyn-containing diet (Cummings, 2012,Scheltens, et al., 
2010,Scheltens, et al., 2012). The mechanisms by which these dietary nutrients 
influence the pathophysiology of AD yet need to be elucidated, and there is the 
need for more studies to confirm their efficacy. In this study we tested the 
hypothesis that the multi-nutrient Fortasyn diet, and a diet consisting of DHA, 
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EPA and UMP without additional nutrients, have a positive effect in delaying AD 
pathology progress both by improving cerebral perfusion and by protecting 
against neuronal degeneration. With this aim, we evaluated cerebral blood flow 
(CBF) and gray and white matter integrity with MR imaging at ultra-high field in a 
12-month-old double transgenic mouse model for genetic AD (APPswe/PS1dE9).  
 
Materials and methods 
 
 Animals 
The APPswe/PS1dE9 founder mice were originally obtained from John Hopkins 
University, Baltimore, MD, USA (Borchelt, et al., 1997), and a colony was 
established at the Central Animal Facility at Radboud University Nijmegen 
Medical Center, the Netherlands. In short, mice were created by co-injection of 
chimeric mouse/human APPswe (mouse APP695 harbouring a human Aβ domain 
and mutations K595N and M596L linked to Swedish familial AD pedigrees) and 
human PS1-dE9 (deletion of exon 9) vectors controlled by independent mouse 
prion protein promotor elements. The two transfected genes cointegrate and co-
segregate as a single locus (Jankowsky, et al., 2001). This line (line 85) was 
originally maintained on a hybrid background by backcrossing to C3HeJ × 
C57BL6/J F1 mice (so-called pseudo F2 stage). For the present work, the breeder 
mice were backcrossed to C57BL6/J for 13 generations to obtain mice for the 
current study. To reduce the variability of the data, only male mice were used for 
the experiment. Throughout the experiments, the animals were housed in a 
controlled environment, with room temperature at 21°C, and an artificial 12:12h 
light:dark cycle (lights on at 7 a.m.). Food and water were available ad libitum. 
The experiments were performed according to Dutch federal regulations for 
animal protection and were approved by the Veterinary Authority of Radboud 
University Nijmegen Medical Center.  
 
Diets 
From two months of age, male transgenic mice (n=27) and wild-type littermates 
(n=43) were assigned to three different diet groups until the end of the 
experiment (Table 1). One group of mice was used as a control group and 
received a standard normal rodent chow with 5% fat percentage obtained from a 
combination of corn oil (2.2%), soy oil (1.9%) and coconut oil (0.9%). In the 
second group the fat composition in the food was replaced by fish oil (3.0%), 
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corn oil (1.9%) and coconut oil (0.1%). In addition, uridine monophosphate 
(UMP) was added (1%). This diet will be called DEU (DHA+EPA+UMP) throughout 
the article. The third group received the same DEU diet with additional nutrients 
such as choline, phospholipids, vitamins B6, B12, C and E, folic acid and selenium. 
This multi-nutrient diet will be called Fortasyn. The composition of the diets is 
shown in Table 1. All three diets were isocaloric. All diets were manufactured and 
pelleted by Research Diet Services (Wijk bij Duurstede, NL) and stored at -20°C 
until use. 
 
5% fat percentage 
 Dietary groups 
Oils 
Control 
[g /100g] 
DEU 
[g/ 100g] 
Fortasyn 
[g / 100g] 
    
% soya oil 1.9 - - 
% coconut oil 0.9 0.1 0.1 
% corn oil 2.2 1.9 1.9 
% fish oil - 3.0 3.0 
    
Additives    
% pyridoxine-HLC - - 0.00033 
% folic acid (90%) - - 0.00067 
% cyanocobalamin  - - 0.00350 
% ascorbic acid - - 0.16 
% dl-α-tocopheryl acetate  - - 0.465 
    
% uridine monophosphate (UMP) - 1.0 1.0 
% choline chloride - - 0.402 
% soya lecithin - - 0.412 
% sodium selenite - - 0.00023 
    
Table 1. Oil sources and additives in the experimental diets.  
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MRI protocol  
MRI measurements were performed at the age of 12 months on a 11.7 T BioSpec 
Avance III small animal MR system (Bruker BioSpin, Ettlingen, Germany) 
equipped with an actively shielded gradient set of 600 mT/m and operated by a 
Paravision 5.1 software platform. We used a circular polarized volume resonator 
for signal transmission and an actively decoupled mouse brain quadrature 
surface coil with integrated combiner and preamplifier for signal receiving 
(Bruker BioSpin). For the MR imaging procedure, the animals were anesthetized 
with isoflurane (3.5% for induction and 2% for maintenance) in a 2:1 oxygen and 
N2O mixture and placed in a stereotactic holder to prevent unwanted movement 
during the scanning. Body temperature was maintained at 37˚C with heated 
airflow and monitored with a rectal temperature probe. Respiration of the 
animal was monitored using a pneumatic cushion respiratory monitoring system 
(Small Animal Instruments Inc, NY, USA). 
After standard adjustments, gradient echo (GE) images in three orthogonal 
directions were acquired to determine an anatomical reference of the mouse 
brain. Image parameters: echo time (TE)=5 ms; repetition time (TR)=630 ms; flip 
angle=16°; field of view=4 cm; matrix size=512×512; spatial 
resolution=0.078×0.078×0.34 mm/pixel; total scan time=8 min. 
Brain perfusion was measured under resting conditions using an established 
arterial spin labelling (ASL) method with flow-sensitive alternating inversion 
recovery (FAIR) technique (Kim, 1995,Kwong, et al., 1991). A spin-echo planar 
imaging sequence preceded by a 180° hyperbolic secant (sech80) RF inversion 
pulse was used. Imaging parameters: TE = 11.8 ms; TR = 13.75 s; image matrix = 
128×128; field of view= 30×30 mm; spatial resolution = 0.234×0.234×1 mm/pixel. 
Inversion parameters: inversion slab thickness = 6 mm; slice margin = 1.5 mm. 
Twenty-five images with increasing inversion times (TIs) (40 ms - 3000 ms) were 
obtained for the T1 calculations, amounting to a total scan time of 24 minutes per 
mouse. Inversion recovery data from the imaging slice were acquired after 
selective inversion interleaved with non-selective inversion. 
Diffusion of water was measured by the protocol of Harsan et al., which we 
modified as described previously (Harsan, et al., 2010,Zerbi, et al., 2013). In 
short, 31 axial slices covering the whole brain were acquired with a spin-echo 
planar imaging protocol (SE-EPI). B0 shift compensation, navigator echoes and an 
automatic correction algorithm to limit the occurrence of ghosts and artefacts 
were implemented. Encoding b-factors of 0 s/mm2 (b0 images; 5×) and 1000 
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s/mm2 were used and diffusion-sensitizing gradients were applied along 30 non-
collinear directions in three-dimensional space. Other imaging parameters were: 
TE = 21.4 ms; TR = 7750 ms; time between the application of diffusion gradient 
pulses Δ = 10 ms; diffusion gradient duration δ = 4 ms; number of segments = 4; 
spatial resolution 0.156×0.156×0.5 mm/pixel; total scan time of 18 minutes for 
each mouse.    
 
Cerebral blood flow calculation 
For each mouse, the FAIR images with different TIs were realigned and resliced 
over the first TI using a rigid-body model, implemented in the Statistical 
Parametric Mapping 8 tool (SPM8, University College London, 
http://www.fil.ion.ucl.ac.uk/spm/). 
Determination of T1 selective and T1 non-selective was performed by fitting the averaged 
signal intensities in each ROI with a three-parameters monoexponential T1 
relaxation curve. The perfusion was calculated from both T1 values using the 
equation: 
 
   
 
 
                 
        
 
 
            
 
 
                
  
 
where λ is the blood/tissue partition coefficient for water, assumed to be 0.9 ml 
g–1 (Leithner, et al., 2008) and T1 blood was assumed to be 2.75s at 11.7T (Lin, et al., 
2012). Regional perfusion was evaluated in the cerebral cortex (all cortical 
regions above corpus callosum), hippocampus, thalamus and in the entire brain 
according to the atlas of Franklin and Paxinos (Franklin and Paxinos, 1997). All 
algorithms were implemented in MATLAB R2008a (Mathworks, Natick, MA, USA). 
 
Diffusion tensor MRI (DT-MRI) parameter estimation 
By measurement of the water diffusivity in multiple directions, DT-MRI 
reconstructs an ellipsoid to model the diffusion in every voxel. The diffusion 
tensor is characterized by the magnitude of the diffusivity over its three axes 
(eigenvectors). The mean diffusivity (MD) is the average of these diffusivities and 
describes the size of the tensor. The axial diffusivity (λ1) is the diffusion aligned to 
the primary diffusion direction and the radial diffusivity (RD) represents the 
diffusivity perpendicular to this main direction. The shape of the diffusion tensor 
is quantified by the fractional anisotropy (FA), which is an index between 0 and 1 
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that indicates to what degree diffusivity is different over the three axes of the 
tensor.  
The pre-processing steps consisted in individual realignment and reslice of the 
diffusion images (SPM8), followed by spatial normalization and tensor 
estimation. For spatial normalization, a study-specific template from the MR 
diffusion images was created of all WT and transgenic animals using Advanced 
Normalization Tools (ANTs. V1.9, http://picsl.upenn.edu/ANTS/). A group-wise 
normalization procedure (SyGN, as implemented in the buildtemplateparallel.sh 
script V0.0.13) was employed on the mean diffusion image of each mouse 
(Avants et al., 2010). The default implementation was followed with four 
iterations, using mutual information as the initial affine similarity metric and 
cross-correlation as ‘greedy SyN’ diffeomorphic transformation metric. A mask 
that included the entire brain was manually defined in the normalized coordinate 
space and transformed to each animal’s native space for use in subsequent 
processing. The diffusion tensor was estimated for every voxel using the PATCH 
algorithm (Zwiers, 2010). This method incorporates realignment and is robust 
against both regional artefacts (e.g. cardiac motion) and slice-wise artefacts (e.g. 
bulk motion) by providing a weight for every voxel that reflects the probability of 
being an outlier in the tensor fitting. From the eigenvalues of the diffusion 
tensor, FA, MD, RD and λ1 were calculated. The resulting volumes were spatially 
normalized to the template space using the affine parameters and deformation 
field obtained at the creation of the template. 
 
Region of interest analysis 
The maps of FA, MD, RD and λ1 were evaluated for significant genotype 
differences with a region of interest (ROI) approach. For the ROI-based approach, 
nine white matter tracts were selected bilaterally across the mouse brain based 
on an atlas (Franklin K, 1997,Franklin and Paxinos, 1997). These regions include 
the anterior commissure (aca), body (bcc), genu (gcc) and splenium of the corpus 
callosum (scc), cerebral peduncle (cp), external capsule (ec), fimbria of the 
hippocampus (fi), and fornix (fo). The hippocampus and cerebral cortex (all 
cortical areas above the corpus callosum) were also defined approximately at -
1.22 up to -2.54 posterior to bregma. 
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Voxel based analysis (VBA) 
Regional differences in spatially normalized FA and MD maps between 
APPswe/PS1dE9 mice and WT littermates and between the diet groups were 
additionally assessed voxel-wise using MATLAB R2008a (Mathworks, Natick, MA, 
USA) and Statistical Parametric Mapping 5 (SPM5, Wellcome Department of 
Clinical Neurology, London, UK) with the SPMMouse toolbox (Sawiak, et al., 
2009). Two t-tests were performed to identify genotype-wise differences in the 
framework of the general linear model. VBA was further assessed between the 
control diet and DEU and Fortasyn diet groups, to reveal diet effects not seen in 
the ROI analysis. Statistical significance for an individual voxel was established at 
p<0.05, uncorrected for multiple comparisons. The locations of significant voxels 
exceeding a minimum cluster size of 4 (to achieve cluster size ≈ 0.05 mm3 as in 
(Dubois, et al., 2008)) were determined and overlaid onto images derived from 
the template image. 
 
Tissue sampling 
Directly following the MR measurements, half of the mice were sacrificed by 
cervical dislocation to collect brain tissue for biochemical analyses, and the other 
half were sacrificed by transcardial perfusion fixation with saline followed by 4% 
paraformaldehyde. Brains were removed from the skull after decapitation. Brains 
for biochemical analyses were snap frozen in liquid nitrogen and stored at -80°C. 
Perfused brains were postfixed for 15h at 4°C in 4% paraformaldehyde and 
subsequently stored in 0.1M PBS with 1% sodium azide at 4°C for 
immunohistochemical stainings.  
 
Amyloid-β staining 
Amyloid-β deposits were visualized using WO-2 antibody (mouse anti-human 
Aβ4–10 from K. Beyreuther, Centre for Molecular Biology, University of Heidelberg, 
Germany). In short, 40μm thick coronal sections were pre-treated with sodium 
citrate solution 0.05M at 85° C for 30 min and incubated for 18h at 4°C with 
primary antibody mouse anti-human Aβ4–10 (1:20.000 in TBS-T). The next day 
sections were rinsed in TBS-T and incubated for 90 min with the secondary 
antibody donkey-anti mouse biotin (1:1500, Jackson ImmunoResearch). 
Thereafter, sections were transferred to a solution containing Vector ABC-Elite 
1:800 (Vector laboratories, Burlingame, CA, USA). The sections were incubated in 
DAB-Ni solution with perhydrol for 10 min and mounted on gelatin-coated slides. 
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After dehydration in alcohol series, slices were cleared with xylol and mounted in 
Entellan. 
The amount of β-amyloid was determined in appropriate sections digitized using 
a Carl Zeiss Axioskop microscope, equipped with hardware and software of 
Microbrightfield (Williston, USA). Extracellular Aβ load was quantified with a 
computer-assisted analysis system (Stereo Investigator, Microbrightfield, 
Williston, USA) using Cavalieri’s probe. Contours along the whole hippocampus, 
along three hippocampal regions (cornu Ammonis area 1 and 3 (CA1, CA3) and 
dentate gyrus (DG)) and in the frontal prelimbic area (PLA) and anterior cingulate 
gyrus (ACg) were drawn. Measurement of Aβ load was defined as the percentage 
of area covered by Aβ. Serial images with 20× magnification were used for the 
quantification by two investigators. 
 
Brain fatty acid analysis  
Fatty acid analyses were performed on homogenized brain tissues – including 
frontal lobe and olfactory bulb - and total lipid was extracted by adding methanol 
and dichloromethane. Subsequently, samples were centrifuged at 3000 rpm for 
10 min and the lower layer (dichloromethane and lipids) was collected. 
Chloroform was added to the upper phase, samples were centrifuged again at 
3000 rpm for 10 min and the lower phase was combined with the first one. The 
chloroform fractions were dried in a SpeedVac®, and 2 ml methanol and 40 μl 
concentrated sulfuric acid were added to the dried extract. The samples were 
heated at 100°C for 60 min, and 2 ml hexane and 0.5 ml 2.5M sodium hydroxide 
solution were added. After vortexing and centrifuging the samples for 5 min at 
3000 rpm, the upper layer was collected and evaporated in a SpeedVac®. The 
fatty acids were dissolved in 125 μl iso-octane and analyzed on a GC-FID with a 
CP-SIL88 column (50 m × 0.25 mm id. 0.22 film thickness). The n6/n3 ration was 
calculated as a sum of analyzed n6 fatty acids divided by the sum of n3 fatty 
acids.  
 
Statistics 
For the statistical analysis, SPSS 18.0 software (SPSS Inc., Chicago, IL, USA) for 
Windows was used. The univariate ANOVA test with diet as between-group-
factor was used to evaluate regional differences in Aβ- load in APPswe/PS1dE9 mice. 
In all other cases, multivariate two-way ANOVAs (MANOVA) with genotype and 
diet as between-group-factors were conducted to analyze possible differences 
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between APPswe/PS1dE9 and wild-type mice, and between the control, DEU and 
Fortasyn diets. If the Bonferroni post hoc test indicated a significant interaction 
between genotype and diet (between-group-factors), the data were split for the 
concerning factor and thereafter analyzed again with the MANOVA. For clarity 
reasons, F-values are not displayed. Furthermore, only between-group 
interactions that reached statistical significance are specified in detail. If the 
overall statistical analysis showed a significant diet effect, we used the post-hoc 
Tukey`s HSD test on the separate groups. Correlation analyses between 
perfusion, diffusion parameters and Aβ load in the whole hippocampus were 
performed with the bivariate Pearson’s correlation method. Statistical 
significance was set at p ≤ 0.05. All values used are expressed as mean ± SEM.  
 
Results 
 
Body weight 
All mice were weighed before the MR measurements. Body weight was affected 
by genotype, with mean body weight being slightly higher in the APPswe/PS1dE9 
mice compared to wildtype mice (38.5 ± 1 g and 35.4 ± 0.7 g, respectively; 
p=0.008). We did not observe differences in the body weight by the various diets.  
 
Cerebral blood flow 
To study genotype and diet intervention effects on cerebral hemodynamic, we 
measured cerebral blood flow (CBF) with a flow-sensitive MRI technique (FAIR 
ASL) in 12-month-old APPswe/PS1dE9 mice and wildtype littermates on the three 
different diets. Four regions of interest (ROI) were analyzed: entire brain, cortex, 
hippocampus and thalamus (Figure 1, c). Since no intra-individual differences in 
CBF between right and left hemispheres were detected between mice groups 
(data not shown), values from both sides were averaged. 
Compared to wildtype, the APPswe/PS1dE9 mice showed a significant reduced CBF, 
independent of diet, in the entire brain (p<0.001) and in the hippocampus 
(p=0.001). In the cortex and in the thalamus, the two-way MANOVA revealed 
genotype×diet interactions; after splitting the data for age and for genotype, we 
found that APPswe/PS1dE9 mice on control diet had a lower CBF also in both 
regions (p<0.001). The APPswe/PS1dE9 mice fed with the DEU diet also showed a 
reduced CBF in the cortex compared to wildtype (p=0.008), while transgenic mice 
fed with the Fortasyn diet had significant reduced CBF compared to wildtype 
littermates only in the thalamus (p=0.011). 
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Figure 1. To measure the cerebral blood flow (CBF) we employed a FAIR MRI 
technique; from a series of EPI-images (a) we were able to acquire high-resolution 
CBF images of the mouse brain (b). CBF was measured in APPswe/PS1dE9 and 
wildtype mice on three different diets (Control, DEU and Fortasyn) in four 
different regions of interest (ROI): Entire brain, cortex, hippocampus and 
thalamus (c). 
 
 
By comparing the different dietary groups, we found significant CBF differences 
in the transgenic mice; specifically, in APPswe/PS1dE9 mice on DEU diet, we 
measured an increased CBF in the cortex and in the thalamus compared to the 
APPswe/PS1dE9 mice on control diet (p=0.045 and p=0.021). Similarly, the 
APPswe/PS1dE9 mice on Fortasyn diet showed increased perfusion in the cortex 
(p=0.046) and a slight increase in the thalamus (p=0.056), when compared to 
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transgenic animals on control diet. No differences in CBF by the diets were found 
in the wildtype mice.  
 
Figure 2. In the cerebral cortex, the two-tailed Peason’s correlation test revealed a 
significant positive correlation between diffusion fractional anisotropy (FA) and 
cerebral blood flow (CBF). 
 
 
 
Diffusion tensor imaging 
Region of interest based analysis 
Quantitative assessment of diffusion tensor derived indices was performed for 
ROIs drawn in white and gray matter regions to assess genotype and diet effects 
in transgenic and non-transgenic mice (Figure 3c, 4c and 5b). Because of severe 
artifacts in the diffusion-weighted images, two mice have to be excluded from 
this analysis. Independent of diet, the APPswe/PS1dE9 mice showed a significantly 
lower axial diffusivity (λ1) compared to wildtype in several white matter tracts, 
such as aca (p=0.05), scc (p=0.034), bcc (p=0.027) and fo (p=0.014). In the latter 
two regions, a decreased mean diffusivity (MD) was also present in transgenic 
mice, possibly linked to the reduced λ1 (p=0.05 and p=0.036, respectively). A 
reduced λ1 in APPswe/PS1dE9 compared to wildtype mice was also measured in the 
cortex (p=0.046). Overall, decreased mean fractional anisotropy (FA) values and 
increased radial diffusivity (RD) values were found in transgenic animals in most 
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of the ROIs analyzed, although they did not reach statistical significance. In the 
fimbria of the hippocampus, a significant genotype × diet interaction for all 
different diffusion parameters allowed to split these data and revealed beneficial 
effects of dietary intervention (not shown). In the APPswe/PS1dE9 mice on control 
diet we found a reduced FA (p=0.049) and increased RD (p=0.022) compared to 
wildtype; these differences were not seen in the DEU and Fortasyn groups. The 
APPswe/PS1dE9 on DEU diet showed a reduced RD (p=0.023) compared to the 
control diet and increased FA and λ1 compared to the Fortasyn diet (p=0.019 and 
p=0.035). In the cerebral cortex, we found that the Fortasyn diet, independent of 
genotype, reduced the MD and RD (p=0.043 and p=0.019, respectively) 
compared with control diet.  
The two-tailed Pearson’s test showed a positive correlation in the cortex 
between the FA and the CBF (p=0.004, Figure 2) and between the λ1 and the CBF 
(p=0.032) in both wildtype and APPswe/PS1dE9 animals. A positive correlation was 
also found between FA and CBF in the hippocampus for wildtype mice (p=0.028), 
but not for APPswe/PS1dE9 (p=0.956). These results suggest that structural integrity 
and anisotropy, as reflected by λ1 and FA, in gray matter are associated with a 
better perfusion.  
 
Voxel-based Analysis 
To determine the occurrence of diffusion changes at a higher spatial resolution 
and to reveal possible genotype and diet interactions not seen in the ROI 
analysis, we applied a voxel-based statistical approach (VBA) to the co-registered 
diffusion maps. As the VBA allowed only two-group comparisons, these analyses 
were conducted between the two genotypes separated by diet groups, and 
between the control diet group and the DEU and the Fortasyn diet groups. For 
the VBA, p-value maps (p-value thresholded at 0.05, minimum voxel cluster size 
set at 0.05 mm3) were overlaid with an anatomical template. The VBA in Figure 3 
and Figure 4 indicates areas in which diffusion parameters FA and MD differ 
significantly between the two genotypes. Voxels that differ significantly between 
the selected groups are lit up, with the color-coding indicating the magnitude of 
difference. In the APPswe/PS1dE9 mice on control diet, areas of the corpus 
callosum and fimbria (fi) showed significantly lower FA and higher MD compared 
to wildtype. Similar changes were detected in other areas, like the internal 
capsule (ic) and the anterior commissure, posterior (acp) (not shown). 
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Figure 3. Representative image of fractional anisotropy (FA) of a mouse brain in three 
orthogonal slices is shown (a). The voxel based analysis (VBA) revealed gray and white 
matter FA changes in APPswe/PS1dE9 mice (b); in the transgenic animals on control diet we 
detected reduced FA in the corpus callosum, fimbria and cortex, as indicated by arrows. In 
mice on DEU diet, the reduced FA in the cortex of transgenic mice was still present, but no 
differences were seen in other brain regions. These genotype differences were absent in 
the mice on Fortasyn diet.  The regions of interest (ROI) based approach revealed a 
reduction of diffusivity along the axons (λ1) in the APPswe/PS1dE9 mice in several white 
matter tracts and in the cortex (c). ROI include the anterior commissure anterior (aca), 
genu (gcc) – body (bcc) – splenium of the corpus callosum (scc), fimbria of the 
hippocampus (not shown), fornix (fo), cerebral cortex (ctx) and hippocampus (hc).  
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Figure 4. Representative image of mean diffusivity (MD) of a mouse brain in three 
orthogonal slices is shown (a). The VBA revealed MD changes in APPswe/PS1dE9 mice on 
control diet, particularly in the dentate gyrus of the hippocampus (b, arrows). These 
genotype differences were not present in the mice groups on DEU and Fortasyn diet. The 
region-of-interest based approach revealed reduced mean diffusivity (MD) in the 
APPswe/PS1dE9 mice in the body of corpus callosum (bcc) and in the fornix (fo), likely due to 
the decreased λ1 in this same regions (c). 
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Figure 5. VBA between the DEU and Fortasyn diet groups, compared to the control diet 
(a). Mice on DEU and Fortasyn diet showed increased FA and decreased MD in several 
white and gray matter regions. Particularly, a widespread reduced MD in the cortex and 
hippocampus is notable by the Fortasyn diet, suggesting an enhanced neuroprotective 
action of this diet. The region-of-interest based approach revealed a reduced mean 
diffusivity (MD) in the cortex in both wildtype and APPswe/PS1dE9 mice on Fortasyn diet, 
compared to the control diet; this effect is likely to follow the decreased radial diffusivity 
in the same region (not shown) (b). 
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Similar to previous findings in the same mouse strain, the VBA demonstrated the 
presence of significant genotype differences in gray-matter structures (Zerbi, et 
al., 2013); in the dentate gyrus the MD was highly increased in transgenic mice 
compared to the wildtype, while the FA did not change significantly. 
Furthermore, in the visual, auditory and somatosensory cortex, several clusters 
of decreased FA were also found in the APPswe/PS1dE9 mice on control diet. 
Genotype differences between mice on DEU diet were less frequent and evident. 
Among them, a decreased FA in the cortex was still present, similar to the 
findings in the control diet group. In the Fortasyn diet group, no notable 
genotype differences were detected, suggesting an amelioration of white and 
gray matter structural integrity in the transgenic mice.  
Data were further analyzed comparing the different dietary groups, to visualize 
the overall effects of DEU and Fortasyn intervention (Figure 5). In the optic tract, 
fi and some areas of the ic we detected higher FA and lower MD in animals fed 
with the experimental diets, compared to the ones fed with the control diet. 
Interestingly, Fortasyn and DEU diets both increased FA and decreased MD in the 
hippocampal and in several other cortical regions, when compared to the control 
diet. All these effects are more evident in the Fortasyn diet (Figure 5-b) than in 
the DEU diet (Figure 5-a).  
 
Amyloid plaque load 
Among the regions of interest analyzed, the highest amount of plaque load in the 
transgenic animals was found in the DG of the hippocampus (12.1±0.6 % of Aβ 
per area), in the GC (11.3±1.2 % of Aβ per area) and PRL (9.6±1.1 % of Aβ per 
area) compared to the CA1 (4.5±0.3 % of Aβ per area) and CA3 regions (1.9±0.3 
% of Aβ per area) (for all comparisons, p<0.001). APPswe/PS1dE9 mice on DEU diet 
showed reduced amyloid plaque burden in hippocampal area CA1 when 
compared to the Fortasyn diet and slightly, but not significantly, compared to the 
control diet (3.35±0.48 % of Aβ per area for DEU; 5.38±0.2 % of Aβ per area for 
Fortasyn, p=0.028 and 4.98±0.54 % of Aβ per area for control, p=0.060). 
However, these differences were not significant when we considered the whole 
hippocampal area (6.78±0.31 of Aβ per area for control; 5.48±0.6 % for DEU; 
6.59±0.66 % for Fortasyn, p=0.203). In the other analyzed regions of interest, no 
effects of the diets were detected. No significant correlations between Aβ load 
and CBF in the hippocampus, and between Aβ load and hippocampal diffusion 
parameters were found. 
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Brain fatty acids 
The relative amounts of different fatty acids in the lipid fraction of the brain 
homogenates are displayed in Table 2. No significant differences between brain 
fatty acid profiles of APPswe/PS1dE9 transgenic and wildtype mice were noted. In 
mice on DEU and Fortasyn diets the relative amount of n3 fatty acids, including 
DHA, increased compared to the control diet (p<0.001), whereas the relative 
amount of n6, including arachidonic acid, decreased significantly (p<0.001). This 
resulted in a pronounced increase in the n3/n6 ratio in DEU and Fortasyn fed 
mice (p<0.001). 
 
 
 DHA AA SFA MUFA PUFA Σn6 Σn3 n3/n6 
 
Wildtype 
       
Control 15.4±0.2 9.1±0.1 43.2±0.2 18.8±0.2 29±0.1 12.6±0.2 15.9±0.2 1.27 
DEU 17.7±0.8* 6.2±0.2* 42.7±1.3 20.7±1.3 28.2±1 8.76±0.3* 18.9±0.8* 2.16* 
Fortasyn 18.4±0.3* 6.4±0.1* 43.1±0.5 19.3±0.3 28.7±0.3 8.7±0.1* 19.5±0.3* 2.24* 
 
APPswe/PS1dE9 
       
Control 14.7±0.3 9.3±0.1 42.9±0.3 19.3±0.3 29.0±0.2 13.2±0.2 15.3±0.2 1.15 
DEU 18.1±0.2* 6.3±0.0* 43.1±0.4 19.8±0.3 28.2±0.1 8.5±0.1* 19.3±0.1* 2.25* 
Fortasyn 18.1±0.3* 6.6±0.1* 43.9±0.7 19.8±0.3 28.7±0.3 9.0±0.1* 19.2±0.3* 2.13* 
         
Table 2. Relative fatty acid composition expressed in percentage of the lipid fraction of 
brain homogenates in wildtype and APPswe/PS1dE9 on three different diets. DHA = 
docosahexaenoic acid; AA = arachidonic acid; SFA = saturated fatty acids; MUFA = 
monounsaturated fatty acids; PUFA = polyunsaturated fatty acids;  *overall diet effect: 
different from control. p<0.001. No genotype effects were seen.  
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Discussion 
In this study we tested whether a novel combination of nutrients including DHA, 
EPA, phospholipids, UMP, choline, vitamins and antioxidants, which are factors 
for membrane synthesis and maintenance via the Kennedy cycle (Kennedy and 
Weiss 1956), prevents the occurrence of AD pathologies in an AD mouse model. 
We show that the APPswe/PS1dE9 mouse model, which is a model for β-
amyloidosis, displays two of the pathological features that are often found in AD 
patients: a reduced cerebral blood flow, which reflect vascular disturbances, and 
water diffusion abnormalities in several brain regions, which reflect neuronal and 
axonal degeneration. In particular, we show that in these mice specific multi-
nutrient diets are able to enhance cerebral perfusion and to protect against 
neurodegenerative processes in both gray- and white matter.  
 
Perfusion  
Epidemiological studies have shown that cardiovascular disorders and other 
vascular-related diseases that lead to chronically diminished cerebral blood flow 
(CBF) are associated with increased risk of AD (de la Torre, 2002),(de Toledo 
Ferraz Alves, et al., 2010). The CBF is therefore considered to be a good 
biomarker to investigate the development of AD.  
Measurement of CBF in small animals is challenging because of smaller volumes 
of interest and higher blood velocity compared to humans. Most of the 
techniques for measuring CBF in rodents are invasive (e.g. laser-Doppler after 
cranial windowing) or require the injection of a contrast agent (e.g. PET with 
intravenous 15O water, 14C-IAP autoradiography or dynamic susceptibility 
contrast perfusion MRI with gadolinium compounds). In contrast, MRI arterial 
spin labelling (ASL) techniques, whereby arterial blood is magnetically tagged 
before it enters the tissue of interest, are fully non-invasive, as they do not 
require the injection of contrast agents (Calamante, et al., 1999). The feasibility 
of the FAIR-ASL technique for the quantitative assessment of CBF has been 
proven in clinical and pre-clinical studies (Kim, 1995),(Oosterlinck, et al., 2011). 
Particularly in mouse studies, the use of ultra-high magnetic field, strong 
gradients and dedicated coils is required to compensate the relatively low signal-
to-noise ratio (SNR) and to prolong the lifetime of the magnetic labelling (Zheng, 
et al., 2010). In the present study we fulfilled these requirements and we were 
able to acquire high-resolution CBF maps of a mouse brain: the CBF values of 
control wildtype animals resemble those previously published for mice with the 
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same anaesthetic setting (Leithner, et al., 2008,Weidensteiner, et al., 
2009,Zheng, et al., 2010). We demonstrated that 12 months old APPswe/PS1dE9 
mice on control diet suffer from a decreased brain perfusion compared to their 
wild type littermates in all the measured ROIs. The reduced CBF found in these 
mice is of particular interest, as it mirrors the brain hypoperfusion status found in 
the majority of AD patients (Alsop, et al., 2000,Ruitenberg, et al., 2005,Schreiber, 
et al., 2005). A recent study in AD patients confirmed that CBF imaging with MRI 
is a valuable tool to detect functional changes in the prodromal and more 
advanced stages of AD and can be used as a marker for disease severity 
(Binnewijzend, et al., 2013). The absence of a correlation between CBF deficits 
and Aβ plaque burden suggests that Aβ plaque deposition is not the primary 
cause of this vascular impairment. However, still other Aβ species, particularly 
soluble Aβ1-40, may be involved in damaging the vessel walls. This can result both 
in a reduced vasodilation activity, caused by a brain endothelial dysfunction with 
diminished production of NO by endothelial cells (E. Farkas and P.G. Luiten, 
2001,Niwa, et al., 2000,Price, et al., 2001), and in a reduced vessel lumen, caused 
by Aβ accumulation in the blood vessel walls (Shin, et al., 2007).  
In addition to the decreased CBF detected in the APPswe/PS1dE9 mice on control 
diet, our data revealed that the multi-nutrient diets are able to enhance the brain 
perfusion in the transgenic mice. In the APPswe/PS1dE9 mice on DEU and on 
Fortasyn diet we measured an increased blood supply in the cortex and in the 
thalamus, compared to transgenic mice on control diet. It is however important 
to mention that, in the hippocampus, the CBF was instead significantly impaired 
in the APPswe/PS1dE9 mice, independent of diet; this brain region is linked to 
memory and cognitive processes and is among others one of the earliest areas 
affected by AD pathology and amyloid plaque deposition in APPswe/PS1dE9 mice 
(Garcia-Alloza, et al., 2006), as well as in patients (Braak and Braak, 1995). It is 
therefore plausible to conclude that these dietary supplementations have the 
potential to significantly slow the occurrence of brain perfusion failure caused by 
AD pathology development, particularly in an early stage of the pathology, before 
brain damages become too big to be averted. 
We believe this effect is determined by two mechanisms. First, the n-3 
components in the diets might have a beneficial effect on systemic circulation. 
Several clinical trials demonstrated the cardiovascular protective effect of n-3 
LCPUFA diets, which are nowadays recommended for patients with a history of 
cardiovascular disease (Lee, et al., 2008). Omega-3 fatty acids reduce the risk of 
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atherosclerosis through interacting with platelet aggregation and might also 
effectively prevent hypertension, with beneficial effect on perfusion (de Wilde, et 
al., 2002,E. Farkas and P.G.M. Luiten, 2001). Multi-nutrient diets containing n-3 
LCPUFA also ameliorate microvasculature endothelium-dependent vasodilation 
processes and protect from cerebral microcirculatory abnormalities (Morgan, et 
al., 2006), often seen in AD patients (de la Torre, 2004) and in transgenic AD 
mouse models (Meyer, et al., 2008,Zerbi, et al., 2012). Second, the increased CBF 
might indirectly reflect an improved neuronal health in APPswe/PS1dE9 mice on the 
DEU and Fortasyn diets. The functional coupling between regional CBF and local 
glucose metabolism has been largely demonstrated in animal and human studies; 
glucose utilization in turn mainly reflects neuronal pre-synaptic activity (Jueptner 
and Weiller, 1995,Kida and Hyder, 2006). Our CBF data therefore might indicate 
that the DEU and the Fortasyn diets maintained cortical neuronal and synaptic 
health in the APPswe/PS1dE9 mice on a physiological level, possibly by slowing 
down the neurodegenerative processes that occur, instead, in the transgenic 
mice on control diet (Zerbi, et al., 2013). Although not directly measured in this 
study, diets providing specific phospholipid precursors have previously shown 
improvements in the generation of new synaptic connections, such as dendritic 
spine growth, neurite branching, neurite protein synthesis and neuritogenesis 
(Knott, et al., 2006,Pooler, et al., 2005,Sakamoto, et al., 2007). The positive 
correlation found in cortex between CBF and diffusion markers of axonal integrity 
(e.g. FA and λ1) further suggests a dual effect of these diets on both neuronal and 
vascular health. Although the correlation of these two measures do not imply a 
cause-effect mechanism, it reinforces the idea that neuronal and vascular health 
are tidily interdependent and are both affected by the genotype and by the 
dietary intervention. This relationship seems lost in the hippocampus of the 
APPswe/PS1dE9, possible due to the advanced stage of AD pathology in this area. 
 
Diffusion 
Diffusion tensor MRI (DT-MRI) measures the incoherent motion of water 
molecules in every voxel from multiple directions and reconstructs the geometry 
of their diffusion into an ellipsoid (Basser, et al., 1994,Beaulieu, 2002). This 
technique is widely used to study neurological disorders, like AD, because water 
molecule diffusion patterns can reveal details about tissue micro-architecture, 
either normal or in a diseased state, which are not measurable by other imaging 
techniques (Kantarci 2011). In AD patients the changes in DT-MRI parameters are 
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consistent, showing decreased fractional anisotropy (FA) in white matter regions 
and increased mean diffusivity (MD) in gray matter regions (Hanyu, et al., 
1998,Kantarci, 2011,S.-K. Song, et al., 2004b). Interestingly, similar alterations 
have been reported in mouse models for AD (Song, et al., 2005,Sun, et al., 2008). 
These changes have been correlated with loss of myelin, decreased axonal 
density and connectivity in white matter (S.K. Song, et al., 2004,Chen, et al., 
2011) and neuronal loss in gray matter (Sykova, et al., 2005). The results 
obtained here from the APPswe/PS1dE9 mice on control diet are in good 
agreement with these previous findings. In white matter areas of anterior 
commissure (aca), fornix (fo) and splenium of corpus callosum (scc) we found a 
reduced axial diffusivity (λ1) in the transgenic mice compared to wildtype. The 
fimbria (fi) of APPswe/PS1dE9 mice on control diet showed decreased FA and 
increased RD. Decreases in FA and λ1 and increases in RD are typically associated 
with axonal injury and myelin degradation, respectively. Such white matter 
changes would effectively constrain the diffusion of water molecules in the 
direction of the fiber bundle, while increasing the diffusivity perpendicular to it 
(S.-K. Song, et al., 2004a).  
In the APPswe/PS1dE9 mice we also measured a decrease in λ1 in the cortex, which 
is possibly linked to the reduced FA visible in the VBA comparison. Furthermore, 
the VBA highlighted an increased MD in the hippocampus, specifically in the 
dentate gyrus. We previously showed that the APPswe/PS1dE9 mice display several 
differences in gray matter diffusion compared to wildtype; these include a 
significant increase in water diffusivity in the molecular layer of the dentate 
gyrus, which was associated with neuronal loss by visualizing myelin and neurons 
with Klüver-Barrera staining (Zerbi, et al., 2013). Few other studies have been 
published on gray matter diffusion using DT-MRI in AD mice. However, there 
have been a number of human studies that reported increased gray matter MD 
in AD patients, which has been ascribed to neuronal degeneration and cell loss 
(Nakata, et al., 2009). Such changes in tissue structure would lead to less 
hindrance for water to diffuse. There are indications about the increased MD in 
gray matter being a better indicator of disease progression in mild cognitive 
impaired and healthy subjects than hippocampal volumetry (Fellgiebel, et al., 
2004)(Kantarci, et al., 2005). 
The analysis of DT-MRI parameters further revealed that dietary intervention 
interferes with the structural damage occurring in both white and gray matter in 
the transgenic mice. In the fi, the changes in RD and FA measured in the 
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APPswe/PS1dE9 mice on control diet were reverted by both experimental diets. 
Furthermore, compared to the control-fed mice, Fortasyn-fed mice displayed a 
significant reduction of MD and RD in the cortex. The effects of dietary 
intervention in diffusion parameters became even more striking when we applied 
the VBA on the separate diet groups. In the mice on DEU diet we found fewer 
differences between genotypes, although differences in the FA of the cortex 
were still present. In mice on Fortasyn diet, almost all the differences between 
transgenic and non-transgenic animals faded, indicating that Fortasyn reduced 
the impact of the trangenicity. By analyzing the diet effects on both genotypes, 
we confirmed that both the DEU and Fortasyn diets similarly increased the FA in 
the cortex and hippocampus and in other white matter regions, such as the cp 
and fi; the Fortasyn diet also highly reduced the MD in the cortex. Together, 
these data indicate a beneficial effect of the diets, and particularly Fortasyn, in 
preventing axonal and neuronal damage in several brain regions, which are 
otherwise severely compromised in transgenic AD mice. In line with these 
results, another study reported a reduced neocortical neurodegeneration in 6-
month-old wildtype and female APPswe/PS1dE9 mice fed with Fortasyn, observed 
by the Amino Cupric Silver staining (Broersen, et al., 2013). In AD patients, 
electroencephalography (EEG) measures showed that Souvenaid® (Nutricia N.V., 
Zoetermeer, The Netherlands), a medical food containing Fortasyn, have an 
effect on brain functional connectivity, supporting the underlying hypothesis of 
an amelioration of neuronal health and synaptic activity (Scheltens, et al., 2012). 
In the light of our results, future studies on brain diffusion-related parameters 
are suggested to confirm the efficacy of Fortasyn supplementation in a clinical 
setting. 
One explanation for the results found may be linked to the n-3 components in 
the experimental diets, and particularly DHA. Many studies revealed that DHA is 
neuroprotective via multiple mechanisms: by reducing arachidonic acid and its 
metabolites (Oksman, et al., 2006); by increasing neuroprotectin D1, which 
down-regulates pro-apoptotic mediators (Bazan, 2005); by increasing the 
production of brain-derived neurotrophic factor (Rao, et al., 2007) and by 
promoting antioxidant defence (Akbar, et al., 2005). N-3 fatty acids also replace 
n-6 fatty acids and cholesterol from cell membranes increasing fluidity of the 
membrane, enhancing receptor binding and affinity, and improving the function 
of ion channels (Bourre, et al., 1991,Bourre, et al., 1989,Farkas, et al., 2002). It 
has also been shown that DHA supplementation was able to alleviate age-related 
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neurogenesis decreases in the hippocampal areas CA1 and dentate gyrus (Dyall, 
et al., 2010), promoting hippocampal neuronal development and synaptic 
functioning (Cao, et al., 2009). The different outcome of the two diets, 
particularly in cortical diffusion, suggests a better maintenance of cortical 
neuronal health by the Fortasyn diet, possibly determined by the inclusion in this 
diet of additional nutritional components that may synergistically improve 
neuronal protective mechanisms. In this experiment, the DEU and the Fortasyn 
diets were equally effective in raising brain n3 fatty acids levels; however, the 
addition of antioxidants like vitamins B, E and C is suggested to improve the 
neuroprotective effects of DHA(Cole, et al., 2009). Previous studies also showed 
that vitamins and antioxidants are necessary to support the biochemical 
processes involved in the Kennedy cycle for phospholipid synthesis (Kennedy and 
Weiss, 1956,Wurtman, et al., 2009) by increasing the availability of the 
membrane precursors (van Wijk, et al., 2012a,van Wijk, et al., 2012b). 
Taken together, these data seem to confirm our initial hypothesis of a higher 
efficacy, in term of neuronal protection, of a multi-nutrient approach. In line with 
this suggestion, is has been recently shown that Fortasyn protected the central 
cholinergic system against Aβ1-42 toxicity in rats infused with Aβ1-42 (De Wilde, 
Penke, van der beek 2011). This specific nutrient combination also showed 
improved searching behavior and swim efficiency in AβPP/PS1 mice during the 
morris water maze cognitive test (Wiesmann et al., 2013).  
 
Amyloid-β pathology  
Contrarily to our expectations, only the DEU diet reduced the amyloid plaque 
burden in the CA1 hippocampal region, and this was only significant compared to 
the Fortasyn diet. In addition, when considering the whole hippocampus, this 
effect vanished, showing no significant differences between control, DEU and 
Fortasyn diets. Previously, various studies have examined the effects of different 
combination of nutrients and dietary supplementation on brain amyloid in many 
transgenic models for AD, with mixed outcome. In a similar mouse model for AD, 
reduced hippocampal amyloid burden due to the supplementation of DHA have 
been reported, albeit not consistently (Arendash, et al., 2007,Green, et al., 
2007,Perez, et al., 2010,van de Rest, et al., 2009). In a more recent study, 6-
month-old female APPswe/PS1dE9 mice showed significantly lower levels of soluble 
Aβ1-40, Aβ1-42 and plaque load when fed with Fortasyn compared to a control diet 
and compared to a DHA and UMP containing diet (Broersen, et al., 2013). The 
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different outcomes between this and our study may derive from the gender 
difference and the age at which the immunohistological examination is 
performed. In our experiment, male 12-month-old mice were used; at this age, 
severe plaque deposition is already present in the hippocampus, covering 
approximately 6-7% of the total hippocampal area compared to the 0.4-0.5% 
measured by Broersen and colleagues (Broersen, et al., 2013). This difference 
seems to indicate that (1) the effects of DHA on Aβ accumulation/production 
mechanisms depend on its dietary context and (2) a multi-nutrient dietary 
intervention could effectively interact against Aβ production and aggregation 
when the pathology is mild and not yet fully developed. A similar hypothesis has 
been suggested from the Souvenir I clinical trial, which reported the greatest 
effect of Souvenaid in the population of patients with very mild AD (mean 
baseline minimal mental state examination (MMSE) = 25.61 (Scheltens, et al., 
2010). These observations, together with epidemiological data of dietary 
patterns on risk reduction of AD (Mi, et al., 2013), suggest a greater opportunity 
of intervention in the very early stage of AD. Nevertheless, in this study the 
amount of plaques did not correlate with the severity of the diffusion changes, 
nor with the perfusion changes. Taken together, these data suggest that 
nutritional intervention can be effective in reducing AD-related pathology, such 
as enhancing perfusion and neuroprotection, and cognitive function (Wiesmann, 
et al., 2013), without necessarily affecting Aβ plaque levels.  
The data presented here is encouraging for planning future clinical studies; to 
confirm the impact on AD development of these specific Fortasyn-based multi-
nutrient diets, measures of brain perfusion and diffusion, next to standard 
cognitive tests, are strongly recommended. Indeed other variables would require 
special considerations when designing clinical trials with n-3 LCPUFA-including 
supplements; in particular, it would be interesting to study the effects of the 
APOE genotype in relation with dietary intervention. The apolipoprotein E (apoE) 
exerts a key role in the transport of cholesterol and other lipids involved in brain 
composition and functioning (Frieden and Garai, 2012). It has been recently 
suggested that the action of lipid-based diets on AD-risk factors, such as 
atherosclerosis (Minihane, et al., 2000), on the risk of developing dementia 
(Barberger-Gateau, et al., 2011) and the incorporation of n3-LCPUFA from the 
diet might differ according to apoE polymorphism (Samieri, et al., 2013). 
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In conclusion, we showed that specific multi-nutrient diets are able to enhance 
brain perfusion and protect against neuronal structural degeneration in our 
mouse model for AD. These results were independent from the amount of Aβ 
plaque deposits and were more evident particularly on structural integrity 
measures in animals on Fortasyn diet. This is in line with the background 
hypothesis of this study: the supplementation of all the nutrients necessary to 
improve cerebral perfusion and promote neuronal membranes and synapse 
formation, rather than single/few components, seems to be a better strategy to 
protect against progression of AD.  
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Summary 
Alzheimer’s disease (AD) is the leading cause of dementia in human. More than 
35 million people suffered from AD in 2010 worldwide, and this number is 
expected to increase in the coming years. It is therefore of the highest priority to 
find a cure against this disease, or a way to prevent it, before it will become an 
unsustainable social and economic burden. A recent study from the US 
Alzheimer’s Association predicted that by delaying the onset of AD by just 5 
years, the costs for the society related to the disease would decrease 
approximately of 50% (http://www.alz.org/documents_custom/trajectory.pdf). 
This ambitious plan however requires more research (1) on the mechanisms via 
which the pathology origins and progresses, (2) on the development of novel 
biomarkers that can reveal the occurrence of AD in its early stage, and (3) on 
novel therapeutic approaches that could significantly interrupt or delay the 
pathology progress in the majority of AD patients. With the work presented in 
this thesis, we experimentally addressed specific questions related to these three 
research lines.  
 
In the first experimental work, described in chapter 2, we aimed to 
comprehensively characterize the occurrence of vascular impairment in a double 
transgenic mouse model for AD (APPswe/PS1dE9) during aging. As vascular 
disorders can either be cause or consequence in the pathophysiology of AD, it 
was relevant for us to understand how and when these deficits occur in relation 
with amyloid-β (Aβ) accumulation. With this aim, we developed a novel method 
to obtain microvascular relative cerebral blood volume (rCBVmicro) maps from 
gradient echo MR imaging by histogram evaluation and we applied a voxel-wise 
approach to detect rCBVmicro changes at the highest possible spatial resolution 
(0.16 millimeter isotropic). At 8 months of age, a decreased rCBVmicro appeared in 
some cortical regions and in the thalamus, which spread over several sub-cortical 
areas and the hippocampus at 13 months of age. Additionally, we showed that 
hippocampal rCBVmicro in 13-month-old wild type and APPswe/PS1dE9 mice 
correlated strongly with capillary density measured with immunohistochemical 
staining. However, no difference in capillary density could be detected between 
the genotypes, indicating no loss of vessels. The rCBVmicro values showed no 
significant correlation with Aβ plaque deposition, nor with presence of Aβ in 
bloodvessel walls, nor with biochemically measured levels of Aβ1-40, Aβ1-42 
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oligomers and fibrillar forms. These results suggested that rCBVmicro reduction is 
possibly caused by an impaired vasoactivity of capillaries and arterioles, which is 
not directly correlated with the amount of Aβ deposition in parenchyma or 
bloodvessel walls.   
 
In the second experiment (chapter 3), we investigated gray and white matter 
water diffusivity changes in the same APPswe/PS1dE9 mice with diffusion-tensor 
MRI (DT-MRI) at ultra-high field. Changes in DT-MRI parameters are thought to 
reflect structural alterations in neural tissue, and may represent a novel way to 
follow noninvasively the severity of neurodegenerative processes. In this 
experiment, we found substantial changes in water diffusion parallel and 
perpendicular to axonal tracts in several white matter regions like corpus 
callosum and fimbria of the hippocampus in the brains of APPswe/PS1dE9 mice. 
These results matched with previous findings of axonal disconnection and myelin 
degradation in AD patients. Moreover, we found a significant increase in 
diffusivity in specific hippocampal sub-regions, which is supported by neuronal 
loss as visualised with the Klüver-Barrera staining. This work demonstrated the 
potential of ultra-high field DT-MRI as a non-invasive modality to describe white 
and gray matter structural changes in mouse models for neurodegenerative 
disorders. 
 
In the third experiment (chapter 4) we investigated the association between the 
cholesterol-transporter apolipoprotein ε (apoE) genotype and the risk of 
developing neurodegenerative diseases. Recently, brain functional connectivity 
(FC) in apoE-ε4 carriers has been investigated by means of resting-state fMRI, 
showing a marked differentiation in several functional networks at different ages 
compared to carriers of other apoE isoforms. The causes of such hampered FC 
are yet not understood; it is suggested that vascular function and synaptic repair 
processes, which are both impaired in carriers of apoE-ε4, can trigger loss of FC 
during aging. To test this hypothesis, we integrated several different MRI 
techniques and immunohistochemical staining in a translational study using two 
models for atherosclerosis and vascular risk factors in AD: the apoE-ε4 and the 
apoE-ko mice. Compared to wildtype mice, we detected profound FC reduction 
in adult and elderly apoE-ko mice, concomitant with strongly reduced brain 
perfusion. In apoE-ε4 mice perfusion deficits appear only later in life, and not 
significant changes of FC were seen. In both mouse models, water diffusion 
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changes commonly associated to axonal disconnection and disorganization are 
found in hippocampal areas. Reduced post synaptic density levels are also 
measured in the hippocampus in both models, at different ages. In conclusion, 
we provide new evidence of a relation between apoE and brain connectivity, 
possibly mediated by vascular risk factors and by the efficiency of apoE as 
synaptic modulator in the brain. Our results showed that FC assessment by 
resting-state fMRI is an excellent tool to investigate neuropathology and aging 
effects in translational research. 
 
All these three studies mentioned here provided valuable knowledge and the 
necessary tools to investigate novel AD prevention strategies in translational 
research. In the second part of this thesis, we applied these methodologies to 
evaluate the effects of specific nutrient diets as a non-pharmacological way to 
prevent genotype-induced AD traits. In chapter 5, we tested the effects of a 
multi-nutrient diet in apoE-ε4 and the apoE-ko mice as models for AD vascular 
risk factors. This specific multi-nutrient diet was developed to support neuronal 
membrane synthesis (and concomitant synapse synthesis) and was expected to 
contribute to the maintenance of vascular health. At 12 months of age, both 
genotypes showed behavioral changes compared to control mice and we found 
increased neurogenesis in apoE-ko mice. The specific multi-nutrient diet 
decreased anxiety-related behavior in the open field, influenced sterol 
composition in serum and brain tissue, and increased the concentration of 
omega-3 fatty acids in the brain. Furthermore, we found that wild-type and apoE-
ko mice fed this multi-nutrient diet showed locally increased cerebral blood 
volume and decreased hippocampal glutamate levels. Taken together, these data 
suggested that a specific dietary intervention has beneficial effects on early 
pathological consequences of hypercholesterolemia, atherosclerosis and other 
vascular risk factors for AD.  
 
To investigate the effects of nutritional intervention as a strategy to retard the 
development of AD-like features, we tested the effects of two multinutrient diets 
in 12-month-old APPswe/PS1dE9 (chapter 6). We measured cerebral perfusion and 
water diffusivity with MRI at ultra-high field, as alterations in these parameters 
correlate with clinical symptoms of the disease. APPswe/PS1dE9 mice on control 
diet showed decreased cerebral blood flow and changes in water diffusion in 
several brain regions, in accordance to findings of hypoperfusion, axonal 
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disconnection and neuronal loss in AD patients. The multi-nutrient diets were 
able to restore the cerebral blood flow of the APPswe/PS1dE9 mice to wildtype 
levels. Animals on the multi-nutrient diets also showed improved structural 
integrity, particularly in the dentate gyrus and in cortical regions. We concluded 
that that a specific diet intervention has the potential to slow AD progression, by 
simultaneously improving cerebrovascular health and enhancing neuroprotective 
mechanisms. 
Overall, the work presented in this thesis proved the utility of advanced MR 
neuroimaging tools for detecting changes in brain structure and function with 
respect to dietary intervention. 
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Nederlandse samenvatting 
De ziekte van Alzheimer (AD) is de meest voorkomende oorzaak van dementie bij 
de mens. In 2010 leden er meer dan 35 miljoen mensen wereldwijd aan deze 
ziekte, en naar verwachting zal dit aantal toenemen in de komende jaren. Het 
heeft dan ook de hoogste prioriteit om een remedie te vinden tegen AD, of een 
manier om het te voorkomen, voordat het een onhoudbare sociale en 
economische last zal worden. Een recent onderzoek van de US Alzheimer’s 
Association heeft voorspeld dat de kosten voor de samenleving met ongeveer 
50% zou afnemen als de ontwikkeling van AD met slechts 5 jaar kan worden 
uitgesteld (http://www.alz.org/documents_custom/trajectory.pdf). 
Dit ambitieuze plan vergt echter meer onderzoek (1) naar de mechanismen die 
bijdragen aan het ontstaan en het verloop van de pathologie, (2) naar de 
ontwikkeling van nieuwe biomarkers die de ziekte van AD al een in vroeg stadium 
kunnen aantonen, en (3) naar nieuwe therapeutische interventies die het verloop 
van de ziekte aanzienlijk zouden kunnen verstoren of vertragen in de 
meerderheid van de Alzheimer patiënten. In de experimenten beschreven in dit 
proefschrift, hebben we specifieke vragen gesteld met betrekking tot deze drie 
onderzoekslijnen.  
 
De eerste studie, beschreven in hoofdstuk 2, heeft als doel om de vasculaire 
stoornissen tijdens veroudering in kaart te brengen in het dubbele transgene 
muismodel voor AD (APPswe/PS1dE9). Aangezien vasculaire aandoeningen ofwel 
een oorzaak ofwel een gevolg kunnen zijn in de pathofysiologie van AD is het 
relevant om te begrijpen hoe en wanneer deze stoornissen zich voordoen in 
relatie tot de ophoping van amyloid-β (Aβ). Om deze vraag te beantwoorden 
hebben we een nieuwe methode ontwikkeld om microvasculaire relatieve 
cerebrale bloedvolume (rCBVmicro) kaarten te verkrijgen van gradiënt echo MR 
imaging door middel van histogram analyse. Om veranderingen in de rCBVmicro 
met de hoogst mogelijke ruimtelijke resolutie (0.16 millimeter isotroop) te 
kunnen detecteren, hebben we gebruik gemaakt van een voxel-wijze benadering. 
Op de leeftijd van 8 maanden was er een verminderde rCBVmicro waarneembaar 
in bepaalde corticale gebieden in het APPswe/PS1dE9 muismodel. Op de leeftijd van 
13 maanden was de verminderde rCBVmicro verspreid over meerdere subcorticale 
gebieden en de hippocampus. Daarnaast hebben we aangetoond dat de rCBVmicro 
in de hippocampus van 13 maanden oude wild type en APPswe/PS1dE9 muizen 
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sterk correleerde met de capillaire dichtheid, zoals bepaald met een 
immunohistochemische kleuring. Er was echter geen verschil te vinden in de 
capillaire dichtheid tussen de genotypen, wat suggereert dat er geen verlies van 
bloedvaten is opgetreden. De rCBVmicro waarden correleerden niet met de 
dichtheid van Aβ plaques, noch met de aanwezigheid van Aβ in de wanden van 
de bloedvaten, of met de biochemisch gemeten niveaus van Aβ1-40 en Aβ1-42 
oligomeren en fibrillaire vormen. Deze resultaten suggereren dat een afname in 
de rCBVmicro mogelijk wordt veroorzaakt door een verminderde vasoactiviteit van 
haarvaten en arteriolen, dat niet direct gecorreleerd is met de hoeveelheid Aβ 
ophoping in het brein of in de bloedvatwanden.      
 
In het tweede experiment (hoofdstuk 3) onderzochten we veranderingen in de 
water diffusiviteit van de grijze en witte stof in dezelfde APPswe/PS1dE9 muizen 
met diffusie-tensor MRI (DT-MRI). Het wordt gedacht dat veranderingen in DT-
MRI parameters structurele afwijkingen in het hersenweefsel weerspiegelen. DT-
MRI zou daarom een nieuwe, niet-invasieve, manier kunnen bieden om de ernst 
van neurodegeneratieve processen te volgen. In dit experiment vonden we 
substantiële veranderingen in de water diffusiviteit, evenwijdig en loodrecht op 
de axonbanen, in verschillende witte stof gebieden zoals het corpus callosum en 
fimbria van de hippocampus in APPswe/PS1dE9 muizen. Deze resultaten komen 
overeen met eerdere bevindingen van axonale disconnectie en myeline afbraak 
in Alzheimer patiënten. Daarnaast vonden we een significante toename van 
water diffusiviteit in specifieke subgebieden van de hippocampus, wat duidt op 
neuronaal verlies zoals ook gevisualiseerd is met de Klüver-Barrera kleuring. Dit 
werk laat de mogelijkheden zien van DT-MRI bij ultrahoge veldsterkte, om op een 
niet-invasieve manier structurele veranderingen in witte en grijze stof te bepalen 
in muismodellen voor neurodegeneratieve ziekten.  
 
In het derde experiment (hoofdstuk 4) onderzochten we de relatie tussen het 
cholesterol-transporteiwit apolipoproteïne ε (apoE) genotype en het risico op het 
ontwikkelen van neurodegeneratieve aandoeningen. Onlangs is de functionele 
connectiviteit (FC) in het brein van apoE-ε4 dragers onderzocht door middel van 
resting-state fMRI. Hieruit bleek een duidelijke differentiatie in verschillende 
functionele netwerken op verschillende leeftijden in vergelijking met dragers van 
de andere apoE isovormen. De oorzaken van deze belemmerde FC zijn nog niet 
bekend; het wordt gesuggereerd dat vasculaire functie en synaptische 
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herstelprocessen, die beiden verstoord zijn in apoE-ε4 dragers, mogelijk het 
verlies van FC tijdens veroudering kunnen veroorzaken. Om deze hypothese te 
testen hebben we verschillende MRI technieken en een immunohistochemische 
kleuring geïntegreerd in een translationele studie met behulp van twee 
muismodellen voor arteriosclerose en vasculaire risicofactoren in de ziekte van 
Alzheimer: de apoE-ε4 en de apoE-ko muizen. In vergelijking met wildtype 
muizen was er een uitgesproken verminderde FC in volwassen en oudere apoE-
ko muizen, alsmede een sterk verminderde hersendoorbloeding. In apoE-ε4 
muizen verschenen stoornissen in de doorbloeding pas op latere leeftijd, en 
waren er niet-significante veranderingen in FC waarneembaar. In beide 
muismodellen werden er veranderingen in water diffusiviteit, die vaak 
geassocieerd worden met axonale disconnectie en desorganisatie, gevonden in 
subgebieden van de hippocampus. Beide muismodellen hadden ook een 
verminderde postsynaptische dichtheid in de hippocampus, op verschillende 
leeftijden. Concluderend, wij lieten nieuwe bewijzen zien van een relatie tussen 
apoE en breinconnectiviteit, wat mogelijk gemedieerd wordt door vasculaire 
risicofactoren en de efficiëntie van apoE als synaptische modulator in het brein. 
Onze resultaten toonden aan dat FC bepaling met behulp van resting-state fMRI 
een uitstekend hulpmiddel is om het effect van neuropathologie en veroudering 
te onderzoeken in translationele studies.  
 
Alle drie experimenten die hierboven zijn genoemd verstrekten waardevolle 
kennis en de benodigde tools om nieuwe preventiestrategieën tegen AD te 
kunnen onderzoeken in translationele studies. In het tweede deel van dit 
proefschrift hebben we deze methodieken toegepast om de effecten van 
specifieke diëten te evalueren, om op een niet-farmacologische manier de 
genotype-geïnduceerde kenmerken van AD te voorkomen. In hoofdstuk 5 
hebben we de effecten van een multi-nutriënt dieet getest in de apoE-ε4 en 
apoE-ko muizen, als modellen voor vasculaire risicofactoren in AD. Het specifieke 
multi-nutriënt dieet was ontwikkeld om de neuronale membraan aanmaak te 
ondersteunen (alsmede de aanmaak van synapsen), en ook werd verwacht dat 
dit dieet bij zou kunnen dragen aan het in stand houden van de vasculaire 
gezondheid. Op de leeftijd van 12 maanden vertoonden beide genotypen 
gedragsveranderingen in vergelijking met controle muizen, en we vonden 
verhoogde neurogenese in de apoE-ko muizen. Het specifieke multi-nutriënt 
dieet verminderde angst-gerelateerd gedrag in het open veld, beïnvloedde de 
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samenstelling van sterolen in het serum en in het brein, en verhoogde de 
concentratie van omega-3 vetzuren in de hersenen. Verder toonden we aan dat 
het specifieke multi-nutriënt dieet zorgde voor een lokaal verhoogde cerebrale 
bloedvolume en verminderde hippocampale glutamaat niveaus in wild-type en 
apoE-ko muizen. Samengevat, deze data suggereren dat deze specifieke 
dieetinterventie gunstige effecten heeft op de vroege pathologische gevolgen 
van hypercholesterolemie, atherosclerose en andere vasculaire risicofactoren 
voor AD.   
 
Om de effecten van voedingsinterventie te onderzoeken als een strategie om de 
ontwikkeling van AD-achtige kenmerken te vertragen, hebben we twee multi-
nutriënt diëten getest in 12 maanden oude APPswe/PS1dE9 muizen (hoofdstuk 6). 
We hebben de cerebrale perfusie en de water diffusiviteit gemeten met behulp 
van MRI bij ultrahoge veldsterkte, aangezien veranderingen in deze parameters 
correleren met klinische symptomen van de ziekte. In overeenstemming met de 
bevindingen van hypoperfusie, axonale disconnectie en neuronaal verlies in 
Alzheimer patiënten, lieten APPswe/PS1dE9 muizen op een controle dieet een 
verminderde cerebrale doorbloeding zien, alsmede veranderingen in de water 
diffusiviteit in verschillende hersengebieden. De multi-nutriënt diëten waren in 
staat om de hersendoorbloeding van APPswe/PS1dE9 muizen te herstellen tot het 
niveau van wildtype muizen. Dieren op de multi-nutriënt diëten lieten ook een 
verbeterde structurele integriteit zien, met name in de gyrus dentatus en in 
corticale gebieden. We concludeerden dat een specifieke dieetinterventie de 
mogelijkheid heeft om het verloop van de ziekte van Alzheimer te vertragen, 
door tegelijkertijd de cerebrovasculaire gezondheid te verbeteren en 
neuroprotectieve mechanismen te stimuleren.  
In conclusie, het werk beschreven in dit proefschrift toont het nut aan van 
geavanceerde MR neuroimaging technieken voor het detecteren van 
veranderingen in hersenstructuur en breinfunctie met betrekking tot 
dieetinterventie.        
 
 
 
 
 
 
Summary – Nederlandse samenvatting 
________________________________________________________________________ 
189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
________________________________________________________________________ 
190 
 
 
 
 
 
 
 
 
  
 
8 
General discussion  
and concluding remarks 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8 
________________________________________________________________________ 
192 
 
 
General discussion and concluding remarks 
________________________________________________________________________ 
193 
 
 
The role of preclinical research in AD. Challenges and limitations 
Identification of novel imaging biomarkers of Alzheimer’s disease (AD) is crucial 
for an early and accurate diagnosis of the disorder. The need for developing 
imaging techniques is pressing, and it is easy to foresee that in the near future 
neuroimaging methods would allow monitoring disease progression and 
distinguishing purely symptomatic treatments from disease-modifying therapies. 
However, while some AD markers are based on direct imaging of pathological 
hallmarks, such as Aβ plaque imaging with PET, many others are surrogate 
biomarkers that identify changes in brain structure and function. For a definite 
diagnosis and to expand the knowledge on AD-related changes, it is therefore of 
the highest importance: (1) to fully understand the biological basis of the 
changes reflected by surrogate biomarkers; (2) to determine the time-course in 
which these pathological events occur and study their interrelationship.  
Preclinical research, mainly based on the use of transgenic mouse models of AD, 
is an emerging field that may have the potential to answer all these questions. 
The use of animal models, specifically developed to homogenously reproduce AD 
brain lesions, allows studying the relationship between a biomarker and its 
biological value, circumventing biases and limitations of human studies. 
Detecting and quantifying the AD pathological processes in the rodent brain 
might be viewed as a challenge, because the mouse brain is approximately 3000-
fold smaller than the human brain. The use of high-field MRI has nevertheless 
allowed to bypass these technical limits and increases the possibilities to discover 
and validate biomarkers of the disease in preclinical research.  
There are, however, other obstacles to overcome in achieving this goal, both 
technical and scientific; for example, while most of the human MRI systems 
operate at 1.5 or 3 Tesla, in small animal MR scanners, the field strength can vary 
from 4.7 to 11.7 Tesla or higher. Although the higher field strength clearly results 
in a higher signal-to-noise ratio, which enables higher resolution acquisition, a 
large variety of artefacts and limitations related to the specific absorption rate 
represent significant challenges in these experiments (Bernstein, et al., 2006). 
Among them, chemical shift- and susceptibility-related artefacts are especially 
common at high field strengths and need to be considered. The broad field 
strength range in the animal systems also involve different relaxation times T1, T2 
and T2
*; this makes the comparison of the results obtained in different 
laboratories more difficult, and limits the reproducibility and the translational 
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aspect of the research. Furthermore, in animal research different types of 
anaesthesia are used, which must be properly chosen and calibrated to the 
specific requirements posed by the animal and the experiment, avoiding 
interference with biological processes (Lukasik and Gillies, 2003); this is especially 
true for cerebral blood flow/blood volume and fMRI studies (Kannurpatti and 
Biswal, 2004). Finally, due to the relatively novelty of high-field small animal 
imaging, translational research still lack a standardized platform to process 
mouse neuroimaging data, and most of the methods described in the literature 
are developed in-house and often difficult to replicate.    
Besides these technical limitations, during the development of the work 
presented in this thesis, we encountered also several biomedical challenges. The 
strongest limitation was the difficulty in comparing our results with other studies 
in different mouse strains. Currently, many mouse models for familial AD, mainly 
expressing familial mutations of the human amyloid precursor protein (APP) and 
presenilins (PS1 or/and PS2), have been proposed (Braidy, et al., 2012); each of 
these models exhibit some of the key aspects of the disease, such as amyloid 
plaques deposition, deficits in cognitive tasks, and abnormal cerebral metabolism 
(Higgins and Jacobsen, 2003,Hsiao, et al., 1996). However, in most of the cases 
these models vary between each other in severity and type of pathology that 
they express, and also differ in the age in which they develop traits of AD. In 
addition, the information gained from models of familial genetic forms of AD may 
not translate to sporadic (or late onset) forms of the disease, the latter of which 
comprises more than 90% of the cases (Hoyer, 2000,Mattson, 2004). In fact, the 
only way to study sporadic AD is to use animal models that mimic one or more of 
the risk factors. All these limitations must be taken into account when designing 
an experiment, when drawing conclusions about the clinical relevance of the 
results obtained, and when comparing the findings with other models.  
To overcome these limitations, some possible routes should be followed: one is 
to convince the scientific community to standardize as much as possible the 
experimental conditions and the use of animal models in their studies. Ideally, 
this would require imposing the same housing/living condition of the animals and 
limiting the number of mouse models used in AD research to one or two strains. 
This last option however is at the moment a too strong limiting factor, since none 
of the existing transgenic models of AD fully recapitulate all of the pathological 
features and behavioural changes found in human patients (see however (Braidy, 
et al., 2012)). Alternatively, it is desirable to exert longitudinal studies with a 
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multi-modality approach, including different MR imaging techniques, to 
characterize the development of the pathology in the selected model in relation 
with its specific mutations as good as possible. It is therefore important to 
develop state-of-the-art methodologies for the acquisition and processing of 
mouse MR neuroimaging datasets, providing all the information needed to be 
used by multiple centres and in different mouse models. These protocols need to 
respect certain criteria of data quality, and must prove their usefulness to 
identify macroscopic/microscopic lesions in these species, as well as functional 
alterations reminiscent of AD pathology. The assessment of these protocols is 
one of the aims of the work presented in this thesis. 
In the first part of this thesis (chapter 2-3-4) we developed and optimized 
methodologies to characterize changes in brain structure and function in animal 
models for familial AD (APPswe/PS1de9) and for risk factors for both vascular 
disorders and AD (apoE4 and apoE-ko). Four MRI methods that are commonly 
used in human studies for the detection of relevant surrogate biomarkers of AD 
are discussed: (1) the assessment of whole-brain cerebral blood volume, with an 
approach that enhances the sensitivity of the measure towards the microvascular 
compartment. (2) the assessment of a fast and high-resolution diffusion tensor 
imaging of the whole brain, that includes a robust tensor estimation and 
automatic artefact corrections. The use of an arterial spin labelling technique to 
measure cerebral blood flow and (4) the assessment of resting-state functional 
connectivity measurements in mice. Each of these techniques was designed to 
require no more than 20-30 minutes for the acquisition, making it possible to 
combine all these different imaging modalities in a single MR session. The 
amount of information acquired could then provide the basis both for studying 
the biological cause of structural and functional brain changes in relation with AD 
and for evaluating the efficiency of future treatment strategies for AD and other 
neurodegenerative disorders.  
 
 
Vascular disorders in AD: cause or consequence? 
There is now overwhelming evidence, also from studies presented in this thesis, 
that vascular disease plays an important role in the development of late-life 
cognitive dysfunction and dementia. But when exactly do vascular impairments 
occur in different mouse models, and to what extent are they related to other 
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pathological hallmarks of the disease? And how do they influence the 
progression of the pathology?  
To answer these questions it was necessary to perform longitudinal studies in 
different mouse strains. First, we used the APPswe/PS1de9 mice as a model of brain 
amyloidosis and familial AD, to study the effects of amyloid-β on the vascular 
system (chapter 2 – 6). In this thesis, we demonstrated that APP and PS1 
mutations cause microvascular cerebral blood volume reduction in cortical 
regions and in the thalamus starting at 8 months of age. These deficits in the 
vasculature spread over several sub-cortical areas and the hippocampus at 13 
months of age (chapter 2); at this age, a strong reduction in cerebral perfusion 
was also detected (chapter 6). The reduced CBV and CBF found in these mice is 
of particular interest, as it mirrors the brain hypoperfusion status found in the 
majority of AD patients (Alsop, et al., 2000), (Ruitenberg, et al., 2005,Schreiber, 
et al., 2005). Importantly, these vascular impairments did not correlate with the 
amount of Aβ plaques in the parenchyma nor in the blood vessel walls. We 
therefore hypothesise that these vascular deficits are caused by other Aβ 
species, which may be involved in damaging the structure and the function of 
vessel walls. In agreement with these findings, it has been shown that soluble 
Aβ1-40 can reduce capillary vasodilation activity, caused by a brain endothelial 
dysfunction with diminished production of NO by endothelial cells (Farkas and 
Luiten, 2001,Niwa, et al., 2000,Price, et al., 2001).  
Because of the strong association between perfusion deficits and cognitive 
impairments, we believe that once these cerebrovascular deficits are triggered, 
the whole pathology aggravates. Following the “vascular hypothesis” cascade by 
de la Torre, such a decrease in cerebral perfusion could lead to increased 
oxidative stress and decreased energy metabolism (de la Torre, 2000b). All these 
events consequently contribute to a vicious circle of the progression of 
neurodegenerative traits typical of AD, such as synaptic loss, increased Aβ and 
NFTs production, increased brain inflammation, brain tissue atrophy and 
cognitive decline (de la Torre, 2000a,de la Torre, 2000c,de la Torre and Stefano, 
2000). Following this interpretation of the results, it is also interesting to include 
in this discussion the correlation found in 12-month-old APPswe/PS1de9 mice 
between hippocampal CBF and diffusion anisotropy measure with DT-MRI 
(chapter 6). The correlation of these two measures reinforces the idea that 
neuronal and vascular health are tidily interdependent. The relevance of this 
dependency is clearly supported by the findings illustrated in chapter 3, where 
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we showed that diffusion parameters changes in these mice reflect neuronal loss 
and damage of the brain tissue at microstructural level.  
 
We then addressed the question “how vascular risk factors can influence the 
development of pathological traits of late-onset AD?”. To this end, we used 
target-replacement apoE-ε4 and apoE-ko mice as models of respectively 
hypercholesterolemia and atherosclerosis. In these mice, we measured CBV and 
CBF in relation to functional connectivity, brain tissue microstructure, behaviour, 
cognition and neuropathology (chapter 3 – 4). 
In the apoE-ε4 mice the results obtained were mixed; we showed no CBV and 
CBF deficits in adult mice (12-month-old), while a reduced cortical and thalamic 
perfusion was found only in older animals (18-month-old). These findings are in 
agreement with human studies in apoE-ε4 subjects, showing a fast decline of 
regional CBF during aging (Wierenga, et al., 2013). These perfusion deficits are 
hence suggested to contribute to the increased risk of developing AD. However, 
no consistent results were found from behavioural and cognitive tests in our 
experiments, nor could we detect significant differences in functional 
connectivity, compared to wildtype mice. Overall, these results indicate that 
cerebrovascular impairments in apoE-ε4 mice occur before other AD-like 
pathological changes become evident, and might trigger brain dysfunction only in 
a later stage, as the pathology progresses. To validate this hypothesis, studies in 
older apoE-ε4 mice are required; the use of very old mice (> 18 months of age), 
however, could introduce biases in the results due to aging-related pathologies, 
making more complex to study the effect of vascular risk factor with this model. 
In the apoE-ko model, we found as expected the strongest vascular pathology, 
specifically manifested as decreased cortical perfusion in both adult (12-month-
old) and old mice (18-month-old) (chapter 4). These deficits are likely to be 
caused by atherosclerosis, aortic aneurysm and endothelial dysfunction that 
these mice spontaneously develop from 3 months of age (Crauwels, et al., 
2003,Trollope, et al., 2011). Simultaneously to cerebrovascular hypoperfusion, 
we detected: increased anxiety, increased serum cholesterol, reduced post-
synaptic density and reduced functional connectivity in apoE-ko mice; all factors 
attributable to AD-like pathology progression. Interestingly, we also noted a 
relative increase in synaptic density in old apoE-ko mice, which may reflect a 
compensatory mechanism in response to early functional synaptic failure or brain 
insults, such as stroke, ischemia, or the measured hypoperfusion (Arendt, 
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2001,Jansen, et al., 2012,Jin, et al., 2004,Li, et al., 2010,Mu and Gage, 
2011,Wang, et al., 2008). This also accords with the enhanced neurogenesis 
shown in apoE-ko mice as described in chapter 5. 
In conclusion, the work presented in this thesis fully supports the idea that 
vascular defects are both cause and consequence of AD pathology. The evidence 
that this thesis provides implicate that AD prevention should focus more on 
keeping hemodynamic parameters in a physiological range. Alterations in these 
parameters should be properly evaluated for the diagnosis of the disease, 
following-up its progression and for assessing the effects of disease-modifier 
therapies. 
 
 
Dietary intervention as therapeutic approaches against AD  
There is increasing recognition that neuroimaging tools should also be 
implemented in studies towards the development of new therapeutic 
approaches. In the second part of this thesis (chapter 5 - 6), we assessed brain 
structure and function with MRI to investigate the effects of nutrition as a 
preventive strategy against AD. 
In the current literature, a mismatch exists between epidemiological data on the 
role of nutrition in AD and the lack of clinical efficacy in nutritional intervention 
studies (reviewed in (de Wilde, et al., 2011)). Several reasons behind these 
inconclusive results may be hypothesised; first, despite the potential utility of 
imaging techniques in monitoring treatment effects, most of the clinical studies 
on nutritional intervention in AD still rely on cognitive measurements as the only 
outcome. Hence, further investigation is warranted to confirm whether 
nutritional approaches impact on other surrogate biomarkers of the disease, 
such as cerebral perfusion, functional connectivity and tissue microstructure. 
These findings would then possibly help the physicians to understand the 
mechanisms of action of the diets, and help them to determine which patient 
can best benefit from the dietary intervention. Second, most of these studies 
were performed in patients with a diagnosis of MCI or AD; in the latter group, 
patients are often in an advanced stage of neurodegeneration, and therefore less 
resilient to therapies. Also, the definite neuropathological confirmation of MCI 
and early AD diagnosis in the patients is very difficult to obtain in these 
populations. Third, the interventions consisted in most of the cases of single 
nutrient supplementation added to their normal diet; because of the 
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concomitant presence of multiple phenotypic traits in AD, it is unlikely that one 
single nutrient can have beneficial effects on all the different aspects of the 
disease. 
In this thesis we tried to overcome these issues by employing a range of different 
MR imaging methods and neuropathological investigations on APPswe/PS1de9 
(chapter 6), apoE-ε4 and apoE-ko mice (chapter 5) to evaluate the efficacy of 
several diets. We fed these mice with multi-nutrient diets specifically designed to 
synergistically enhance the synthesis of synaptic membranes (Kamphuis and 
Scheltens, 2010) throughout their life. Some of the components in these diets, 
such as omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA), have also 
been shown to improve vascular health (Lee, et al., 2008). We therefore 
hypothesised that these nutrient combinations have the potential to slow AD 
progression, by simultaneously improving cerebrovascular health and enhancing 
neuroprotective mechanisms. A similar diet composition has been supplied in 
mild AD patients in two randomized controlled clinical trials, showing 
improvements in the delayed verbal recall task and better cognitive performance 
(Cummings, 2012,Scheltens, et al., 2010,Scheltens, et al., 2012). One of the goals 
of our studies was to confirm their efficacy by using advanced imaging 
biomarkers and provide evidence of the mechanisms by which these dietary 
nutrients influence the pathophysiology of AD. 
In agreement with our hypothesis, we showed that these multi-nutrient diets 
were able to significantly enhance the cortical and thalamic brain perfusion in 12-
month-old APPswe/PS1dE9 transgenic mice (chapter 6). In addition, the brain 
diffusion changes found in this strain, which have been correlated with loss of 
myelin, decreased axonal density and connectivity in white matter (Song, et al., 
2004),(Chen, et al., 2011) and neuronal loss in gray matter (Sykova, et al., 2005), 
were diminished in the mice fed with the multi-nutrient diet. Overall, the data 
presented strongly suggest an effect of the diets in maintaining both vascular and 
neuronal health in the APPswe/PS1dE9 mice onto physiological levels, possibly by 
slowing down the neurodegenerative processes compared to the transgenic mice 
on control diet (Zerbi, et al., 2013). These effects may explain the behavior and 
cognitive improvements found in APPswe/PS1dE9 on the similar multi-nutrient diet 
composition (Hooijmans, et al., 2009,Wiesmann, et al., 2013).  
Some promising effects of these multi-nutrient diets are also shown in mouse 
models for vascular risk factors in AD (chapter 5). In 12-month-old apoE4 and 
apoE-ko mice this combination of nutrients decreased anxiety-related behavior, 
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partly reduced total cholesterol levels, and increased the concentration of 
omega-3 fatty acids in the brain. Furthermore, we found that wildtype and apoE-
ko mice fed this multi-nutrient diet showed locally increased cerebral blood 
volume and decreased hippocampal glutamate levels. Based on these results, we 
suggest that a specific dietary intervention is able to alleviate early pathological 
consequences of hypercholesterolemia and vascular risk factors for AD. 
Overall, the work presented in this thesis demonstrated the utility of advanced 
MR neuroimaging tools for detecting changes in brain structure and function 
with respect to dietary intervention. Furthermore, we also revealed novel 
important mechanisms by which these diets may affect AD onset and 
development; up till now, the beneficial effect of these diets was suggested to 
derive from an increased production of phospholipids to sustain synaptic genesis 
and repair processes (Wurtman, et al., 2009,Wurtman, et al., 2006). In our 
studies, we show that the strongest and most consistent effect of these diets 
involved the amelioration of cerebrovascular health. Based on previous 
experiments in our lab and from literature, we associated this effect with the 
presence of omega-3 fatty acids and the B-vitamins in these diets (Hooijmans, et 
al., 2009,Lecerf, 2009). In our last experiment (chapter 6), we proved that these 
two protective mechanisms on vascular and neuronal health (revealed by 
diffusion) are both enhanced by the diets, and may positively influence each 
other. Although decreased cerebral perfusion has been recognized as an early 
and important contributor to AD pathology and cognitive decline (Altman and 
Rutledge, 2010), we believe that this aspect is not sufficiently considered in 
human nutritional intervention studies. To ultimately prove the translational 
aspect of this research, we therefore encourage physicians to include perfusion 
(and diffusion) MRI analysis in future human clinical studies. Indeed, in all our 
experiment the diets were supplemented before the pathology is documented – 
for each mouse model – and throughout the life of the animals; it would be 
interesting for future studies to understand whether a short period of 
supplementation would have similar effects. In this way, one can prove if these 
multinutrient diets should better be recommended to normal subjects as 
preventive strategy against AD development, or also to patients as an effective 
treatment. 
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Concluding remarks: towards understanding the biological underpinnings of AD’s 
biomarkers.  
The uncovering of biomarkers for AD has dramatically increased the 
opportunities for a more effective diagnosis of the pathology, and for targeting 
therapeutics to patients who require them and who can best benefit from them. 
In this thesis we demonstrated some potential translational applications of these 
biomarkers, which could be applied to human studies. There are, however, many 
obstacles to overcome in achieving this purpose. The effectiveness of 
translational research is seriously limited by many factors. Some of these 
challenges are scientific, requiring standardization of the protocols for acquisition 
and processing, and a detailed characterization of the pathological changes of 
the animal models used. Also, more knowledge and validation of the biological 
basis of changes in surrogate biomarkers is needed. One example is the 
interpretation of the diffusion tensor imaging alterations. Despite that the 
technique is now widely used as well in the clinic, little is known about the 
neuroanatomical implication of the changes in water diffusivity; in most of the 
cases, many different interpretations of the results are at one’s disposal. With 
the unique possibilities offered by animal research, we tried to clarify the 
meaning of diffusion changes in AD by comparing MR results with 
immunohistochemical stainings. In this way, we were able to successfully 
correlate the increased hippocampal diffusivity found in our APP/PS1 mice, which 
well-resemble the findings in patients, with neurodegenerative processes in the 
granulate layer of the dentate gyrus (chapter 3). This result represents a real 
novelty of the study, but further investigations are possible; for instance, the 
exact origin of diffusion defects in the white matter is still uncertain: highly 
hydrophobic amyloid-β deposits might cause constraints on water diffusion but 
these defects might also come from loss of myelin or alterations in the fiber 
microstructure. It would be very valuable to characterize the white matter 
pathology in a future study with a multi-modal imaging approach; for example, 
by combining DT-MRI imaging with multi-photon microscopy, we could aim to 
test the hypothesis that changes in white matter water diffusion detectable with 
MRI represent and correlate with microstructural axonal disorganization and 
myelin loss(Farrar, et al., 2011). Resting-state fMRI is another increasingly used 
neuroimaging tool to measure brain function. The growing interest generated on 
this topic is reflected by the marked rise of publications in recent years. 
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Nevertheless, these measures ironically suffer from a lack of insight into their 
biological meaning. Trying to fill this gap, we assessed in this thesis resting-state 
functional connectivity (FC) in aging wildtype, apoE-ε4 and apoE-ko mice. Thanks 
to the advantages offered by animal research with respect to human studies, we 
were able to relate those changes with results from perfusion, diffusion and 
synaptic density measurements. We foresee that this study represents just the 
beginning of a new era in preclinical research, in which the use of multi modality 
approaches will expand the knowledge about how and why FC changes occur. 
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List of abbreviations 
 
AA    arachidonic acid  
Aβ    amyloid-β  
aca    anterior commissure 
ACg    anterior cingulate gyrus  
AD    Alzheimer’s disease  
apoE    apolipoprotein E  
AβPP    amyloid-β precursor protein  
BBB    blood brain barrier  
bcc    body of corpus callosum 
BOLD    blood oxygen level dependent 
CA1    cornu ammonis 1  
CA3    cornu ammonis 3  
CAA    cerebral amyloid angiopathy  
CATCH  critically attained threshold of cerebral 
hypoperfusion  
CBF    cerebral blood flow  
CBV    cerebral blood volume  
CNS    central nervous system  
CO    control diet  
cp    cerebral peduncle 
CRLB    Cramér-Rao lower bounds  
DG    dentate gyrus  
DHA    docosahexaenoic acid 
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DEU  multi-nutrient diet enriched with 
docosahexaenoic acid, eicosapentaenoic 
acid, and uridine monophosphate  
DT-MRI  diffusion tensor magnetic resonance 
imaging 
ec    external capsule 
ELISA    enzyme-linked immunosorbent assay  
EPA    eicosapentaenoic acid  
EPI     echo planar imaging 
FA   fractional anisotropy 
FAs    fatty acids  
FAD    familial Alzheimer’s disease  
FAIR   flow-sensitive alternating inversion 
recovery 
FC*   functional connectivity ( *chapter 4 ) 
FC  Fortasyn® Connect multi-nutrient diet 
enriched with docosahexaenoic acid, 
eicosapentaenoic acid, uridine 
monophosphate, phospholipids, choline, 
folic acid, vitamins B6, B12, C, E and 
selenium  
fi     fimbria of the hippocampus 
FID    free induction decay  
fo    fornix 
FOV     field of view 
gcc     genu of corpus callosum 
GE     Gradient Echo 
Abbreviations 
________________________________________________________________________ 
209 
 
GLUT-1    glucose transporter type 1  
IHC   immunohistochemistry  
IML  inner molecular layer (of the dentate 
gyrus)  
λ1     axial diffusivity 
lc-PUFAs    long-chain polyunsaturated fatty acids  
MCI    mild cognitive impairment  
mI    myo-Inositol  
MRI    magnetic resonance imaging  
(1H) MRS   proton magnetic resonance spectroscopy 
MD     mean diffusivity 
MUFA    mono unsaturated fatty acids  
MWM    Morris water maze  
n3    omega-3 fatty acids  
n6    omega-6 fatty acids  
NFTs    neurofibrillary tangles  
n.s.    not significant  
OA    oleic acid  
OF    open field  
OML  outer molecular layer (of the dentate 
gyrus)  
PBS    phosphate buffered saline  
PET    positron emission tomography  
PLA    prelimbic area  
PS1    presenilin 1  
PS2    presenilin 2  
PUFA    poly unsaturated fatty acids  
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rMWM    reverse Morris water maze  
RD    radial diffusivity 
ROI    region of interest  
rsfMRI   resting-state functional magnetic 
resonance imaging 
SAD    sporadic Alzheimer’s disease  
scc     splenium of corpus callosum 
SE   Spin Echo 
SFA    saturated fatty acids  
SIPBs  synaptophysin-immunoreactive 
presynaptic boutons  
SL    stratum lucidum (of the CA3 area)  
SPECT  single-photon emission computed 
tomography  
SR    stratum radiatum (of the CA1 area)  
STEAM    stimulated echo acquisition mode  
TE   echo time 
TI   inversion time 
TR     repetition time 
UMP    uridine monophosphate  
USPIO    ultra small particles of iron oxide  
VAPOR  variable pulse power and optimized 
relaxation delays. 
VBA     voxel-based analysis 
WT     wild type 
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“If our brains were simple enough for us to understand them, we'd be so simple 
that we couldn't.”  
- Ian Stewart, The Collapse of Chaos: Discovering Simplicity in a Complex World 
 
The first time I read this phrase, from Ian Stewart, I was fascinated by the 
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